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INTRODUCTION
Coronary artery disease (CAD) remains the principal cause of death despite
reductions in CAD mortality that have been observed over the past decades in
developed countries (McGovern et al., 2001; Rosamond ct al., 1998). Declining
rates of first and recurrent acute myocardial infarction (AMI) seem one of the
factors contribunng to the decreasing trend in CAD mortality (Tunstall Pedoe et
al., 1999), which is probably the result of both primary and secondary prevention
strategies such as improved medical treatment. Average overall in-hospital
mortality after AMI decreased from 29"» during the 1960s to 21% during the
1970s and to 16% during the 1980s (Widdershoven & De Vrcedc Swagetnakers,
1997). In-hospital mortality further decreased to 10% in 1988, and remained the
same in 1994 despite further aging of the population. The impact of medication on
the decline in CAD mortality has been described as being substantial (I lunink et
al., 1997).
The positive impact of medication regimens on preventing or postponing
recurrent coronary events should not in any way be trivialized. Drugs, however,
may exert annoying side effects, which may decrease patients' quality of life, or
even restrain patients from complying with prescribed medication regimens. A
second approach to the reduction of CAD risk factors is by means of interventions
aimed at behavior modification. After all, many of the risk factors for (.AD arc
either directly or indirectly related to lifestyle. For example, smoking, elevated
serum cholesterol levels, high blood pressure, obesity and lack of physical exercise
are established CAD risk factors. Psychological factors, such as hostility, vital
exhaustion and depression have been found to exert elevated risk as well (I'rasurc-
Smith, I^sperance, & Talajic, 1995; Kop, Appels, Mendes de I>eon, de Swart, &
Bar, 1994; Miller, Smith, Turner, Guijarro, & Hallct, 1996). Moreover, multiple risk
factors often act in a complex and synergetic way.
In the past, several trials have been conducted to bring about behavior change in
coronary patients in order to reduce subsequent risk of a recurrent event. A mcta-
analysis suggested that health education and stress management programs for
coronary patients yielded a significant reduction in mortality and recurrence of
myocardial infarction (Dusseldorp, Van Klderen, Maes, Mculman, & Kraaij, 1999).
Moreover, these positive effects were moderated by significant favorable changes
in risk factors.
During the past decades, several studies were conducted that intended to improve
risk factors in CAD patients. Some of these studies, which evaluated long-term
comprehensive interventions, reported promising results concerning reduced risk
factors and even cardiac mortality. Although the study is restricted by
methodological shortcomings since the patient's informed consent was asked after
randomization had been performed - leading to a clear selection bias - the Lifestyle
Heart Trial reported substantial positive effects on cholesterol levels after a long-
term behavioral intervention, with subsequent positive changes in atherosclerotic
lesions (Ornish et al., 1990). In the Recurrent Coronary Prevention Project
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(RCPP), a long-term intervention brought about significant reduction of type A
behavior after 1 year and 4,5 years of follow-up, and this was found to be related
to fewer cardiac recurrences (Friedman et al., 1986). In the RCPP, CAD patients in
the intervention group received 62 type A group-counseling sessions of 90 minutes
duration during 4,5 years, of which 20 sessions were offered during the first year.
A study by Hurell ct. al (Project New life) supported the idea that reduction of
type A behavior can be achieved in AMI patients, after 35 90-minute sessions
spread over 1 year (Burell et al., 1994). Reduction in type A behavior was
associated with reduced cardiac morbidity and mortality in CABG patients, after
17 thrcc-hr group sessions held over 1 year followed by 5-6 booster sessions
during each of years 2-3 (Burell, 1996).
These results induced us to develop a more concise (8 weekly 2,5-hr sessions
followed by 3 booster sessions) intervention that was based on the most salient
and promising trials of the past decades, i.e. the RCPP, the Lifestyle Heart Trial,
and Project New life. The RCPP had been conducted in order to study the
feasibility of altering type A behavior after AMI. The treatment program in the
RCPP was based on an expanded cognitive social learning model, and
conceptualization of type A behavior and hostility considered cognitive factors,
behavioral factors, physiologic factors and environmental factors. Treatment in the
cognitive area consisted ot self-instructional training, evaluation of basic
cognitions, and mental relaxation. Behavioral treatment included behavioral drills
to alter physical activities characteristic of type A behavior. In the environmental
area, features of the patients' social environment were evaluated, whereas in the
physiologic aspect of the treatment program patients were informed about
biochemical processes in stress reactions. Project New Ijfe was a behavioral
secondary prevention program aimed at modifying type A behavior in CABG
patients. The interventions used in Project New life were patterned after the
RCPP. The lifestyle Heart Trial evaluated a comprehensive lifestyle program for
patients with CAD, which included a low-fat vegetarian diet (10% of calories as
tat), moderate aerobic exercise, stress management training, smoking cessation and
group support.
The intervention we developed was primarily based on the methods of these three
major long-term clinical trials. Contrary to these apparently successful trials,
however, we intended to develop an intervention that would be remarkably shorter
and thereby presumably cheaper and easier to implement in general health care.
The intervention was developed dunng the years 1992-1995 at the Academic
Hospital of Maastricht, and was aimed at risk factor modification and behavioral
change in coronary patients.
Guidelines for cardiac rehabilitation increasingly stress the importance of
individually tailored treatments (British Association for Cardiac Rehabilitation,
1995; Nederlandse Yereniging voor Cardiologie en de Nederlandse Hartstichting,
1995). Studies that prove the effectiveness of tailored programming are, however,
lacking. For this reason, we distinguished patients that were likely to benefit from
the intervention from patients that were not likely to benefit from it, planned on
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the basis of risk assessment and individual need. It was assumed that patients with
multiple risk factors would profit most from the intervention.
The present study was carried out to answer two questions: (1) D<x's this cardiac
rehabilitation and secondary prevention program contribute to a favorable
reduction in clinical risk factors and psychological distress? (2) Is it useful to select
CAD patients for this intervention? \X'e presumed that the intervention would be
effective in reducing modifiable nsk factors for CAD and emotional distress.
Moreover, we expected that patients, who were selected as patients with relatively
unfavorable risk factor profiles, would profit more from the intervention than
patients who were not selected as such.
Chapter 1 of this thesis starts with an overview of nonpharmacological
interventions, which have aimed to reduce CAD nsk factors. In chapters 2 and 3,
the effects of the intervention concerning psychological and clinical nsk factors arc
studied. The subject of chapter 4 differs from the other chapters in its subject. We
originally intended to report on the effects of the intervention on morbidity and
mortality rates, but since hardly any patients died or had recurrent myocardial
infarctions during follow-up, no firm conclusions could be drawn. \X'c postulated
that since mortality rates arc decreasing in time because of improved medical
treatments, it would be harder for recent studies to report on the effects of
interventions on mortality rates than it had been for older studies. 'l*his issue
eventually led us to study the influence of secular trends on the effects of
psychoeducational intervention studies for patients with CAD, which is described
in chapter 4. In chapter 5, the use of prc-selccting patients for the multifactorial
intervention is discussed. The thesis is concluded with a general discussion in
which implications and tentative explanations of the study results arc discussed,
and suggestions for future research arc made.

CHAPTKR1
RISK FACTOR MODIFICATION
THROUGH NON-PHARMACOLOGICAL
INTERVENTIONS IN PATH-NTS
WITH CORONARY HEART DISEASE - A REVIEW
Scbregts, E.H.W.J., Falger, P.R.J., Bar, I-.W.H.M. (2000). Risk factor
modification through nonpharmacological interventions in patients with
coronan- heart disease. Journal of Psychosomatic Research, 48, 425-441.
Chapter 1
ABSTRACT
Coronary Heart Disease (CHD) is still the main cause of death in developed coun-
tries. Because of improved treatment many patients survive the acute phase of a
myocardial infarction, which makes secondary prevention of CHD of major
importance. Most risk factors responsible for the development and progression of
CHD arc associated with behavior. Therefore, interventions aimed at behavior
change may contnbute to nsk factor modification and secondary prevention of
CHD. The effects of separate risk factor modification efforts by means of
randomizcd-controllcd clinical trials of non-pharmacological interventions in
patients suffering from CHI) arc reviewed. Interventions aimed at healthy lifestyles
may stimulate smoking cessation rates, reduce elevated serum total and LDL
cholesterol concentrations and favorably modify type A behavior in CHD patients.
Moreover, reduction of coronary atherosclerosis has been reported after intensive
lifestyle and exercise interventions, whereas exercise and type A behavior
interventions may also lead to reduced CHD morbidity and mortality. As for
hypertension and obesity, studies aimed at secondary prevention are lacking.
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INTRODUCTION
Coronary heart disease (CHD) is still the single main leading cause of death in
most modern, industrialized countries, even though data suggest that mortality
rates from CHD arc declining (Thorn, 1989). This decrease in CHD mortality may
be explained by primary prevention efforts and by a decline in population risk
factor levels, particularly lower smoking rates and beneficial changes in dietary
habits (Beaglehole, 1990). Most of the decline, however, is primarily a consequence
of reduced mortality among patients with acute myocardial infarction (AMI). This
is the result of more intense cardiologic treatment and improvements in the
treatment of patients through risk factor modification (Hunink et al., 1997). It thus
seems that the declining mortality can largely be explained by better management
of patients with established CHD. This also explains why the number of
hospitali/ations from CHD is steadily growing, in spite of reduced mortality rates.
More adults survive their AMIs when middle-aged, and consequently, the pancnt's
life span is lengthened. They may, however, suffer more often from heart failure
when older. Moreover, as the general populanon ages, the rise in hospitah/ations
will increase accordingly.
In recent years, researchers and clinicians have tried to counteract the rise in CHD
by means of primary and secondary prevention strategies, for instance by-
promoting behavioral change. Secondary prevention of CHD is thus of major
importance, since so many patients survive their AMIs. Clinical treatment of CHD
patients consists primarily of pharmacological therapy (i.e., fi-blockcrs, aspirin,
ACE inhibitors, lipid-lowering agents, etc.), whereas only limited advice is given
concerning behavioral change, such as smoking cessation. This is reason for
concern, since most risk factors responsible for the development or acceleration of
coronary atherosclerosis are generally associated with behavior and cognitions.
Smoking, lack of physical exercise and inadequate coping with 'stress', for instance,
are preventable forms of risk behavior, whereas elevated serum cholesterol, obesity
and hypertension often correlate with an unhealthy diet. Interventions aimed at
behavioral change instead of - or adjunct to - pharmacological therapy may have
several advantages, one of which is that harmful side effects of medication could
be diminished, and as a consequence, life qualm- improved (|acob. Wing, &
Shapiro, 1987; Linden & Chambers, 1994; Shapiro & Jacob, 1983).
The purpose of the present paper is to answer the following two-part question: Do
non-pharmacological interventions actually contribute favorably a) to risk factor
modification in patients with CHD, and b) in doing so, to a reduction of mortality,
morbidity or to favorable changes in atherosclerotic stenosis? Meta-analysis would
have been difficult to perform, because of the substantial diversity in study
methods and intervennons, and the relatively small number of studies performed
with coronary patients.
Chapter 1
METHODS
A computer search was performed on MEDLINE and PSYCHlit, and relevant
articles mentioned with the references but not found in these files were also used.
(Key words included smoking, cholesterol, diet, physical exercise, training, type A
behavio(u)r, hypertension, blood pressure, obesity, weight, non-pharmacological,
program(me), intervention, CUD, myocardial infarction, CABG.)
We restricted ourselves to non-pharmacological interventions aimed at
modification of smoking, scrum cholesterol, physical exercise, type A behavior,
hypertension, or body weight.
'I"hc following criteria were used for inclusion of a trial in the review:
1) Treatment condition in which patients were offered a non-pharmacological
intervention aimed at CHI) risk factor modification. Non-pharmacological
interventions included: a) counseling/advice concerning health behavior; b)
cognitive-behavioral approaches to risk factor modification. Interventions based
on these approaches attempt to alter behavior by modifying the antecedents and
consequents of that l>ehavior, and by involving people's cognitions in behavior
changes; c) interventions not incorporating cognitive or behavioral techniques, but
aimed at direct risk factor reduction, e.g. offering exercise training or a lipid-
lowcring diet. 2) Treatment focused on changing one risk factor in particular.
Interventions focusing on multiple risk factors were only included as far as one of
these risk factors was the main object of change. 3) Study population consisting of
patients with established CHI), i.e., patients with angiographically documented
coronary artery disease, or patients who had had PTCA, AMI, or CABG. 4) One
or more control conditions. 5) Random assignment to conditions. 6)
Documentation of outcomes had to include at least modification of one of the
above-mentioned risk factors, reduction of mortality, morbidity or favorable
changes in atherosclerotic stenosis (i.e., regression, stabilization, or prevention of
progression).
It was intended to include controlled, randomized, non-pharmacological trials on
hypertension and obesity reduction in CHD patients. However, our computer
search did not yield any publications in which the effects of blood pressure
reduction or weight loss were studied as secondary prevention, by means of non-
pharmacological treatment. Consequently, these risk factors were omitted from
discussion. Nevertheless, primary prevention studies suggest that blood pressure
reduction can be achieved through non-pharmacological interventions. Programs
wined at exercise/weight reduction in particular may result in substantial favorable
effects on blood pressure, comparable with those achieved with drug treatment
(Jacob, Chesnev, Williams, Ding, <S: Shapiro, 1991). Stress management techniques
seem to result in reduced blood pressure levels as well, but effects are generally
modest (|acob et al.. 1991; Jacob et al., 1987; Shapiro, Hui, Oakley, Pasic, &
Janincr. 1997; Yen, Patrick, & Chie, 1996).
For more precise information about the contents of the randomized controlled
trials, the reader is referred to the tables; these include type of intervention,
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number of patients, length of follow-up, and main results. As /rvalues arc shown
in the table, these will not be mentioned in the text.
SMOKING
Cigarette smoking is the single most important risk factor for the development and
progression of CHD. Smoking appears to accelerate the athcrogenic process in
both a dose- and duration-dependent manner. Among the damaging effects of
smoking on the cardiovascular system are acute increases in blood pressure and
coronary vascular resistance, reduction in oxygen delivery, impaired dilation of the
coronary vessel wall, enhancement of platelet aggregation, increased filmnogen
production, and depression of HDL cholesterol (Rigotti & Pasternak. 1996).
Although patients with AMI face a potentially life-threatening situation which can
be expected to result in considerable emotional distress, about half or two thirds
of these patients will soil be smoking or resume smoking six months to five years
after the incident (Havik & Maeland, 1988; Rigotti & Pasternak, 1996). Smoking
cessation may lead to a significant reduction in mortality in coronary patients, as
well as to a reduced rate of hospitalization for AMI (Vlictstra, Kronmal, Obemun,
Frye, & Killip, 1986). Beneficial effects of smoking cessation were described as
early as 1975 when Wilhclmsson et al. showed that patients who stopped smoking
after a first AMI, reduced their chance of suffering a second nonfatal incident by
50% (p<.01); the same applied to cardiovascular mortality (p<.()5) (Wilhclmsson,
Vcdin, Rlmfeldt, Tibblin, & Wilhelmsen, 1975). Reduced mortality after smoking
cessation was confirmed in later studies (Aberg ct al., 1983; Daly, Mulcahy,
Graham, & Hickey, 1983; Saloncn, 1980; Sato et al., 1992; Sparrow, Dawber, &
Colton, 1978). In coronary patients, the risk of having a coronary event declines
soon after smoking cessation and is largely dissipated after 2-3 years. The
beneficial effects were found to persist for at least 13 years (Daly ct al., 1983;
Rosenberg, Palmer, & Shapiro, 1990; Salonen, 1980; Taylor, Houston-Miller,
Haskell, & DeBusk, 1988).
Secondary prevention trials for coronary patients: implementing smoking
cessation
A number of interventions have been developed to reduce modifiable risk factors
for CHD, and smoking was the first factor that became a target for change. This is
reflected in the often less than perfect research designs used in the 1960s and
1970s to evaluate these interventions. Therefore, only a few randomized controlled
studies were found that studied the effects of non-pharmacological programs on
smoking cessation in coronary patients (table 1). Taylor ct al. determined the
influence of exercise training on smoking behavior in patients who had suffered an
AMI (Taylor et al., 1988). At 6 months follow-up, the prevalence of smoking did
not differ significantly between regular exercise and no-cxcrcisc or controls.
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I lowcver, cigarette consumption was significantly less in patients who exercised
than in control patients.
Later, Taylor ct al. published a different type of intervention for smoking cessation
(Taylor, Houston-Miller, Killen, & DeBusk, 1990). This time, the intervention was
offered during hospitalizarion due to AMI and was maintained thereafter for 5
months, through regular telephone contact. One year after AMI, the smoking
cessation rate was significantly higher in the intervention group.
()ckene et al. studied the effectiveness of a similar type of intervention in patients
with angiographically documented CHD (Ockenc et al., 1992). The program was
initiated in the hospital, and was continued after discharge through counseling
visits or by telephone calls. Compared to controls, slightly more intervention
patients quit smoking. Sub-analysis showed further that the intervention was more
effective in patients with more severe CHI), who had been admitted with AMI.
()nly a few programs focus exclusively on smoking cessation. Some multimodal
programs incorporated multiple risk factors, including smoking, and have found
conflicting results. Some of these programs have found significantly higher
smoking cessation rates in coronary patients receiving intervention compared to
control patients (I)eBusk et al., 1994; Van Hldcren-Van Kemenadc, Maes, & Van
den Broek, 1994).' Other studies, however, did not find such results (Allen, 1996;
Carlsson, l.indberg, Wcstin, & Israelsson, 1997). Participation of the partner in the
program seemed important in stimulating smoking cessation of coronary patients
in one particular study (Van Uldercn-Van Kcmcnade ct al. 1994).
In summary, the above-mentioned studies show that non-pharmacological
interventions may boost smoking cessation rates in AMI patients. Exercise training
by itself may not suffice for stimulating smoking cessation, but behaviorally
oriented interventions, incorporating cognitive and behavioral smoking cessation
icchnic|ues, have shown positive results. Because the interventions consist of
different components, it is difficult to determine which components contributed to
the favorable effects. However, standard behavioral techniques included in one of
these interventions (i.e., teaching patients methods of coping with situations likely
to cause relapse) have been shown to be effective in facilitating smoking cessation
(Killen. Taylor, & Maccoby, 1984). In addition, the likelihood of quitting seems to
be affected by seriousness of disease; the effects were especially strong in AMI
patients. Ix-ss is known about the success of smoking cessation interventions in
patients after coronary artery bypass graft surgery (CABG). One study showed
identical cessation rates in control and intervention groups; half of all patients
resumed smoking after surgery, a finding which was not affected by an m-hospital
smoking cessation program in the intervention group (Rigotti, McKool, &
Shiftman, 1994). Thus, suqirisingly, after more than 25 years of research there still
is an urgent need tor well-designed studies focusing on smoking cessation in
coronary patients.
' Studies aimed at multiple nsk factors without particular focus on smoking cessation arc not
included m talilc I
Id
Table 1. Randomized controlled srudies on non-pharmacological interventions aimed at smoking cessation in coronary patients.
Source Research question/
population
Intervention Results
Taylor et al.,
1<)88
Effect of exercise
training on smoking
after AMI
Individual or group exercise training .V26 42
weeks
after AMI
No intervention 26
(5 *»«//>*•
- 31° •> of training sublets (E) vs. 39° o of no training
sub)ects ((.") quit smoking (NS).
- Self-reported cigarette consumption was half as great in
E ( 1 1 + 7 cigarettes/day) as in C (22 ± 16
cigarettes/day) (ft *^  03).
Taylor et al.,
1990
Effect of non- i
pharmacological
smoking cessation
intervention in patients
after AMI (
Intervention during hospitalizanon
focused on smoking cessation and rclaP**
prevention, telephone contact until 5
months after discharge
No intervention
86
- 61° o in E had stopped smoking vs. 32% in C (on the
assumption that all patients lost to follow-up were
smoking;/* = .001).
Ockene ct al..
1992
Effect of non-
pharmacological
smoking intervention in
patients with
angiographically
documented coronarv
anen- disease
Individually delivered behavioral muln
component smoking lntcrvcnnon;
motivation for ccssanon. areas of cone***'
regarding smoking cessation, problems
and possible solution were discussed.
C >ne SCSSK >n during hospitalizanon, aftt'
discharge telephone or individual
counseling sessions
Advice only
135
62° o of E stopped smoking vs. 51% of f J (ft = .06).
The intervention was most effective for patients with
more severe coronary artery disease who had been
admitted with AMI: of thw group, 85% m li stopped
smoking vs. 63% of C (ft < .01).
5?" o of E stopped smokmg vs. 48% of C (ft = .06;.
Effect of mtervennon was mediated by severity of
disease: among paoents with 3-veuel disease, 65% of E
quit smoking vs. 41% of C (ft < 01)
Rigotn et al, Effect of non-
phamucokigical
sm< >king cessation
intervention in paoents
after CABtJ
Cogninvc-behavn)ral smolang cessation
and relapse prevention program, teachir*
cogrurrve and behavKiral smoking
ccssanon techniques. 3 sessions during
hospitalizanon.
No inten ennon
44
No <un*acalh significant difference* were found
between E and C in validated continuous nonsmoking
rates (both groups 51% at 1 year. 44% at 5.5 years,^ =
.52).
_ li; Experimental omdinon; C: Control condition
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HYPERCHOLESTEROLEMIA
The essential role of elevated serum cholesterol levels in the etiology of
atherosclerosis is now well established (LaRosa et al., 1990; Adult Treatment Panel
II, 1994). The increased risk of CHD is determined first by elevated levels of low-
density lipoprotein (LDL) cholesterol (Le., > 130 mg/dL or > 3.4 mmol/L), which
is thought to promote atherogencsis when oxidized, and second by reduced levels
of protective high-density lipoprotein (HDL) cholesterol (i.e., <35 mg/dL or <0.9
mmol/L), whereas total scrum cholesterol level, the HDL/LDL ratio, as well as
the level of triglyccrides, arc of additional importance. Foods that are rich in
saturated (animal) fats and cholesterol are the main source of elevated serum
cholesterol and increase the risk of CHD, whereas polyunsaturated fatty acids may
lower serum cholesterol levels.
Pharmacological treatment of serum cholesterol, especially LDL cholesterol, leads
to primary and secondary prevention of cardiovascular incidents and mortality
((iould, Rossouw, Santancllo, Heysc, & Furbcrg, 1995; Levine, Keaney, & Vita,
1995). This was most convincingly shown in the Scandinavian Simvastadn Survival
Study (Scandinavian Simvastatin Survival Study Group, 1994). Over a 5.4 years
follow-up period, simvastatin produced mean reductions in total cholesterol and
LDL cholesterol of 25% and 35%, respectively. Moreover, mortality was reduced
in coronary patients (/> = .0003). Apart from these and other study results, it is
becoming increasingly clear that coronary patients with normal and mildly elevated
levels of serum cholesterol may benefit as well (Scandinavian Simvastatin Survival
Study Group, 1994).
Secondary prevention trials for coronary patients: reducing serum
cholesterol
Already between 1960-1970, several controlled trials studied whether reduction of
serum cholesterol by a diet low in saturated fat and cholesterol and rich in
polyunsaturated fat would reduce cardiovascular recurrences or improve survival in
patients after first AMI or in patients with ischemic heart disease (l.eren, 1970;
Research Committee, 1965; Research Committee to the Medical Research Council,
1968; Rose, Thomson, & Williams, 1965; Woodhill, Palmer, I^elarthaepin,
McGilchrist, & Hlackct, 1967). Results were generally disappointing: patients
following this diet did not fare any better, and in one study even slightly worse
(Rose et al., 1965), than controls. These early studies were, however, characterized
by some methodological shortcomings, such as recruitment of low-risk patients
only, while drug treatment and baseline cholesterol levels were not reported.
Moreover, these trials included very high intakes of polyunsaturated fatty acids,
sometimes resulting in a total fat intake of > 40%, despite being low in saturated
fats and cholesterol (De l^orgeril, Salen, Monjaud, & Delaye, 1997). Changes in
scrum cholesterol levels were in general modest, suggesting that treatment failure
might have been caused by inadequate reductions of lipids. The lack of serum
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cholesterol reductions in these early studies reflects the limited knowledge of the
cholesterol-atherosclerosis interrelationship in those dap.
Recent trials studied the effects of more intensive dietary treatment on cholesterol-
lowering in CHD patients, some of which used objective anenographic assessment
of changes in the suse of the coronary arterial lumen before and after intervention
(table 2). In 1983, Omish et al. showed in a randomized pilot study that a strictly
vegetarian diet combined with stress-management training resulted in
improvements in cardiovascular status, such as clinically meaningful decrease in
plasma cholesterol levels and, in particular, a reduction in frequency of anginal
episodes (Ornish ct al., 1983). The lifestyle Mean Trial was the first randomized
trial to show that these comprehensive lifestyle changes in coronary patients could
lead to actual regression of atherosclerosis (Ornish ct al., 1990). After one year,
significant differences were found between intervention and control patients with
respect to serum lipid levels and extent of coronary atherosclerosis, in favor of
paoents in the intervention group. It was concluded that comprehensive lifestyle
changes may be able to bring about substantial regression of severe coronary
atherosclerosis after only one year, without the use of lipid-lowcring drugs. Recent
data confirmed ongoing regression in patients who continued to adhere to these
lifestyle changes after five years, with a resulting significant reduction in new
coronary events by about 250 " o compared to controls (()rnish et al., 1998).
Implementation of the lifestyle Heart Trial intervention program also appeared to
be feasible in heart patients in a rehabilitation center in Ciennany (Schcrwitz et al.,
1995) and in a primary health care center in the Netherlands (I'algcr & Voorhocvc,
unpublished).- Results of these latter studies at 3 and 12 months follow up were
rather similar to those of the lifestyle Heart Trial. However, no conclusions could
be drawn regarding regression of coronary artery stenoses, since repeated
quantitative coronary arteriography was not performed.
In a different randomized controlled trial, Watts et al. assessed the effects of a
lipid-lowering diet, either with or without cholesterol-lowering medication
(cholestyramine), on coronary atherosclerosis (Watts et al., 1992). After 3 years, the
diet-intervention group showed significant reductions in total cholesterol, LDL-
cholesterol and triglyceridcs compared to controls, which did not show any
significant changes. In the diet plus cholestyramine group, an additional 10-20%
reduction in cholesterol levels was observed. Compared to controls, the
proportion of patients showing overall progression of coronary artery stenoses was
significantly reduced by both interventions. These findings support the role of a
regular lipid-lowenng diet in males with CHD, even when serum cholesterol
concentrations are moderately elevated. If necessary, these effects could be
enhanced by pharmacotherapy.
- Smcc these studies were not randomized controlled tnals, (hey are not included in table 2.
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Table 2. Randomked controlled studies on non-pharmacological interventions aimed at reduction of serum cholesterol in coronary
patients.
Source Research question/ Intervention
population
Results
Omish et al.,
1983
l-.ffect evaluation of
dietary changes in
combination with stress
management training in
paoents with lschcrruc
heart disease
Intervention with a vegetarian diet 23
(average daily intake of 1,400 calories) and
stress management training 'i.e.
stretching/relaxation, (applied)
meditation), during a period of 24 days
C No intervention 23
Significant differences between F. and C in reduction of
total serum cholesterol (-21% and -3%. respectively,^ <
0001) and rcducaon of tnglycendes (-16% and 0%.
respectively;^ < .01). but also reduction of HDI.
cholesterol (-F% and -2%, respectively;^ < .0001); no
significant difference between Li and C in total
cholcstcrol/HDl. ratio (-8% and -1%, respectively).
Significant difference between F. and C in frequency of
anginal episodes (-91% and -6%, respectively; /> <
.0001). '
Orrush cr al.,
1990
To determine whether
comprehensive lifestyle
changes affect coronary
atherosclerosis in
patients with CHD
Intervention aimed at lifestyle 28
modification: low-fat vegetarian diet
(<10% of calories as fat), stress
management training (stretching
/breathing, meditation), moderate
exercise, stopping smoking, group support
No intervenoon 20
Significant difference between E and C in reduction of
fat intake y> < .0001), in E reduced total scrum
cholesterol (E and C -24% and -5%, respectively;/! =
.02), reduced I.DL cholesterol (- 38% and 6%,
respectively;/) = .007). No differences between E and C
in tnglycendcs (£ = .25) and HDI. cholesterol (^  = .83).
In E regression of percentage diameter stenosis from
40.0° o to 3"\8%: in C, progression from 42.7% to
46.1% Qfr = .001).
- table continues —
Table 2 - continued
Source Research question/ Intervention
population
Retulli
Watts ct al.. The effect of dietary re- El
l')92 ducnon of plasma cho-
lesterol concentrations E2
on coronary athcroscle- C
rosis in patients with
angina or past AMI
I jpid-lowenng diet: total fat intake was 26
reduced to 2""" o of dietary energy
Ijpid-lowenng diet plus cholesryramine 24
No intervention 24
- Groups El and E2 significant reduction in total scrum
cholesterol (-14% and -25%, respectively;^ < .001), not
in C (-2° o;/> = .15) El and E2 reduced IDI .
cholesterol (-16% and -36%, respectively;/" < .001), not
in C; (-3%;/. = 24) El and E2 reduced chol/UDJ-
chol. raao (16% and 24° o, respectively;^ < .001), not
in C (+2.7%;^ = .50) El reduction of trjglycendrs (-
20%;^< .005).not in E2 (+!%./> = .97) andC (+1%,^
= .86). No difference in HDI. cholesterol in El (p =
.82). E2 (^  = .29). and C (/> = 62)
- Proportion of patients who showed progression of
coronary narrowing significantly less in El and E2
compared to C (El 15%, R2 12%, C 46%;/> < 02) In
El and (12 greater proportion of patients showing
regression of coronary narrowing (El 38%; E2 33%; C
4%;/.< 02;
Singh et aL, The effect of a E
cardioprotccdvc diet on
complications and
mortality in patients C
with suspected AMI or
unstable angina pectons
F-at reduced diet ^within 24-48 hours of 204
AMI) rich tn soluble dietary fiber, ano-
oxfciant ntamins and minerals
Fat reduced diet 202
/ 2 /now/A/.
- Significant differences between E and (. m reduction of
total serum cholesterol (E -13% vs. C -5%;/> < 01;,
IJDI. cholestertJ (Ii -12% vs. C- 6%;^ < .01),
tnglycendes (E -15% vs. C -6%;^ < 01), increase in
HDJ. chfJesterol Oi. +6% vi. C -4%,^ < .05), and
reduced body waght <E -10% vs C 5%;/ < .01)
- In E significantly lower incidence of cardiac events (E
25% vs. C 41%;^ < .001) and lower total mortality (E
10*. vs C 19*o,^ < .01) compared with C
K: I-jEperunental contbthin. (^ : ('ontrol condiaon
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Several randomized studies have been conducted that were not primarily aimed at
cholesterol reduction, but focused on reduction of multiple risk factors. These
trials, in which a low-fat diet was one of several components in the intervention
program, reported slower rates of progression of coronary artery stenoses (Haskell
ct al., 1994; Niebauer et al., 1997).' This was accompanied by significant reductions
in I -1)1. cholesterol, plasma triglycerides, and increased HDL cholesterol in only
one of the studies, (Haskell et ah, 1994) however.
That comprehensive dietary changes in coronary patients may not only lead to
reduced scrum cholesterol levels and regression of atherosclerotic lesions, but also
to reduced cardiovascular complications and mortality, was shown by Singh et al.
(Singh et al., 1992). A simple fat reduced diet was compared with a
cardiovasoprotcctive diet reduced in fat and rich in soluble fiber, antioxidants, and
minerals. Both diets resulted in weight loss and modest serum cholesterol
reductions, but in patients on the cardiovasoprotective diet lipoprotein
concentrations showed a larger change and cardiac events also occurred
significantly less often. Apart from the Singh et al. trial, two other trials were
conducted that were not primarily designed to reduce cholesterol, but questioned
whether diets low in saturated fats supplemented with polyunsaturated fats such as
fish intake, or supplemented with antioxidant vitamins or fiber, might reduce CHD
morbidity and mortality in coronary patients (Burr et al., 19H9; De l^ orgeril et al.,
1994).* These trials were remarkably successful in reducing CHD and overall
mortality, whereas the impact of the diets on reducing serum cholesterol was in
general modest. Apparently, even without substantial change in the degree of
luminal stenoses, modest reductions of serum cholesterol could lead to significant
reductions in cardiovascular morbidity or mortality (Scandinavian Simvastann
Survival Study Group, 1994; Singh ct al., 1992). These reductions in clinical events
could reflect a stabilization of stenoric lesions and inhibition of thrombus
formation (Blankcnhorn & Hodis, 1994; Brown, Zhao, Sacco, & Albers, 1993;
Rosenson & Tangney, 1998).
In sum, these studies showed that elevated serum cholesterol concentrations can
be reduced by intensive dietary modifications. No specific behavioral or cognitive
techniques were described in any of the studies, to help patients adopt a low-fat
diet in everyday life. In two studies interventions consisted of serving a vegan diet
to patients during a residential retreat with additional classes in food preparation
(Ornish et al., 1990; Ornish et al., 1983), or simply of instructions by a dietician in
one study (Watts et al., 1992). It appeared that major changes in dietary habits
could be achieved, with positive consequences for the atherosclerotic process.
Adopting a strictly vegetarian diet (<10% of calories as fat) seems more effective
than a less radical dietary change (Ornish et al., 1990). The beneficial effects can be
seen after 1 year, may persist much longer, and may already be apparent after three
months. It should be noticed, however, that some interventions did not solely
consist of a low-fat diet (Ornish et al., 1990; Ornish et al., 1983). The relative
contribution of each component of the lifestyle program(s) is, therefore, obscure.
' As these studies were not primarily aimed at cholesterol reduction, they are not mentioned in
table 2.
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Another point ot discussion concerns the impact of a small regression of coronal)'
atherosclerosis on mortality rates among people with CUD. This question remains
unanswered, but it seems that even a small amount of regression in a critically
stcnosed artery has a large effect on myocardial pcrfusion and thus on functional
status (Ornish ct al., 1990). In addition, plaque stabilization or other measures
might also be a reason for an improved outcome, as has been suggested in the
statin trial (Scandinavian Simvastatin Survival Study Group, 1994). All three lipid-
lowenng trials were randomized, controlled clinical trials including an average of
25 patients in each treatment condition (Ornish et al., 1990; Ornish ct al., 1983;
Warts et al., 1992). As these study populations arc rather small, prudence is advised
before drawing firm conclusions. Moreover, these relatively small numbers of
patients may reflect the drawback associated with trials offering comprehensive
lifestyle changes; they attract a selective group of highly motivated patients to
participate, but a considerable number of eligible patients may not be reached. This
not only causes selection bias, but seriously restricts generalizability of treatment
results to the general population of CUD patients as well, and considerations
should be made as to which strategy is the most cost-effective one. Despite all this,
an intensive lipid-lowenng diet does seem advisable for coronan' patients, and
psychological strategics should be developed to maintain motivation in eligible
patients.
LACK OF PHYSICAL ACTIVITY
Prospective epidemiological studies strongly indicate that an inactive lifestyle is
associated with an increased risk of CUD (Berlin & Colditz, 1990). This
association can be explained in part by the relation between lack of exercise and
traditional risk factors for CUD. Sufficient daily physical exercise can prevent or
reduce obesity. Moreover, regular exercise is associated with reductions in blood
pressure and scrum cholesterol levels; the physically active were found to have
reduced I.DL cholesterol and triglyccride levels, and increased HDI. cholesterol
(Blumcnthal & Emery, 1988; NIH Consensus Development Panel on Physical
Activity and Cardiovascular Health, 1996; Rigotti, Thomas, & Ixaf, 1983).
Independent of these indirect effects through modified traditional risk factors, an
active lifestyle does also directly exert favorable physiological effects, such as
reduced heart rate during exercise and at rest, and increased muscular oxygen-
uptake, which eventually leads to reduced myocardial oxygen demand (Bar &
Vonken, 1990). In CHD patients long-term exercise training may even improve
ventricular function over time (Giannuzzi et al., 1997; Obcrman et al., 1995).
Moreover, physical exercise may have favorable psychological effects, such as
reduced feelings of depression and anxiety', improved quality of life, and improved
mental functioning (Berlin & Colditz, 1990; Kuglcr, Seelbach, & Kruskcmpcr,
1994).
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Secondary prevention trials for coronary patients: increasing physical
exercise
Despite improved cardiorespiratory fitness and reduction of the traditional CHD
risk factors, evidence that exercise diminishes risk of reinfarction or prolongs life
in patients with established CHD remains equivocal. Although many studies
reported beneficial effects on cardiovascular morbidity and mortality after exercise,
differences between exercise and control groups were generally modest and did
not always reach statistical significance.
In 1982, May published a review of randomized controlled trials that focused on
secondary prevention after AMI through physical training (May, Eberlein, Furberg,
Passamani, & DeMcts, 1982). Only studies with sample sizes of more than 100
patients were included. ()ver a ten-year period, only six studies were identified that
met these criteria. Although none of these studies showed statistically significant
reductions of mortality between intervention and control groups, all except one
showed a positive trend favoring physical training. Grouping of these studies with
a total of 2,752 patients showed diat increased physical exercise following AMI
would lead to a significant 19% reduction in total mortality', compared with
controls. Obviously, although most studies indicate favorable effects of physical
training on mortality, individual studies may often be too small to show statistical
significance.
To overcome this problem, mcta-analyses were conducted. More than 4,000
patients were included in the meta-analyses of Oldndge et al. and O'Connor et al.
(O'Connor ct al., 1989; Oldridge, (Juyatt, Fischer, & Rimm, 1988). Table 3 shows
the studies included in the Oldridge analysis, because these studies consisted of
relatively large study samples. Whereas individual study results were not always
significant, meta-analysis indicated a significantly reduced mortality (O'Connor et
al. 20" o, ami Oldridge et al. 24%) following physical training. No significant
differences were found, however, concerning non-fatal recurrent infarctions.
Moreover, effects were found only in studies with at least 3 years of follow-up. As
not all studies focused exclusively on physical exercise, those effects could possibly
have been the result of modification of multiple risk factors (Oldridge et al., 1988).
The reduction in mortality may be explained by various mechanisms, e.g., exercise
training may improve myocardial perfusion by preventing the progression of
coronary artery stenoses to a certain degree in CHD patients (Kubo, Yano, Hirai,
Yabuki, & Machii, 1992; Schuler et al., 1992; Hambrecht et al., 1993).* Regression
of coronary narrowing, however, may occur only in patients who spend an average
of 5 or 6 h/week of regular physical exercise. These beneficial effects appear to be
maintained after 6 years of risk intervention (Nicbauer et al., 1997).
Many studies evaluated interventions in which the effects of physical exercise were
stvidied among other risk factors, but only some of these focused primarily on
physical exercise. Individual studies focusing on effects of physical reconditioning
often encounter several methodological problems: relatively many patients
randomized to the experimental groups drop out (resulting in small sample sizes),
* The papers by Schuler et al. (1992). Hambrecht ct al. (1993) and Niebaucr et al. (1997) were
part otOne large study: <ml\ the Hambrecht studv is reported in table 3.
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or patients in control groups start training by themselves. To increase statistical
power, meta-analyses have been conducted, which have shown statistically
significant reductions of mortality after physical exercise. Meta-analyses can,
however, lead to false conclusions, because of publication bias (studies showing
negative results are less likely to be published). Moreover, often srudy designs and
patient samples of individual studies lack comparability, which could lead to false
positive conclusions.
Thus, unequivocal evidence for the favorable effects of physical exercise on
cardiovascular morbidity is not yet available, although cardiovascular mortality
seems to be reduced. Unfortunately, those interventions (generally) offered
supervised group exercise programs to patients, but were not aimed at stimulating
individual exercise in everyday life. e.g. through cognitive/behavioral strategics. It
therefore remains debatable whether patients will continue to exercise in the long
term. Although there is soil controversy concerning the effects of physical exercise
on cardiovascular morbidity and mortality, it is certainly recommended as standard
rehabilitation procedure for coronary patients, considering overall favorable
psychosocial and physiological effects (Kugler et al., 1994).
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Table 3. Randomized controlled studies on interventions aimed at physical exercise in coronarv patients.'
Source Research question
/population
Intervention JV Results
Krntala ct
aL. 1T2
f Effect of physical
exercise in panents
after AMI
E Physical exercise program, including risk
factor management, during 12 months
C No intervention 81
No significant differences between E and C in total
mortality (both groups 14°o), cardiovascular mortality
(10*o and 12°o, respectively), or non-fatal recurrences
(8*o and 5%, respectively).
Wilhelmsen F.ffect of physical
et al., 1975 exercise in panents
after AMI
E Physical exercise program, including risk 158
factor management, during 48 months
C No intervention 157
No significant differences between Ei and C in total
mortality (18% and 22%, respectively), cardiovascular
mortality (18% and 21%, respectively), or non-fatal
recurrences (16% and 18° o, respectively).
Kallio et al.,
1979
Effect of mulaplc risk
factor inter-vention in
patients after AMI
Mulnfactonal intervention program 188
aimed at health education and psycho
social problems, including program
aimed at physical exercise, during 3-12
months
No intervention 187
Significant difference between E and C in
cardiovascular mortality, in favor of the intervention
group (19% and 29%, respectively;/) < .05); no
significant differences in total mortality (22% and 30%,
respectively) and non-fatal recurrences (18% and 11%,
respectively).
E: Experimental condition; C: Control condition
- table continues -
'Studies extracted from Oldndge et al., 1988
Table 3 - continued
Source Research question
/population
Intervention Result*
Shaw. 1981 Effect of physical
exercise in paaents
after AMI
E Physical exercise program during 36 323
months
C No intervention 328
No significant differences between E and C; m total
mortaliry (5% and 7%, respectively), cardiovascular
mortaliry (4% and 6%, respectively), or non-fatal
recurrences (5° <• and 3%, respectively).
(larson et
al.. 1982
Effect of physical
exercise in patients
after AMI
E Physical exercise program, including risk 151
factor management, during 12 weeks
C No intervention 152
25 *»*//>/•
- No significant differences between E and 0 in total
mortality ( 8% and 14%, respectively) and non-fatal
recurrences (8% and 7%, respectively).
Rechniraer
et al.. 1983
Effect of physical
exercise in paoents
after AMI
E Physical exercise program, during 48 379
months
C No intervention 354
No significant differences between E and f" in cardio-
vascular mortality tooth groups 4%) and non-fatal
recurrences (10% and 9%, respectively)
Roman et
al.. 1983
Effect of phvsical
exercise in patients
after a first AMI
E Physical exercise program, during 42 93
months
C No intervention 100
No significant differences between E and f. in total
mortality (17% and 27%, respectively), cardiovascular
morality fl4% and 24%, respectively) and non-fatal
recurrences (10% and 8%, respectively).
K: i--xpenmental condition; C: Control condition
table continues -
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Table 3 - continued
Source
Vermeulen
et al., 1983
Research question
/population
F.ffect of physical
exercise in paocnts
after a first AMI
Intervention
E
C
Muladisciplinary intervention anmed tt
physical exercise and other risk factors.
during 6-8 weeks
No intervention
AT
4~
51
Results
($0 •»»/>>/.
- No significant differences between E and C in
cardiovascular mortahtv (4% and 10%, respectively)
and non-fatal recurrences (9% and 18%, respectively).
\Xorld
Health Or-
ganization,
1984
Effect of physical
exercise in patients
after AMI
Eleven different programs aimetd at 705
multiple risk factors and physical
exercise, during (varying per stuidy) 6-36
weeks
No intervention 655
Two out ot eleven studies showed significant
differences between E and C in total mortality
(Warsaw, 3% and 18%, respectively;^ < .05; Ghent,
18* o and 4%, respectively; /> < .01); one study found a
significant difference in cardiovascular mortality
(Ghent, 14% and 4%, respectively;/! < .05), and two in
non-fatal recurrences (Brussels, 13% and 2%,
respectively. /i < .05; Hungary', 9° o and 0%,
respectively;/! < .01).
Marra et al..
1985
Effect of physical
exercise in panents
after AMI
E
c
Physical exercise program.
weeks
No intervention
durimg 8-9 81
80
5 JWOHMJ:
No significant differences between E and C in total
mortality (7% and 6%, respectively), cardiovascular
mortality (6% and 5%, respectively) and non-fatal
recurrences (6° o and 11%, respectively).
E: Experimental condition, C: Control condition
table coinnnues -
Table 3 - continued
Source Research question Intervention
/population
Results
Kubo ct a).,
19<)2
Effect of exercise trai-
ning on prevention ot
restenosts in patients
after PTCA
E Physical exercise program, during 12 18
weeks
C No intervention 20
Effect of physical E Physical exercise program dunfg 12
Significant difference in progression of stenosis
between E and C (82% and 120%, respectively;^ <
.05).
No significant difference in proportion of patients
with restenosis between E and C (17% and 40%,
respectrvery).
I Umbrecht
ct al.. 1993 activity on cardio-
rcspiratory fitness and
ptx>gTcssion of
comnarv athero-
sclerosis in patients
with CAD
months, and low-fat diet
No intervention
29
33
Significant difference between E and C in proportion
of patients who showed progression and regression of
coronary artery stenosis (progression in E 10% vs. C
45%; regression in E 28% vs. C 6%;^ < .001).
E: Experimental condition. C: Control condition
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TYPE A BEHAVIOR
In the etiology of CHD the role of the type A behavior pattern as a potential risk
factor has received considerable attention. The Western Collaborative Group
Study was the first large prospective study that confirmed the association between
this behavior pattern, characterized by a continuously harassing sense of time
urgency and easily aroused or 'free-floating' hostility, and elevated risk of CHD.
Type A behavior was associated with a two- to threefold increased risk for AMI
compared with the type B pattern, which was defined as die relative absence of
type A characteristics (Rosenman et al., 1975). This positive association with
incidence of CUD was also found in a substantial number of prospective and case-
control studies throughout the world (Appels, Jenkins, & Rosenman, 1982;
Matthews & Nayncs, 1986). Moreover, global type A behavior has been found to
predict recurrent coronary incidents (Brackett & Powell, 1988; Jenkins, 1976;
Matthews & Hayncs, 1986).
In contrast to the consistent and often strong relationships reported before 1985,
subsequent findings have raised questions about this relationship, as some studies
failed to find strong associations between global type A behavior and CHD
(booth Kewley & lnedman, 1987; Matthews, 1988). The studies that found no
associations were, however, frequently characterized by high-risk study
populations, i.e. patients with known atherosclerotic disease, in contrast to healthy
population studies. This rcstnction of range may lead to a decrease in magnitude of
the associations between CHD and type A behavior (Miller, Turner, Tindale,
Posavac, & Dugoni, 1991). Moreover, nonsignificant findings most often occurred
in studies using self-report measures of type A behavior, such as the Jenkins
Activity Survey or the Bortner Rating Scale. It is now well-established that these
self-rating scales show only low correlations with CHD, in contrast to the
Structured Interview [SI] for measuring type A behavior (Miller et al., 1991). These
conflicting findings have cast scnous doubts on the validity of type A behavior as a
risk factor for CHD. Indeed, in the original Western Collaborative Group Study it
was shown that in survivors of AMI, type A behavior was associated with a lower
risk of subsequent CHD mortality over 22 years of follow-up (Ragland & Brand,
1988). Therefore, recent studies have emphasized the importance of studying the
different components of type A behavior. These showed that particularly the
'hostility' component is associated with increased risk of CHD (Miller et al., 1996;
Smith, 1992). The 'time-urgency' component should, however, not be disregarded
in the diagnosis of type A behavior as contributing to increased CHD risk
(l'riodman & Ghandour. 1993).
The physiological mechanisms by which stress and type A behavior may affect
CHD are increasingly becoming clear. There are strong implications that persons
exhibiting type A behavior may habitually react to stress with an exaggerated
response of the sympathetic nervous system, leading to chronic increases in
catccholaminc secretion (Schneider, 1994). Excessive adrenergic activity could
possibly contribute to CHD through several mechanisms (McEwen, 1998), one of
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which is that platelet-aggreganon is stimulated, eventually leading to occlusive
thrombus formation in susceptible individuals (lxrvine et al., 1985). That
psychological stress may indeed potentiate platelet activation was found by
Markovitz et al. (Markovitz, Matthews, Kiss, & Smitherman, 1096). Moreover, this
effect seems to be modulated in part by personality traits associated with Cl ID:
Type A behavior, and in particular hostility, was related to greater platelet reactivity
during acute stress (Markovitz et al., 1996). lividence has also been found of
increased cardiovascular and neurohormonal reactivity among type A's, especially
males, to various laboratory tasks, or even chronic elevation of catccholaminc
secretion on laboratory tasks (Williams, Suarez, Kuhn, Zimmerman, & Schanberg,
1991).
Secondary prevention trials for coronary patients: modifying type A
behavior
Studies in employed, healthy populations have shown that type A behavior (and its
components) may be modified (Clill ct al., 1985; Suinn & Bloom, 1978). A mcta-
analysis of 18 controlled studies indicated that type A behavior may be modified in
coronary patients as well (Nunes, Frank, & Kornfeld, 1987). This analysis
suggested that interventions in which a combination of treatment technujiies was
used, thus addressing a number of different facets of the behavior pattern, may be
most effective in reducing type A behavior. Moreover, treatment of the type A
behavior pattern was associated with a reduction in coronary' events of about 50%;
being based on only two studies, however, this finding should be treated with
caution. To a certain extent, the findings of this meta-analysis were weakened by
measurement problems. Most instruments were self-report measures of type A
behavior that might reflect an experimenter expectancy effect instead of true
change, and only a few studies used measures that were validated predictors of
CHD, such as the original Structured Interview (SI) and the Videotaped Structured
Interview (VSI). The use of validated predictors would seem most important for
the evaluation of treatments aimed ultimately at modification of clinical CHD.''
The Recurrent Coronary Prevention Project (RCPP) was the first and as yet largest
trial that studied whether type A behavior could be modified, and what effects this
might exert on subsequent cardiovascular morbidity and mortality rates (table 4)
(Friedman et al., 1984; Friedman et al., 1986; Friedman et al., 1982). At 4.5 years
follow-up, reductions in global type A behavior as well as in its components were
significantly larger in the type A-intervention group as compared to the control
group. This reduction was dose-dependent, such that an increasing number of
treatment contacts was associated with increasing change. Moreover, the cardiac
recurrence rate was significantly less in the experimental group receiving type A
counseling. The reductions in type A behavior and cardiac recurrence appeared to
be maintained 1 year after cessation of behavioral counseling. Moreover, when
subjects originally randomized to the control group were exposed to 1 year of type
* Table 4 contains only studies that used the original SI and the VSI to mca»urc type A behavior.
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A behavioral counseling after the original srudy was ended, a significant decrease
both in the intensity of their type A behavior and in the rate of cardiac recurrence
appeared to occur during this same year (Friedman et al., 1987).
Faucnts undergoing type A counseling in the RCPP showed significant reductions
not only in type A behavior, but also in depression, and increases in self-efficacy
and social support. An increasing number of treatment contacts in the type A
counseling group was associated with larger changes in these psychosocial
outcomes. Thus, reduced cardiac recurrences in the experimental group may partly
be explained by changes in psychosocial factors, and may not exclusively be
attributed to type A behavior modification (Mendes de Leon, Powell, & Kaplan,
1991).
In a Swedish study it was found that an intervention aimed at type A behavior
modification and based on the RCPP model, was associated with significant
reductions of type A behavior in treated patients (Burcll et al., 1994). These results
were maintained at 1-year follow-up. Treated patients also tended to have fewer
cardiac recurrences than control patients. Reduced cardiovascular morbidity and
mortality was also found exclusively in post-CABG patients, after participation in a
comparable type A behavior intervention program (Burell, 1996).
Thus, not many studies were carried out on type A behavior modification in
coronary patients. The few studies that used the SI and the VSI (the only measures
that proved valid for measuring type A behavior), all showed that this behavior
pattern is amenable to changes. Although in one of the trials the study population
was rather small (Burell et al., 1994), indicating that the results should be
interpreted with caution, all three trials showed a reduction of recurrent cardiac
events after type A behavior modification. All trials studied a comparable type of
intervention, using a diversity of cognitive/behavioral techniques to realize the
behavior changes. The major drawback of these programs, however, was that they
were lengthy (5 1 year), and therefore not easily applicable in general health care
services. Moreover, the intensity of these programs may only attract highly
motivated patients, leaving large groups of patients untreated. Still, the positive
results concerning reduced recurrences warrant treatment of type A behavior.
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Table 4. Randomued controlled studies on non-pharmacological interventions aimed at reduction of type A behavior in coronary
panents.
Source Research
question/
population
Intervention Results
Friedman et al..
1982. 1984,
1986
Possibility of
altering type A
behavior in patients
after AMI, and the
effect of such
alteration on car-
diovascular mor-
bidity and mortality
Cardiac counseling concerning diet, 592
physical exercise, medical information,
and in addition type A behavior
counseling. The psychotherapeunc
counseling contained 1) relaxation
learning (progressive muscle relaxation
and mental relaxation); and 2) behavioral
learning: a) recognition and modification
of exaggerated arousal reactions,
b) instruction in self-observation and
self-assessment techniques, 3)
restructuring of environment, 4)
cogmnvc-affccnve learning. 44 sessions
during 3 years
Cardiac counseling, without type A 270
behavior counseling
/
Significant difference in favor of E in rates of nonfatal
infarction (1% in II vs. 3% in C;^ < .05).
Significant reduction in type A behavior in E (39%;^ <
.001) and in C (21%,/> < .05). Reduction in E
significantly larger than in C (p < .001).
Significant difference in favor of E in cardiovascular
recurrences (E:7% vs. C:13%;^ < .005).
No significant difference between E and (. in cardiac
death rates.
Significant reduction in type A behavior in E (45%;^
< 000!) and in C (27%;/>< .05). Reduction in F.
significantly larger than in C (^> < .001).
Significant difference in favor of E in cardiovascular
recurrences (E:13% vs. C:21%;/> < 005).
No significant difference between E and (. in cardiac
death rates.
F: Experimental condition; C: Control condition
table continues
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Table 4 - continued
Source Research
question/
population
Intervention Results
BureU et al., Hffects of type A E Cardiac counseling in healthy life-style,
1994 behavior risk factors, medical informanon, and in
modifkaoon in addiaon type A behavior counseling; 35
patients after AMI sessions during 1 year
C Cardiac counseling, without type A
behavior counseling
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Significantly Urgcr reducoon of type A behavior y> <
.02) m E than in C."
Reduced cardiovascular recurrence rate in E compared
with C (/>< .05).-
Burcll,1996 Effect of
modification of
type A behavior
and psychosocial
risk factors in
CABCJ patients C
Behavioral intervention aimed at re- 128
ducnon of type A behavior and psycho-
social nsk factors; 17 sessions during 1
year, followed by 5-6 booster sessions in
the 2nd and 3rd year
No intervention 133
Significant reduction in rvpc A behavior in E, not in (2
(,<> < .0003).
Significantly lower rate of cardiovascular recurrences
in E than in C (11° o and 14° o, respectively; /> < .05).
Significantly lower total mortality rate in E than in C
(5° o and 12° o, respectively; /> = .02).
E: Experimental condition, C: Control condition
' percentage not reported in article
DISCUSSION
In order to study the effects of risk factor modification by means ot" non-
pharmacological interventions in patients suffering from CHD, we scrutinized
even- risk factor separately. Each factor was amenable to modification through
interventions aimed at behavior change. Bchaviorally oriented interventions,
incorporating cognitive and behavioral smoking cessation techniques, showed
positive results in reducing smoking rates in AMI patients (Ockene et al.. 1992;
Taylor et al., 1990). l^ ess favorable results were found for CABCI patients (Rigotti
et al., 1994). Elevated serum cholesterol concentrations were reduced by intensive
dietary modifications. Thus, major changes in dietary habits can be achieved in
CHD patients, and this may even lead to stabilization or regression of coronary
atherosclerosis. These favorable effects may not solely be attributed to the
adoption of a low-fat diet, since in some interventions additional components were
included, such as stress-management or exercise training (Ornish et al., 1990;
Ornish ct al., 1983). Several studies indicated that physical exercise may prevent
progression of atherosclerosis as well. Secondary prevention programs aimed at
increasing physical exercise seem to bring about reduced cardiovascular mortality
and morbidity, although unambiguous evidence concerning these effects is still
lacking. Finally, modification of type A behavior is possible through interventions
based on multiple cognitive-behavioral techniques. Furthermore, reduction in type
A behavior may lead to reduced morbidity in AMI and CABCi patients.
Only a few randomized, controlled studies have been earned out that focused
primarily on changing one risk factor only. Moreover, trials that met our inclusion
criteria were often directed at changing several other risk factors as well. In
addition, trials often used a multimodal approach to the modification of health
behaviors, integrating a number of cognitive-behavioral methods within one
intervention. Overall, this seriously limits firm conclusions concerning the relative
contributions of each additional component to the study effects. Moreover, trials
were often relatively small, especially the studies on cholesterol reduction, so
prudence is called for in the interpretation of results.
Still, from this review several conclusions can be drawn. Most importantly,
behavioral modification of each separate risk factor may add considerably to usual
care in coronary patients. It is clear, however, that risk factors of CHD are additive
in their effects and considerable attention must therefore be paid to all important
risk factors rather than concentrating on a single factor such as smoking. Factors
that confer the highest relative risk in a given patient should have priority. Thus,
programs focused on modification of multiple risk factors may be expected to be
more effective. Convincing evidence in this direction was shown in a recent mcta-
analysis (linden, Stossel, & Maurice, 1996).
A further conclusion is that in selected patients endowed with exceptional
motivation, impressive changes in cardiovascular status arc feasible if
comprehensive lifestyle changes are made. This was particularly clear in the study
by Niebaucr et al. (Niebauer et al., 1997), where documented regression of
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coronary narrowing occurred in patients who were willing to exercise 5 to 6
h/week, as well as in the Ufestylc Heart Trial (Ornish et al., 1990; Ornish et al.,
1998). Although the latter was a randomized study, patients were asked to take part
only after they had been randomized to either the control or the experimental
groups. Drop-out rates were rather high: 47% of the experimental group and 58%
of the control patients refused to participate. It is conceivable that the remaining
patients were highly motivated to make certain lifestyle changes. Scherwitz et al.
observed that patients in the intervention group were indeed primarily highly
motivated, well-educated coronary patients (Scherwitz et al., 1995). So these
encouraging findings may not be easily translated to the general population of
coronary patients. It therefore remains a challenge for behavioral medicine to
develop enduring motivational strategies with these patients. One important
question raised by these trials is whether so radical a lifestyle change is actually
necessary to delay the />/t/j;/m/0« of coronary atherosclerosis. l>ess comprehensive
changes might have somewhat less favorable, but still positive, effects, and may be
acceptable for many more patients. Moreover, even modest reductions of serum
cholesterol lead to significant reductions in cardiovascular morbidity or mortality
(Scandinavian Simvastatin Survival Study Group, 1994). The lifestyle Heart Trial,
however, showed that clinically significant /r^rm/o// of coronary atherosclerosis is
feasible only if lifestyles arc changed radically; patients with the best adherence
showed the most regression, in particular after five years of follow up (Ornish et
al., 1990; Ornish ct al., 199H). The attitude of someone willing to make
comprehensive lifestyle changes may often be quite different from that of
someone preferring invasive procedures (i.e., FTCA, CABG). The decision to
make comprehensive lifestyle changes requires commitment, discipline and
willingness to assume personal responsibility for one's health (Ornish, 1998).
In spite of the largely favorable results of all reviewed studies, some trials did not
show unequivocal significant reductions in cardiovascular mortality or morbidity.
Although the patients' life quality was not an outcome variable that we focused on,
in our opinion it is equally important to also study improvements in paoents' well-
being and life quality as possible effects of non-pharmacological interventions. It is
well known that while quality of life may improve, changes in morbidity or
mortality cannot always be shown. Several other psychological outcomes of non-
pharmacological interventions should be studied as well, in particular depression
and vital exhaustion. Not only are depression and vital exhaustion frequently
mentioned consequences of AMI, they have also been shown to adversely affect
prognosis in patients with (illl) (l*ord et al., 1998; Frasure-Smith ct al., 1995; K.op
et al., 1994). These mood states are increasingly being recognized as important
targets for intervention, both pharmacological and cognitive/behavioral (Rozanski,
lMumenthal,& Kaplan, 1999).
The lack of significant reductions in cardiovascular mortality or morbidity in some
trials may partially be explained by the relatively small size study populations; these
simply may have been too small to detect any clinically significant differences.
Behavioral intervention studies generally are of necessity labor-intensive and most
often long-lasting, which raises qucsoons about the feasibility of this approach on
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a larger scale. Moreover, these evaluation studies are dependent on disease
incidence, as a result of which the number of subjects under study is often
unintentionally small. In this case, mcta-analysis may offer a solution; significant
effects may be detected that are otherwise not demonstrable us such in each single
study. The wide divergence of methods of intervention makes meta-analyses less
valid, however. Another problem often encountered with intervention studies is
selective drop-out; the experimental group may thus represent primarily highly
motivated patients as in the Ornish trials, because the less motivated drop out
before the end of intervention.
It should be emphasized that although some studies did not find significant overall
effects, they often do show favorable effects within specific patient subgroups.
Most studies focused on the mean effects of one particular rehabilitation program.
This way, individual differences in effects may be lost. Sub analyses may show
these effects; for example, a smoking cessation program that was not effective for
the entire group of coronary pancnts showed positive results tor patients with
severe AMI (Ockene et al., 1992).
Thus, to be maximally effective, risk management should focus on selection of
patients most likely to benefit from a particular program, or even better, patients
should be referred to such treatment which is most appropriate for their needs.
This is in accordance with recent general guidelines for cardiac rehabilitation as
formulated in Great Britain, the Netherlands, and other European countries, which
emphasize determination of the patients' needs, and individual subgoals for
rehabilitation (British Association for Cardiac Rehabilitation, 1995, Ncderlandse
Vereniging voor Cardiologie en de Nederlandse Hartstichung, 1995). In theory, the
most suitable type of cardiac rehabilitation should be chosen, but in actual practice,
the needs of individual patients arc still barely taken into account. To optimize the
effects of cardiac rehabilitation, every patient should be screened to determine
which risk factors contributed to his or her condition, after which the most
suitable cardiac rehabilitation program should be applied. Very likely this approach
will improve the patients' motivation, which could have a favorable influence on
the effects of the intervention. It was shown that exceptionally motivated patients
make comprehensive lifestyle changes which lead to improved cardiovascular
status. In order to reach the majority of patients, better applicable, though effective
behavioral interventions should be developed. In particular, the motivation to
sustain acquired lifestyle changes will have to be reinforced by noticeably favorable
effects, which ought to be larger with more intensive changes. Whatever the
patient decides, the cardiologist and psychologist should support this decision and
explain the relative risks, benefits, costs and side effects of each secondary
prevention approach, be it invasive or non-invasive, pharmacological or non
pharmacological (Ornish, 1998). Therefore, new research should focus on
maintaining motivation or the lack thereof in patients, as well as on the
modification of this latter attitude, e.g., by scrutinizing the quality of information
that patients receive from cardiologists and psychologists. In the final analysis, lack
of motivation most often leads to relapse and impaired prognosis.
37

CHAPTER 2
PSYCHOLOGICAL EFFECTS OF A
SHORT BEHAVIOR MODIFICATION PROGRAM
IN PATIENTS WITH ACUTE MYOCARDIAL
INFARCTION OR CORONARY ARTERY BYPASS
GRAFTING
Sebregts, E.H.W.J., Falger, P.R.J., Appels, A., Kcstcr, A.D.M., Bar, I-.W.H.M.
Psychological effects of a short behavior modification program in patients with
acute myocardial infarction or coronary artery bypass grafting. A randomi/cd
controlled trial.
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ABSTRACT
The effects of a short intervention on behavioral risk factor modification in
patients with coronary artery disease on type A behavior, vital exhaustion, and
depression were studied. Acute myocardial infarction patients or patients who
underwent coronary' artery bypass grafting were randomly assigned to an eight-
week multiple risk modification group program (// = 94) or a control group (n =
90) that received usual care with standard physical exercise training. Patients were
assessed before intervention, directly after intervention and at 9-month follow-up.
The intervention was effective in reducing hostility and total type A behavior at
postintcrvention (^  = .01) and at 9-month follow-up (p = .03). The intervention
had no overall impact on vital exhaustion. For patients with high baseline scores of
vital exhaustion, however, the intervention reduced vital exhaustion at 9-month
follow up compared to controls ty> = 03). No main effects were found for
depression measured by the Beck Depression Inventor)', whereas we unexpectedly
found that the percentage of patients with major depression was reduced in the
control group, but not in the intervention group. The results indicate that a short
behavioral intervention for coronary patients can result in relatively large and
persistent reductions in some psychological risk factors. Stronger effects might be
achievable in more distressed study populations. In view of the negative findings
on diagnosis of depression, we do not unequivocally advise the intervention to the
general population of AMI and CABG patients.
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INTRODUCTION
Coronary artery disease (CAD) is the leading cause of death in most industrialized
Western countries. Many psychological factors have been linked to CAD, as they
may be detrimental consequences ot the disease, or because they may exert an
additional nsk for the CAD patient. The significance of intervening in
psychological nsk factors is elucidated by several recent studies that have stressed
the influence of psychosocial risk factors on stabilizing underlying cardiovascular
pathophysiology (Hemingway & Marmot, 1999; Rozanski et al., 19')')). Prognosis
of patients with CAD may be adversely affected by vital exhaustion and depression
(Frasurc-Smith et al., 1995; Kop et al., 1994), whereas the type A behavior pattern
is another psychological factor that has been linked to CAD (Bracken & Powell,
1988; Jenkins, 1976; Matthews & Haynes, 1986; Rosenman et al., 197.S). Several
studies reported cpidcmiological uncertainties regarding type A behavior as being
an independent risk factor for recurrent AMI (Ragland & Brand, 1988; Smith,
1992). Nevertheless, the attention paid to this behavior pattern in rehabilitation
programs seems legitimate, since several clinical trials have demonstrated that an
intervention on type A behavior after AMI reduces the nsk of a new coronary
event (Burell, 1996; Burell et al., 1994; Friedman et al., 1986). Moreover, reducing
type A behavior may lead to a decrease in psychological distress factors related to
CAD, particularly vital exhaustion. In previous reports, it was postulated that vital
exhaustion might reflect a breakdown in adaptive mechanisms to prolonged and
uncontrollable psychological stress (Appels, 1990; Appels & Mulder, 1989; lalger,
1989). Type A behavior, a style of behavior characterized by a continuously
harassing sense of time urgency and easily aroused hostility, has been suggested to
increase the nsk of becoming exhausted.
Cardiac rehabilitation trials that showed clear positive results in reducing type A
behavior and psychological distress, and in reducing cardiovascular morbidity, are
comprehensive and lengthy (Burell et al., 1994; Fnedman et al., 1986). Such
intensive time-consuming programs arc not easily applicable in general health care
settings. Therefore, we intended to develop a relatively short intervention program
of eight weeks, accessible for a large group of AMI and Coronary Artery Bypass
Grafting (CABG) patients. Although many studies that demonstrated favorable
effects of psychosocial interventions were aimed at modification of one risk factor
in particular (Sebregts, Falger, & Bar, 2000), our intervention explicitly addressed
multiple modifiable nsk factors. It was directed at the reduction of psychological
stress / distress (type A behavior in particular), reduction of excessive
consumption of dietary fat, elevated serum cholesterol, lack of physical exercise,
and - although less explicitly - smoking and insufficient social support through
involvement of the patients' partners in the intervention (Falgcr, Sebregts, Van
Leuteren, & Bar, 2(XX>).>
' Effcos of the intervention on improving dietary habits and cholesterol are described in
chapter 3.
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The present paper presents the psychological effects of this intervention program.
We tested the hypothesis that the intervention reduces A behavior, vital exhaustion
and depression.
METHODS
Participants
All patients admitted to the University Hospital Maastricht, in Maastricht, the
Netherlands, during the period of February 1996 until November 1997 were
identified as eligible for the study by a team of physiotherapists working at the
hospital's physiotherapy department. These patients were referred to them by
cardiologists for physical training following AMI or CABG. Patients included were
less than 70 years of age, who were admitted to the University Hospital Maastricht
with a confirmed diagnosis of AMI, CABG, or both, and who were able to
participate in the regular physiotherapy exercise-program starting early after
discharge at the hospital. Two hundred patients were to be included in the study, a
number that was based on feasibility within the time limits of the study. Patients
were excluded if they were non-Dutch speaking, illiterate, or if they were currently
suffering from any psychiatric disorder that would severely disturb participation in
the intervention.
Procedure
After informed consent was given, patients were randomly assigned to either the
intervention (« ~ 106) or a control group (// = 98). A stratified randomization
procedure was developed by a person not further involved in the study to allocate
men and women to the intervention or control group. The outcome of the
randomization was put in a sealed envelope, and patients received this envelope
after the baseline interview. Both groups (intervention and control) received usual
medical care. For patients that were assigned to the intervention, the intervention
started within 3-8 weeks after discharge.
Psychological assessments for the intervention group were performed (1) at
baseline before the beginning of the intervention, (2) 8 weeks later immediately
after the intervention, and (3) 9 months after termination of the intervention,
which was approximately one year after admission to the hospital. Measures for
control patients were collected at comparable moments in time. Psychological
measures consisted of interviews and self-report questionnaires. The interviewers
(four in total) remained unaware of patient group assignment. All interviews were
recorded on videotape. Interviewers received an intensive training in conducting
and scoring the interviews.
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Usual care
Both the control group and the intervention group received the same usual medical
care, consisting of regular check-ups by a cardiologist who was blinded to group
allocation, and they all had postdischarge exercise training sessions. In the
Netherlands, exercise training is part of the usual care for patients with AMI or
CABG. Patients received standardized exercise training 3 times a week during 6
weeks.
During the regular medical check-ups, standard usual care was offered, comparable
to the care patients received who did not participate in the study. This meant that
the cardiologist systematically checked the clinical history, performed physical
examination, a 12-lead ECG recording was done and if appropriate, blood tests
were performed. Titrarion of drugs was performed until clinical results were
satisfactory. The cardiologist provided concise information on risk modification,
e.g., patients were advised to eat a low-fat diet. For each AMI patient exercise- tests
were performed according to the Bruce Protocol during hospitalization, and one
year after discharge. The CABG patients only had an exercise test one year after
discharge.
Intervention
In addition to the usual care described above, patients allocated to the intervention
were offered a combined stress-management and health education program during
eight weekly 2.5-hr sessions. Table 1 presents the outline of the program. The
contents of the intervention were primarily based on the methods of three major
long-term clinical trials, the Recurrent Coronary Prevention Project (Brackc &
Thorescn, 1996), Project New Ijfe (Burell, 1996), and the Ufestyle Heart Trial
(Omish et al., 1990), adapted to a format that would be feasible within the context
of a short intervention program. During the sessions, 6 to 10 cardiac patients and
their partners (whose participation was encouraged) were informed about CAD
risk factors and risk factor modification by a multidisciplinary team (table 1). The
first hour-and-a-half consisted of didactic presentations of these issues, including
advice and/or exercises to actively modify each participant's CAD risk factor
profile. In the remainder of each session participants were encouraged to report
their experiences with the issues at hand. Each session was concluded with
breathing and relaxation exercises based on the work of Van Dixhoorn (Van
Dixhoorn, 1997). The purpose of these exercises was primarily to increase the
patients' sense of relaxation and body awareness. Patients were given the oppor-
tunity to take an audiocassctte tape home with them to practice these breathing
and relaxation exercises. At the end of most sessions, patients were given
homework assignments, as well as written information, with reference to the
specific topics mentioned above. AU sessions were led by a psychologist, and cither
a social worker or a pastor was present as cothcrapist. After the last session, three
follow-up sessions were scheduled at 3, 6, and 9 months, in order to discuss the
achievement patients had made with respect to risk factor modification.
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Table 1. Contents of the intervention sessions
Sciiion Contents
1. Explanation of the aim of the intervention. An inventory is made of the
patients' histories and risk factors (psychologist).
2. The concepts of atherosclerosis, AMI and CABG (cardiologist).
3. Healthy diet (dietitian). Pancnts are given advice to cat a low-fat diet, how to
do K), and the health benefits of radical low-fat dietary changes are pointed out
to them. Special attention is paid to the favorable effects of a vegetarian diet.
4. Physical exercise (physiotherapist).
5. Type A behavior/hostility and stress: I (psychologist). Strategics are discussed
for modification of type A behavior. Signs and symptoms of type A behavior
are presented, together with epidemiological evidence about the pathogcnicity
of type A lwhavior. Ma|or behavioral drills from the Recurrent Coronary
Prevention Project are discussed.
6. Type A behavior/hostility and stress: II (psychologist). The concept of chronic
sympathetic hyperarousal as ma|or pathophvsiological process underlying type
A behavior is introduced. Health-promoting coping strategies with life stressors
and daily hassles, and prevention ol anger, hostility and aggression are
discussed and practiced.
7. Personal values and social support systems (pastor).
K. Evaluation of the program and identification ol problems in the process of
behavior change (psychologist). Contribution of general practitioner to
recovery process and behavior change (general practitioner).
Psychological measures
Ty/v ,-1 Ww/w was measured using a Dutch version of the Videotaped
Structured Interview (VSI) (Friedman & Powell, 1984). The VSI covers three
principal components of type A behavior: hostility, time urgency and insecurity.
An interviewer notes the content of a participant's responses to 32 questions, and
also observes and records specific psychomotor and physiologic manifestations
diagnostic of type A behavior (e.g., tense posture, head nodding when interviewer
speaks, interruption of the interviewer). For practical reasons it was not possible to
score psychomotor characteristics for the total study population. Instead,
videotaped interviews of a random sample of 50 patients were renewed to score
psychomotor, behavioral and physiologic manifestations of type A behavior at
baseline and 9-month follow-up.
I 7/rf/ r.v/««.r/fo» was measured by the Maastricht Interview for Vital
Hxhaustion (MIVH) (Meesters & Appels, 1996a; Meesters & Appels, 1996b). The
interview contains 23 items that can be answered by either jw (1 point) or «o (0
points). A score of ^ 8 is considered positive for vital exhaustion.
/ V/rr.fW /w<W .f/<;/c was assessed using a structured interview according to
the Diagnostic and Statistical Manual of Mental Disorders (third edition, DSM-III-
R) classification of Major Depressive Disorder (Structured Clinical Interview for
DSM 111 R, orSCID).
In addition to the interview, the Beck Depression Inventory (BDI) was
administered (Beck, Rush, Shaw, & Hmery, 1979). The BDI contains 21 items,
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covering symptoms and attitudes displayed frequently by depressed patients.
Scores < 10 represent none or minimal depression; 10-18 mild to moderate
depression; 19-29 moderate to severe depression; 30-63 severe depression (Bock,
Steer, & Crtrbin, 1988).
Clinical data
Clinical data, used for baseline comparisons of the intervention and control group,
were collected by a cardiologist from the University Hospital Maastricht, who was
blinded to the patients' group allocation. Structured inventories were filled out,
which contained items concerning the patient's medical history (obtained from the
medical files), angina pectons, dyspnea, enzymatic infarct size during
hospitalizadon, medication, and echocardiographic as well as angiographic data, if
available. In addition, during follow-up cardiac complaints and cardiac or other
events were recorded.
Statistical analyses
Analyses were performed according to the intention-to-treat principle, meaning
that patients were analyzed in the original groups formed by randomization.
Effects of the intervention on psychological outcome measures were assessed by
means of analyses of covariance (AN(X)VA), using the baseline scores as a
covariate to correct for differences in scores at baseline between the control and
intervention group. In addition, for each of the psychological outcome measures,
the variables gender, age, and 'AMI (+ CABCJ) versus (!AB(i only' were used as
preplanned covariates in the analyses. This last variable was included because of
the possible influence an AMI experience might have on the psychological
outcome measures. logistic regression analyses were used to compare the
intervention and control groups on SCID depression. Separate analyses were
performed for effects at postintervention and 9-month follow-up.
After these main analyses, an interaction variable (iroup Allocation x Baseline-
Score was included in the ANCOVAs to check whether intervention effects were
different for patients with high or low baseline scores on the psychological
variables. If the interaction variable was significant, subgroup analyses were
performed for patients with high or low baseline scores.
RESULTS
Participants and baseline characteristics
Figure 1 shows a flowchart of the patients approached for participation in the
study. 204 patients gave signed informed consent, which was 67% of all eligible
patients. One hundred patients refused to participate for the following reasons:
work or too busy (17%), no need, or knows how to make lifestyle changes without
help (17%), visiting the hospital too often, it will be too much (12%), not
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motivated to make changes (6%), personal or health problems (6%), partner does
not take part (5%), does not want any obligations (4%), prefers not to be
confronted with disease (4%), too shy to take part in group intervention (2%),
docs not want to hear other patients sorrows (2%), other (5%), unknown (20%).
Compared to participants, nonparticipants were more often female (participants
13.7% female vs. nonparticipants 33.0%; /> = .00). There were no differences
between participants and nonparticipants in mean age (55.6 vs. 57.3, respectively;/)
= .13) and cardiac incidence for which they were hospitalized (participants 69.1%
AMI, 7.8% AMI + CABG, 23.0% CABG; nonparticipants 73.0% AMI, 5.0% AMI
+ CABG, 22.0% CABG;/> = .62).
In spite of considerable efforts to reduce missing data to a minimum, dropouts
could not be avoided. Of all 204 patients included in the study, 20 dropped out,
reducing the total number of patients in the study to 184. Since they dropped out
before baseline measurement — the time at which patients received their group
allocation, this cannot have invalidated the randomization. Baseline demographic
and clinical characteristics of the total sample of 184 patients in the study are
shown in table 2. With reference to the psychological variables (type A behavior,
vital exhaustion, depression), statistically significant differences between patients in
the intervention group and control group were found on vital exhaustion, and a
trend for significance was found for BDI depression. On average, patients
randomi/i'il to the intervention group had higher scores on vital exhaustion (£ =
.05) and BDI depression >^ = .07) than patients in the control group (table 2).
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304 eligible paoenrs
100 excluded (refused to participate)
204 randomly allocated
106 allocated to intervention
92 received intervention
(12 dropped out before baseline
measurement, 2 did not
participate)
Psychological follow-up at
posnntcrvennon: « = 91
9 months: » = 89
89 in analysis
17 excluded (16 lost to follow
-up, 1 died)
98 allocated to usual care
control group
8 dropped out ol the
study before baseline
measurement
Psychological follow up at
posnntcrvention: « - 81
9 months: » = 86
81 in analysis
17 excluded (lost lo follow
up)
Figure 1. Flowchan of patients included in the study
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Table 2. Baseline characteristics of patients in control group («=94) and
intervention group (»=90)
Characteristic
Male
Clinical history
Previous myocardial infarction
Previous CA B(i
Previous PTf !A
Reason for admission
Myocardial infarcuon
Myocardial infarction + CABG
CAW;
Medication at entry in the study
Beta-blockers (2) '
Nitrate* (2)
Platelet inhibitor drugs or anticoagulant!) (2)
Clinical Mains at t-ntrv in the study
Angina pec tons (3)
Dyspnea (3)
Mean age, years |.VD|
Ixhocardiography at discharge: LVMF |J"DJ(58)
Psychological variables
Ty|x- A behavior (total) |.S7)|
Vital exhaustion |.W)| (1)*
Depression |TO| (HOI) (12)
"o Major Depression (SCID) (19)
Intervention
(*/.)
86.2
24.5
4.3
11.7
73.4
7.4
19.1
86.0
37.6
89.2
283
35.5
55.6 |8.0]
53.3 |9.0|
220.1 |54.7|
6.2 [4.9|
8.4 |6.8]
14.9
Control
(*/•)
86.7
22.2
2.2
8.9
66.7
7.8
25.6
82.0
29.2
87.6
16.9
29.5
55.2 |9.7]
51.6|11.4|
210.5 [62.4)
4.8 |4.5|
6.7 |5.2|
9.0
No/r 'Numbers in parentheses arc numbers of patients tor whom data arc not
available.CABCi — Coronary Artery Bypass Grafting; PTC A = Percutaneous Transluminal
Conmarv Angioplastv. I.YK1' = I .eft Ventricular Injection l-raction; BD1 = Beck Depression
Inventory. Range of scores for each measurement: Type A behavior 2-385; Vital exhaustion
0 23. Depression (BDI) 0-63.
Type A behavior
Scores on type A behavior and its components at baseline and follow-up are
reported in table 3. For two of the three different components of type A behavior,
the intervention effect was significant. In the intervention group, the reduction of
the cognitive hostility scores was 9.0 points larger than in the control group at
postintervention (ANCOVA, 95% CI: -15.1 / -2.8, F (1,164) = 8.24, /> = .01), and
7.7 p,,ims at 9 month follow up (95% CI: -14.5 / -0.9, F (1,164) = 4.97, /> = .03).-
Thc reduction in time urgency scores was 11.5 points larger in the intervention
group than in the control group at postintervenrion (95% CI: -19.8 / -3.2, F
(1,164) = 7.49,/. = .01) and 9.9 points larger at 9-month follow-up (95% CI: -18.0
/ 1.9, /• (1,164) = 5.94,/) = .02). The reduction in insecurity scores was 0.8 points
- Reported differences between control group and intervention group in this and subsequent
sections of chapter 2 are adjusted for baseline differences and aforementioned covanatcs
(ANCOVA).
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larger at postintervention, and at 9-month follow-up 1.8 points larger in the
intervention group than in the control group, a difference that was not significant
at posnntervenaon (95% CI: -6.5 / 5.0, F (1,164) = 0.07,/) = .79) or at 9-month
follow-up (95% CI: -7.5 / 4.0, F (1,164) = 0.37./) = .54).
In a random sample of 50 patients, psychomotor characteristics of type A behavior
hardly changed from baseline to 9-month follow up. The intervention group did
not differ from the control group regarding change of psychomotor hostility and
psychomotor time urgency scores, which was 0.6 points larger in the intervention
group (hostility, 95% CI: -6.1 / 5.0, F(l,44) = 0.04,/) = .84; time urgency. 95% CI:
-8.4 / 7.3, F(l,44) = 0.02,/> = .88).
ANCOVA was performed with the 50 patients whose psychomotor type A
characteristics were known, to compute the impact of the intervention on overall
type A behavior (psychomotor plus cognitive type A behavior; not in table). The
reduction in overall type A behavior at 9-month follow-up was 56.9 points larger in
the intervention group than in the control group (95% CI: -92.0 / -21.7, F (1,44) =
10.63,/) = .IK)). Figure 2 shows the reduction in overall tvpe A behavior at follow-
up for intervention and control patients (» = 50). The reduction from baseline in
type A behavior is expressed in overall .VD at baseline.
Table 3. Type A behavior and its components - mean scores at baseline, at
postintcrvention and at 9-month follow-up in the intervention and control group
Measure
Type A behavior / cognitive:
Hostility
Baseline
Post
9 months
Tune Urgency
Baseline
Post
9 months
Insecurity
Baseline
Post
9 months
Type A behavior / psychomotor
Hostility
Baseline
9 months
Time Urgency
Baseline
9 months
Af
74.1
50.3
53.6
100.1
62.6
66.5
45.4
24.4
25.8
32.3
31.6
42.1
42.1
Intervention
.17)
20.8
25.2
25.3
25.5
29.5
29.6
21.1
20.0
20.6
18 0
14.6
15.2
13.2
*
89
89
89
22
22
A/
71.2
57.2
58.9
983
72.8
75.0
434
24 1
26 3
37 0
35.0
50.0
46.6
Control
.17)
23.8
25.5
29.5
29.0
32.3
32.1
225
219
22.6
13 6
116
14.3
15.5
*
81
81
81
28
28
.N'o*. Range of scores for each measurement: Cognitive: f losriliry 2 145; Time Urgency 0-160;
Insecurity 0-80 Psychomoton Hostility 0-110; Time Urgency 0-110.
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- Control Intervention
Baseline 9 months
Figure 2. Changes in overall type A behavior in J"D at 9-month follow-up, for the
control group and the intervention group.-
Vital exhaustion
Table 4 shows the scores on vital exhaustion and depression. Due to missing data
there may be small differences in the number of subjects for the different outcome
measures.
The intervention group showed a reduction in vital exhaustion at post intervention
and 9 month follow-up, whereas the control group only showed a reduction at
postintervention. No statistically significant differences were found between the
scores of patients in the intervention and control group at postintervention; the
reduction was 0.1 points larger in the control group (ANCOYA, 95% CI: -1.1 /
1.4, /• (1,163) = 0.05,/) = 0.82) and 1.0 points larger in the intervention group at 9-
monih follow-up (95% Cl: -2.5 / 0.5, /-(1,163) = 1.64,/) = 0.20).
Although no significant intervention effects were reported in the total study
population on vital exhaustion, a significant (^> = .01) interaction of Group
Allocation (control/intervention) by Baseline Score in the ANCOVAs showed that
the effect of the intervention on vital exhaustion depended upon baseline scores. A
more favorable effect of the intervention on vital exhaustion was found in patients
with relatively high baseline scores, whereas no effects were reached in patients
who scored low at baseline. This is illustrated in figure 3.
Moreover, a sub analysis with patients who scored 8 or higher on the interview for
vital exhaustion showed that for this exhausted group of patients, the intervention
group showed a reduction in vital exhaustion which was 4.7 points larger than in
-' Figure 2 the ditYercnce between control group and intervention group m decrease of type A
behavior ttum baseline to tollo\vup:/> - .002.
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the control group after 9 months (95% Cl: -8.7 / -0.6, r-' (1,37) = 5.42, /> = .03).
Whereas the vital exhaustion scores in the intervention group dmpped from 11.5
[3.6] at baseline to 6.5 [6.5] at 9-month follow-up, the scores in the control group
dropped from 12.0 [3.4J at baseline to 11.5 [6.0] at follow-up.
Table 4. Mean scores on psychological outcome measures at baseline, at
posrintervention and at 9-month follow-up in the intervention and control group
Measure
Vital Exhaustion
Baseline
Post
9 months
Depression (BDI)
Baseline
Post
9 months
5.9
5.5
4.6
8.5
7.7
6.9
Intervention
.575
4.7
5.3
5.7
6.9
6.0
4.8
*
89
83
Af
4.7
4.4
4.7
6.4
5.8
5.8
Control
.57)
4.2
4.8
5.5
4.6
4.9
5.1
HO
75
i\o/r BDI = Beck Depression Inventor)-. Range of scores for each measurement: Vital
exhaustion 0-23; Depression (BDI) 0-63.
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Figure 3. Change in vital exhaustion scores from baseline to 9-month follow up
for different baseline scores of vital exhaustion.
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Depression
Differences between the intervention and control group in the scores of
depression (BDI) at postintervention and at 9-month follow-up were not
significant; the reduction was 0.5 points larger in the control group at
postintervention (ANCOVA, 95% CI: -0.8 / 1.7, /•"(1,152) = 0.50,/> = .48) and 0.1
points at 9-month follow-up (95% CI: -1.3 / 1.4, F (1,152) = 0.01,/) = .92). A
nearly significant (/> = .06) interaction in the ANCOVAs showed that the favorable
effect of the intervention on depression at 9-month follow-up was larger in
patients with unfavorable baseline scores of depression than in patients who
scored more favorably. A sub-analysis with patients who scored high on BDI
depression at baseline, however, revealed no significant intervention effects, since
the reduction was only 0.9 points larger in the intervention group than in the
control group (95% CI: -3.8 / 2.1, F(l,42) = 0.34,/) = .56).
The percentage of depressed patients as measured by the SCID interview increased
iti the intervention group from 15% at baseline to 17 % at postintervention and
21% at 9-month follow-up; in the control group 9% were depressed at baseline,
5% HI postintervention and 18% at 9-month follow-up. Effects on depression as
measured by this interview were assessed by means of logistic regression analyses.
At posrintcrvention, the odds ratio (OR) for depression as measured by the SCID
interview was 3.68 in favor of the control group (95% CI: 1.10 / 12.37,/> = .04).
The difference between the intervention group and the control group disappeared
at 9-month follow-up (OR = 1.01, 95% CI: 0.44 / 2.31,/. = .99).
Morbidity and mortality
The intervention group did not differ from the control group in number of
recurrent events at any of the follow-up measurements. All patients survived
during the 9-month follow-up period, apart from one patient in the intervention
group. Tlie cause of death was non-cardiac (cancer). A total of 17 patients had
experienced one or more recurrent cardiovascular events during the nine months
of follow-up; 9 in the intervention group and 8 in the control group. Ten patients
had had a CAIKJ operation (6 in the intervention group and 4 in the control
group), anil 8 patients underwent a PTC A (3 in the intervention group and 5 in the
control group) during the follow-up period. None of the patients experienced a
(recurrent) myocardial infarction.
DISCUSSION
The results of this study show that type A behavior can be reduced in coronary
patients through a relatively short intervention program aimed at behavior change
and risk reduction. In addition, patients who were exhausted at baseline showed
less vital exhaustion after 9 months compared to control patients. The reductions
that were found in type A behavior and vital exhaustion may have favorable
consequences for the prognosis of coronary patients, since these factors have been
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associated with increased nsk of a coronary incident (Bracken & Powell, 1988;
Kop et al., 1994). Moreover, it seems that the reductions can be achieved in a
relatively short period of time.
Caution is warranted, however, since the favorable reductions we found in type A
behavior were not reflected in the psychomotor characteristics of the behavior
pattern. Therefore, the possibility that intervention patients gave socially desirable
answers to the questions concerning type A behavior cannot be completely ruled
out.
Type A behavior was not only reduced in the intervention group, but in the
control patients as well. In our study, several factors may account for this decline.
First, patients after AMI or after a CABG probably try to change their behavior
spontaneously to reduce the risk of a recurrent event. The interview to assess type
A behavior at baseline - which was repeated at follow-up - may have made patients
more aware of their own behavior, which subsequently stimulated behavior
change. After each interview, the interviewer gave a short summary of the major
contents of each part of the interview, including the results of the Structured
Interview assessment. Second, the reduction in the control group might partly be
the result of contamination of treatment. Patients of both groups were able to
communicate with each other during the collective weekly physical therapy
sessions that formed a part of their usual care treatment, so information about the
program could have been exchanged.
Could the favorable effects of the intervention on type A behavior and vital
exhaustion be explained by regression to the mean, especially since the effects were
found in the high-risk group? In the total study population, the intervention group
had higher baseline scores than the control group, a difference that can only be
explained by coincidence, since randomization was performed with allocation
concealment, and by a person not further involved in the study. Because of the
higher baseline exhaustion scores, the intervention group can be expected to show
a larger reduction in those scores than the control group. In the subgroup analysis
of patients with high levels of exhaustion, however, the control group and the
intervention group did not differ in baseline scores. Thus, the fact that vital
exhaustion in the intervention group dropped to a lower level than in the control
group cannot be explained by regression to the mean.
No favorable effects were found on depression. Percentage of patients with major
depression as classified by the SCID even declined in the control group at
posrintervention, but not in the intervention group. This negative finding
dissipated at 9-month follow-up. Moreover, in accordance with previous studies,
among the dropouts a higher percentage of patients were depressed than among
the non-dropouts (Cooper, Uoyd, Weinman, & Jackson, 1999; I.anc, Carroll, Ring,
Beevers, & lip, 2001). Since depression constitutes a nsk for future cardiac events,
this is an alarming observation for which a solution has not yet been found
(Carney, Freedland, Yeith, & Jaffe, 1999; Ixspcrancc & Irasurc Smith, 20(X);
Wulsin, Vaillant, & Wells, 1999).
Although no significant effects were found in the total study group for vital
exhaustion and depression as measured with the BDI, it should be noted that the
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intervcnaon frKused more directly at modifying type A behavior than at altering
depression and vital exhaustion, which were addressed more indirectly. Specific
attention for vital exhaustion and depression might have increased favorable
intervention effects.
Comparison with relevant studies
In a review on nsk factor modification through nonpharmacological interventions
in coronary patients (Scbregts et al., 2000), three major randomized clinical trials
were found evaluating an intervention aimed at type A behavior modification
(Burell, 1996; Burell et al., 1994; Friedman ct aJ., 1986). All three studies reported
significant reductions of type A behavior after a lengthy, time-consuming
intervention. One of these studies reported a significant reduction in BDI scores
for the treatment group compared with the control group as well (Burell, 1996).
The considerable advantage of our program over previous trials is that the patients
were offered a relatively short intervention, which is easily applicable in general
health care settings. In our study, overall type A behavior decreased after 9 months
by 1.4 .V/J in the intervention group, whereas the control group showed a decrease
of 0.6 .17). The Recurrent Coronary Prevention Project (RCPP) showed
comparable reductions in Videotaped Structured Interview scores of type A
behavior after comprehensive type A behavioral counseling during 4.5 years
(Friedman ct al., 19H6).
In a meta-analysis published by Dusseldorp et al (Dusseldorp et al., 1999), the
effects of psychoeducational health education and stress management programs
for coronary heart patients were examined. In this meta-analysis, no effects of
psychoeducational programs were found in regard to depression. Several large
studies were included in this meta-analysis (Frasurc-Smith et al., 1997; Jones &
West, 1996). The results of the study presented in this paper do not differ from the
majority of these previous studies. In order to reduce depression in patients with
coronary artery disease, we may need to adapt the contents of our interventions.
Limitations of the study
The sub analyses with patients with high baseline scores were not preplanned, but
were conducted since baseline scores on psychological variables in our study group
were generally low. The total study population scored 5.3 on the MIVE. Although
this is higher than a mean score of 3.6 observed in healthy males, it is considerably
lower than a score of H or higher, at which point persons are said to be exhausted
(Meesters & Appels, 1996b). The mean BDI score for depression in our study was
7.5, while persons scoring 10 or higher are considered depressed. So, in these
patients, little improvement could be expected, and positive intervention effects
might have been found if patients had been more distressed at baseline. This is
indeed suggested by the positive interactions that were found with intervention
effects and baseline measurements. Higher scores of vital exhaustion and
depression were associated with larger favorable effects of the intervention. Future
intervention studies should focus on more distressed study populations.
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This study was not conducted around one primary outcome measure, but we used
multiple outcomes. Multiplicity of outcomes increases the nsk ot" some false-
positives. In a study such as this, more than one measure of outcome is relevant,
however, which is illustrated by the fact that most studies on cardiac rehabilitation
programs use multiple outcome measures. Moreover, if we correct the positive
results for type A behavior for multiplicity of outcomes, significant results arc still
found for the favorable reduction in overall type A behavior after 9 months, and
for the favorable reductions in cognitive hostility scores at postintervenrion as well
as for the reduction in cognitive time-urgency scores at postinterventioii and at 9-
month follow-up.
Due to the design of the study it is impossible to indicate which elements or
components of the intervention attributed to the positive results. We could not
control for nonspecific aspects of the intervention such as attention and the
mutual support given by the participants. We merely wanted to study whether a
short intervention can be effective in reducing detrimental psychological factors in
CAD patients. Consequently, the srudy was designed with two arms only:
intervention and usual care. No separate arm, for example, was formed by an
intervention without attention to type A behavior. Therefore we cannot say that
especially this part of the intervention resulted in the reduction of type A behavior.
Another weakness is formed by the absence of a thorough registration ot exercise
habits. It is possible that changes in exercise have contributed to the beneficial
effects of the study. However, we consider that to be an unlikely explanation
because all patients were stimulated to exercise as part of the standard physical
rehabilitation program all patients received.
Despite these limitations, the results of this intervention study indicate relatively
large and persistent reductions in type A behavior, although this is not reflected in
the patients' psychomotor characteristics of type A behavior. Although no main
effects of the intervention are seen in scores of vital exhaustion, the results indicate
reductions in vital exhaustion after the intervention in patients with high baseline
exhaustion scores, thus, those who need it. No main intervention effects are found
in BDI depression scores. The higher reduction in percentage of patients with
major depression that was found at postintervention in the control group
compared to the intervention group, however, should make us cautious of advising
the intervention to the general population of AMI and CABCJ patients under the
the age of 70.
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APPENDIX TO CHAPTER 2:
SECONDARY PSYCHOLOGICAL OUTCOME MEASURES
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Introduction
The aforementioned results show the primary psychological outcome measures of
this study, i.e. type A behavior, vital exhaustion and depression. Quality of life and
anxiety served as secondary outcome measures, and die results concerning diese
outcomes arc reported below (table A). The results will briefly be described in die
general discussion of this thesis.
In addition, post-hoc analyses will be presented in which differential effects of die
intervention were studied for men and women, lor this purpose, an interaction
variable Group Allocation by Gender was included in the aforementioned
ANCOVAs for studying intervention effects on psychological variables.
Secondary psychological outcome measures
^«tf///y 0/ /*/<• was determined by a Dutch translation of the
Multidimensional Index of life Quality (MILQ), which is a 35-item instrument for
measuring quality of life in patients with cardiovascular disease (Avis et al., 1996).
Kach item is scored on a 7-point scale reflecting the respondent's degree of
satisfaction with the item, ranging from 1 (= very dissatisfied) to 7 (= very
satisfied). The total score was computed by taking the unweighted sum of all
scores.
,'f».vr>/)' was measured by administering a Dutch version (ZBV) of the
Spiclbcrgcr State-Trait Anxiety Inventory (STAI) (Spielbergcr, Gorsuch, &
l.ushenc, 1970; Van der Plocg, Defares, & Spielbcrger, 1980). Both the State and
Trait scales of the STAI contain 20 items. Each item is scored on a 4-point scale,
ranging from 1 (= not at all) to 4 (= very much).
Table A. Results of ANCOVA comparing the intervention and control group on
postintervention and at 9-month follow-up scores of quality of life and anxiety, in
which baseline scores are used as a covariate"
Measure
Quality of life
Baseline
Post
9 months
State Anxiety
Baseline
Post
9 months
Trait Anxiety
Baseline
Post
9 months
Intervention
A/
178.0
189.5
190.0
39.0
38.8
38.0
38.0
38.3
36.6
JO »
32.7 83
29.5
28.1
11.8 80
11.9
10.9
11.5 80
11.5
10.7
Af
183.7
190.6
192.0
38.0
35.4
35.6
36 8
36.1
35.5
Control
JT>
26.8
25.4
27.0
9.2
10.6
9.6
8.6
10.0
9.5
76
75
76
I-
2.13
0.39
3.821
212
0.81
0.04
No*. Range of scores for each measurement: Quality of Life 35-245; State and Trait
Anxiety 20-80. '(lovariatcs in these analyses were baseline score. gender, age.
"AMI (+C'.ABCi) VS. ('..UK; only" •/> < .05. V < .10
58
Psvcholoijifal ctYccts
Gender differences in intervention effects
Previous publications raised the suggestion that interventions may have a different
effect on men and women (Brezinka and Kittel, 1995; l-'rasurc-Smith et al., 1997;
Linden, 2000; Linden et al., 1996; McGee and Horgan, 1992). In our study, the
interaction variable Group Allocation by Gender was nearly significant or
significant in the analyses of vital exhaustion (/> < .10), quality of life (^> < .05), state
anxiety >^ < .05) and trait anxiety >^ < . 10), suggesting more favorable intervention
effects for men than for women. There were not enough women in our study to
conduct separate analyses for women. The number of men was large enough to
conduct separate analyses. Although sub-analyses for men did not yield significant
intervention effects on the reduction of anxiety, we found (with a trend for
significance) that the intervention was effective in reducing vital exhaustion. At 9-
month follow-up, men in the intervention group showed a 1.5 larger decline in
vital exhaustion (baseline 5.82, 9 months 4.18, * = 77) compared to control
patients (baseline 4.45, 9 months 4.69, » = 71), ANCOVA, 95% CI: -3.0 / 0.1, F
(1, 143) = 3.26, /> = .07. Moreover, the increase in quality of life was 5.7 points
larger in men in the intervention group compared to controls at posrintervention,
95% CI: 0.3 / 11.2, F ( l , 133) = 4.39,/> = .04, and 5.2 points larger at 9 month
follow-up, 95% CI: -0.9 / 11.3, F (1, 133) = 2.83,/> = .09 (Intervention: baseline
177.6, post 189.9, 9 months 191.4, /» = 71; Control: baseline 184.0, post 190.0, 9
months 191.3, » =67).
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CHOLESTEROL CHANGES IN CORONARY PATIENTS
AFTER A SHORT BEHAVIOR M( )DII'ICATI( )N
PROGRAM
Scbregts, E.H., Falger, P.R., Bar, F.W., Kester, A.D., and Appels, A. (2003)
Cholesterol changes in coronary patients after a short behavior modification
program. International Journal of Behavioral Medicine, 10, 315-330.
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ABSTRACT
Scrum cholesterol changes after an 8-week behavior modification program for
patients with coronary artery disease (CAD) were studied in a randomized
controlled clinical trial. Acute myocardial infarction (AMI) or coronary artery
bypass grafting (CABCi) patients were randomly assigned to the intervention (« =
94) or to usual care (» = 90). After 9 months' follow-up the intervention was
effective in reducing total cholesterol and LDL cholesterol levels, particularly in
patients with high baseline lipid levels. After correcting for changes in dose of
statins during follow-up, effects were weakened, but for patients with high baseline
cholesterol levels favorable effects remained. In these patients, the intervention
group showed a decline of total cholesterol and LDL cholesterol levels of 20% and
29%, respectively, compared to a 12% and 19% reduction in the control group >^
< .01). These effects could not be explained by changes in dietary fat consumption.
An unexpected finding was a lower increase in HDL cholesterol in the intervention
group than in the control group.
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INTRODUCTION
In clinical practice, the standard procedure to reduce the risk exerted by an
elevared cholesterol level in coronary artery disease ((IAD) panents is through
pharmacological treatment, i.e., cholesterol-lowenng agents (usually statins) and a
cholesterol-lowering diet. Since the statins are already quite effective in reducing
cholesterol levels (Sacks et al., 19%; Scandinavian Simvastarin Survival Study
Group, 1994), the question arises whether behavior modification interventions can
make an additional contribution to this reduction.
In a recent review on the effects of nonpharmacological interventions for CAD
patients, it was concluded that interventions aimed at a healthy lifestyle reduce
elevated serum total and LDL cholesterol concentrations in CAD patients
(Sebregts et al., 2000). Some of the studies reported in this review even showed a
reduction of coronary atherosclerosis after successful modification of patients'
lifestyles (Niebauer et al., 1997; Ornish et al., 1990; Watts et al., 1992). However,
the use of statins nowadays is more widespread than during the time these studies
were conducted. Moreover, such favorable effects were found in trials evaluating
intensive interventions with a duration of at least one year and was probably
reached only in a selective group of highly motivated CAD patients (Niebauer ct
al., 1997; Omish et al., 1990).
If interventions need to be this comprehensive to successfully alter elevated serum
cholesterol levels and other risk factors, probably only a minority of eligible CAD
patients will be reached. Moreover, such interventions arc too expensive and too
rime-consuming to implement in general health care. Applicability of behavioral
interventions in general health care would be improved if interventions were short
- but nonetheless as effective as the comprehensive ones.
In the present study it was intended to alter serum cholesterol levels in acute
myocardial infarction (AMI) or Coronary Artery Bypass drafting (CABCi) patients
through a relatively short intervention, which is directed at the improvement of a
healthy lifestyle - dietary habits in particular - and reduction of psychological
stress.' This paper tackles the following questions: (1) Docs this intervention lead
to reduced scrum cholesterol levels? (2) If so, can the reduced cholesterol levels be
explained by (a) altered medication regimen, or by (b) reduced dietary fat
consumption?
METHODS
Participants
All patients admitted to the University Hospital Maastricht during the period of
February 1996 until November 1997 were identified as eligible for the study by a
team of physiotherapists working at the hospital's physiotherapy department.
Psychological effects of the intervention will be published elsewhere.
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These patients were referred to them by cardiologists and cardiac surgeons for
physical training after AMI or CABG. Patients included were < 70 years of age;
who were admitted to the University Hospital Maastricht with the confirmed
diagnosis of AMI, CABG, or both; and who were able to participate in the regular
physiotherapy exercise-program after discharge from the University Hospital
Maastricht. The number of patients that was included in this study was based on
feasibility within the time limits of the study. Patients were excluded if they were
non-Dutch-speaking, illiterate, or were currently suffering from any psychiatric
disorder that would severely disturb participation in the intervention. During this
21-month period, signed informed consent was given by 204 patients (67% of all
eligible patients).
Procedure
After informed consent was given, patients were randomly assigned to either the
intervention (« = 106) or to the control group (/» = 98). Both groups received
usual medical care. Patients that were assigned to the intervention group enrolled
into a multiple risk modification program for secondary prevention of CAD. This
intervention started within 3-H weeks after discharge.
Questionnaires concerning dietary habits and interviews concerning smoking for
the intervention group were assessed (1) at baseline, before the beginning of the
intervention, and (2) 9 months after termination of the intervention (approximately
one year after admission). Measures for control patients were collected at compara-
ble moments in time. The interviewers remained unaware of patient group
assignment.
Usual care
Both the control group and the intervention group received the same usual
medical care, consisting of regular check-ups by a cardiologist who was blinded to
patient group allocation, and postdischarge exercise training sessions. In the
Netherlands, exercise training is part of the usual care for patients with AMI or
CABG. Patients received standardized exercise training three rimes a week during
6 weeks.
During the regular medical check-ups, standard usual care was offered, comparable
to the care patients received who did not participate in this study. This meant that
the cardiologist systematically checked the clinical history, performed physical
examination, did a 12-lead HCG recording, and, if appropriate, performed blood
tests. The cholesterol level of each patient was followed until his or her cholesterol
reached satisfactory levels. The cardiologist provided concise information on risk
mollification like unfavorable cholesterol levels and the favorable effects on
prognosis of lowering cholesterol. In case of elevated values at baseline, patients
were advised to eat a low-fat diet, and cholesterol-lowering drugs were given, after
which serum cholesterol was measured and amount of drugs was increased until
the results were satisfactory. The following were considered high levels: elevated
total cholesterol levels > 5.0 mmol/L (193 mg/dl), elevated LDL cholesterol > 3.0
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mmol/L (116 mg/dl) (as these were the cholesterol levels above which it was
advised to intervene), reduced HDL cholesterol < 1.0 mmol/L (39 mg/dl), and
elevated level of tnglycerides > 2.0 mmol/L (177 mg/dl). In the panents already
treated with cholesterol-lowenng drugs, further ritrarion of this medication was
performed if needed. For each AMI patient exercise-tests were performed
according to the Bruce Protocol during hospitalization, and one year after
discharge. The CABG patients only had an exercise test one year after discharge.
Intervention
In addition to the aforementioned usual care, patients allocated to the intervention
group were offered a combined stress-management and health education program
during eight weekly 2.5-hr sessions. The contents ot the intervention were
primarily based on the methods of three major long-term clinical trials, the
Recurrent Coronary Prevention Project (Bracke & Thoresen, 1996), Project New
Life (Burell, 1996), and the Ijfestylc Heart Trial (Orrush et al., 1990), adapted to a
format that would be feasible within the context of a short intervention program.
During the eight weekly sessions, 6 to 10 cardiac panents and their partners
(whose participation was encouraged) were informed about CAD risk factors and
risk factor modification by a multidisciplinary team. The first hour-and a half
consisted of interactive didactic presentations of these issues, including advice,
exercises to actively modify each participant's CAD risk factor profile, or both.
Patients were given advice to eat a low-fat diet, how to do so, and the health
benefits of radical low-fat dietary changes were pointed out to them. Special
attention was paid to the favorable effects of a vegetarian diet, and information
was given on cholesterol, e.g., the benefits of a low total and I.DI. scrum
cholesterol. In the remainder of each session participants were encouraged to
report their experiences with the issues at hand. P.ach session was concluded with
breathing and relaxation exercises based on the work of Van Dixhoorn (Van
Dixhoorn, 1997). The purpose of these exercises was primarily to increase the
patients' sense of relaxation and body awareness. At the end of most sessions,
patients were given homework assignments, as well as written information, with
reference to the specific topics mentioned earlier.
Clinical data
Clinical data were collected by a cardiologist who was blinded to the patients'
group allocation. Serum cholesterol (total, LDL, HDL, tnglvcendes) used for the
study was measured in a fasting state, at least at baseline and at 9-month follow-
up. Height of the panents was measured during the first outpatient visit, whereas
weight was measured during all visits, from height and weight measures. Body
Mass Index (BMI) was calculated.
Additional clinical data, used for baseline group comparisons, were collected
through structured inventories, which were filled out by the same cardiologist.
Among other things, this baseline inventory contained items concerning the
patient's medical history (obtained from the medical files), angina pectoris,
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dyspnea, enzymatic infarct size during hospitalization, medication, and
echocardiographic as well as angiographic data, if available. In addition, during
follow-up cardiac complaints and cardiac or other events were recorded.
Interviews and questionnaires
Dietary fat consumption was measured through a self-report questionnaire, in
which the respondent is asked about his or her food consumption during the last 4
weeks (Fcunckes, Van Stavcren, De Vries, Burema, & Hautvast, 1993; Feunekes,
Van Staveren, Gravcland, De Vos, & Burema, 1995; Wagcningen University,
1993). From this questionnaire, consumption of fat (in grams/day) could be
calculated by means of a computer program (Wageningen University, 1993). Self-
reported smoking habits and alcohol consumption were measured through a
structured interview on lifestyle (Falger, 1989).
Data analysis
First, docs the intervention lead to reduced serum cholesterol levels? Analyses were
performed according to the intention to treat principle, meaning that patients were
analyzed in the original groups formed by randomization. All patients allocated to
the intervention group were included in the analyses irrespective of their level of
participation. I Effects of the intervention on cholesterol level were assessed by
means of analyses of covariance (AN(X)VA), using the baseline cholesterol levels
as a covariate to correct for differences in scores at baseline between the control
and intervention group. In addition, for each of the outcome measures, the
variables gender, age, cholesterol-lowering medication and antidiabetic medication
at baseline, and "CABG vs. no CABG" were used as covariates in the analyses.
One of the reasons this last variable was included was because cholesterol levels
can be temporarily reduced as a consequence of a CABG operation itself.
After these main analyses, an interaction variable (Group Allocation x Baseline
Cholesterol Level) was included in the ANCOVA to check whether intervention
effects were different for patients with high or low baseline cholesterol levels. A
posteriori, we compared change in alcohol consumption, smoking rates and BMI
from baseline to follow-up between control and intervention group, as these
factors may be related to cholesterol level.
Second, can reduced cholesterol levels in the intervention group be explained by
(a) altered medication regimen, or (b) reduced dietary fat consumption? (a) To
check whether (possible) effects could be explained by altered medication regimen,
changes of cholesterol-lowering medication from baseline to follow-up were
studied tor the intervention group and the control group. Changes of cholesterol-
lowering medication from baseline to follow-up were then added as a covariate in
the ANCOVA, to study whether this led to any changes in reported intervention
effects, (b) To study whether changes in rat consumption were different in
intervention and control group, an ANCOVA was performed in which baseline
dietary fat consumption was used as a covariate. Other covariates were copied
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from the cholesterol analyses (with the exception of baseline cholesterol-lowering
medication). An interaction variable was later added to the model to study whether
results were different for patients with high or low baseline die tan' fat
consumption. In case of a significant interaction, separate analyses were performed
for patients with high (> 80 g fat intake per day, based on guidelines for fat
consumption carried out by Dutch nutritionists) and low (S SI) g tat intake per
day) baseline dietary fat consumption. In order to study whether the reported
changes in dietary fat consumption contribute to changes in serum cholesterol
level, an ANCOVA was performed in which change in dose of statins from
baseline to follow-up was used as a covanate.
After these initial analyses, the aforementioned analyses were repeated using the
method of'the last observation carried forward". Missing values at follow up were
replaced by the last observation, which was carried forward. Missing data at
baseline were replaced by the mean of all baseline values, provided that at least one
follow-up measurement was available.
RESULTS
Baseline characteristics and number of patients remaining in this study
after 9 months
In spite of considerable efforts to reduce missing data to a minimum, dropout*
could not be avoided. Of all 204 patients included in the study, 20 dropped out,
reducing the total number of patients in the study to 184. Since they dropped out
before baseline measurement - the time at which patients received their group
allocation, these patients were not aware of group allocation. Baseline demographic
and clinical characteristics of the total sample of 184 pancnts in the study arc
shown in table 1. No major differences were found between the intervention and
control group.
Initial analyses
00 .
Table 2 shows changes in scrum lipid levels during the intervention period. After 9
months, serum total cholesterol dropped by 8% in the intervention group, and by
2% in the control group. The difference in reduction of total scrum cholesterol
level between both groups reached stanstical significance, /• (1, 160) = 5.45,/> =
.02. A stronger decline in I.DI. cholesterol (15%) was observed in the intervention
group than in the control group (10%), which was close to significance, /• (1, 157)
= 3.48,/> = .06. HDL cholesterol increased both in the intervention group (11%)
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and in controls (23%), with a significant difference between both groups in favor
of the control group, /•" (1, 157) = 9.90, /> = .00. Tnglycerides showed a slight
decrease in both groups, without any difference between the control group and the
intervention group, /•' (1, 159) = 0.22,/) = .64. The effects of cholesterol-lowering
medication will be described shortly.
Table 1. Baseline characteristics of patients in intervention and control group
Characteristic
Male, %
Mean age, yr |.rD|
Clinical history
Previous myocardial infarction, %
Previous CAIK, , ' .
Previous PTC.A. %
Reason tor admission
Myocardial infarction, %
Myocardial infarction + CAB(i,%
C.AB(i.%
Clinical status at entry in the study
Angina pcitoris, % (3)'
Dyspnea, "..(3)'
Infant size: ASAT maximum, 171. |.fO| (2)'
I.VKI'. % |TD| (58)'
Kxcrcisc tolerance, minutes |.VD]''
Intervention
f-/> = 94)
86.2
55.6 [8.0|
24.5
4.3
11.7
73.4
7.4
19.1
28.3
35.5
174.3| 138.2|
53.3 |9.0|
8.8 [2.2]
Control
fa =90)
86.7
55.2 [9.7|
22.2
2 2
8.9
66.7
7.8
25.6
16.9
29.5
193.2| 18(>.1|
51.6 |11.4|
8.7 |2.31
iVe/r CAIKi Coronary Artery Bypass Cirafting; PTCA = Percutaneous Transluminal
Coronary Angioplasty; ASAT = Asparutc Aminotransfcrase; IAT.F = I .eft Ventricular
1'iection I'raction.
'Numbers in parentheses are numbers of patients for whom data were missing,
'•r.xcrcisc tolerance at entry in the study (walk test according to Bruce protocol)
was only available for 90 AMI patients and not fur CABG patients.
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Table 2. Serum lipid levels in the intervention and control group at baseline and at
9-month follow-up*
Measure
Total Cholesterol (mmol/1.)
Baseline
9 months
LDL Cholesterol (mmol/L)
Baseline
9 months
HDL Cholesterol (mmol/L)
Baseline
9 months
Tnglycendcs (mmol/L)
Baseline
9 months
Intervention
Af
5.17
4.74
3.48
295
0.95
1.05
1.91
177
1.22
0.78
1.12
068
0.30
0.30
1 25
1.00
*
84
84
83
83
83
83
84
84
Af
5.09
4.«P
3.47
3.14
0.94
1 16
1 68
1.57
Control
JD
1.03
0.81
0.98
0.79
U.27
0.32
0.71
0.84
•
84
84
82
82
82
82
83
83
i\'o/». 'To convert cholesterol values from mmol/L to mg/dl, multiply by
38.67. To convert tnglyccnde values from mmol/L to m^/dl, multiply by
88.57.
The interaction variable Group Allocation x Baseline Cholesterol Ixrvel reached
significance for total cholesterol (^  = .02) and LDL cholesterol (/> - .01); thus,
effects of the intervention on total cholesterol and 1.1)1. cholesterol were
significantly related to baseline lipid level. The effect of the intervention on
reducing total serum cholesterol was present only in patients with relatively high
baseline cholesterol. This is illustrated in figure 1, which shows the changes in
cholesterol levels in the intervention and control group for patients with different
cholesterol levels at baseline. In patients with elevated baseline total cholesterol
levels (i.e., > 5.0 mmol/L), total cholesterol dropped by 20% in the intervention
group, whereas in the control group total cholesterol level fell by 12%, / ( I , 75) =
8.58. /> = .00.
In patients with elevated total cholesterol levels (> 5.0 mmol/L), LDL cholesterol
fell by 29% in the intervention group. The reduction was smaller in the control
group, where patients showed a 19% decrease in LDL cholesterol, / • (1 , 75) = 9.56,
/> = .(X). In patients with elevated cholesterol levels, no intervention effects were
found for HDL cholesterol, F (1, 75) = 1.64, /> = .20 and triglyccndcs, /"•" (1, 75) =
0.09,/>= .76.
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D (Control B Intervention
< = 4 > 4 - 5 > 5 - 6 > 6 - 7 > 7 - 8
Baseline total scrum cholesterol level (mmol/L)
Figure 1. Change in total scrum cholesterol level from baseline to 9-month follow-
up in intervention and control group.
Alcohol consumption, smoking rates, and BMI could not account for any of the
effects, as no difference was found between the intervention and the control group
in change in alcohol consumption from baseline to follow-up (« = 164,/) = .76),
number of patients that had cjuit smoking (intervention group 21.3%, control
group 22.2%, w = 170, /> = .89), and change in BMI (intervention group increase of
1%, control group 2%, » = 165,/> = .67).
To check whether the difference in reduction of total scrum cholesterol and LDL
cholesterol between the intervention and control group could be explained by a
difference in cholesterol lowering medication regimen during follow-up, both
groups were a posteriori compared with regard to change in prescribed dosage of
cholesterol lowering medication from baseline to follow-up. Cholesterol-lowering
medication at baseline and at tollow-up is described in table 3. At 9-month follow-
up, Kl% of all patients received statins, whereas a minority of 10% received
cholesterol-lowering medication other than statins. The control group and the
intervention group did not differ in percentage of patients receiving cholcsterol-
lowenng medication. During the 9-month period, however, the intervention group
had a larger increase of prescribed dosage of statins (7.1 milligrams) than the
control group (4.\ milligrams,/) = .06).
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Table 3. Cholesterol-lowering medication at baseline and at 9-month follow-up in
intervention and control group
Medication
All cholesterol-lowering
medication
Intervention
Control
Sunns
Intervention
Control
Cicmfibrozil
Intervention
Control
Acipimox
Intervention
Control
< 'holestvramine
Intervention
Control
54.8
51.2
52.4
50.0
4.8
2.4
0.0
0.0
0.0
1.2
Baseline
dose in nig/day
(JO)'
„ C
10.8 (12.5)
10.0(12.0)
57.1 (257.1)
21.4(145.7)
0.0 (0.0)
0.0 (0.0)
0.0 (0.0)
0.1 (0.9)
%
83.3
86.9
81.0
81.0
8.3
8.3
1.2
1.2
0.0
1.2
9 months
dose in nig/day
-
17.9(16.7)
14.3(12.5)
85.7 (337.7)
100.0 (333.7)
3.0 (27.3)
3.0 (27.3)
0.0 (0.0)
0.1 (0.9)
84
84
84
84
84
84
84
84
84
84
r 'Mean dose (in mg/day) fr>r entire control group or intervention group
•included arc only those patients with known lipid levels at baseline and at follow up, i.e.,
onlv patients who arc also included in the cholesterol analyses.
'Dose prescriptions of all cholesterol -lowering medication can not be added
There were no differences between both groups in dose prescriptions in any of the
other cholesterol-lowenng medications.
If the former ANCOVAs were corrected for change in prescribed dosage of statins
from baseline to follow-up, the favorable effects of the intervention on reduction
of total serum cholesterol reached a trend for significance, /• (1, 160) = 3.62,/) =
.06. In an analysis with the subgroup of patients with elevated baseline total
cholesterol level, controlling for statin changes during follow-up did not alter the
significance of the favorable effects, /• (1, 75) = 5.69, /> = .02. The effects of the
intervention on LDL cholesterol changed slightly after controlling for statins in the
total study population, F (1, 157) = 2.05,/) = .15. I-'or the subgroup of patients
with high baseline cholesterol, however, the difference between intervention and
control group remained significant, /• (1, 75) = 6.10,/) = .02. Controlling for statins
in the HDL and tnglyceride analyses did not change any of the results that were
previously found. In the subgroup of patients with elevated cholesterol levels, after
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controlling for statins HDL cholesterol increased to a larger extent in the control
group compared to the intervention group, F( l , 74) = 5.22,/> = .03.
During follow-up, dietary fat consumption decreased in the intervention group by
15 grams per day (from 100 grams/day to 85 grams/day), whereas the control
group showed a reduction of 8 grams per day (107 at baseline, 99 at follow-up).
ANCOVA demonstrated that the difference between both groups was almost
significant, F (1, 142) = 3.71, /> = .06. The intervention was more effective in
reducing dietary fat consumption in patients with lower baseline dietary fat intake
than in patients with higher dietary fat intake at baseline, which was demonstrated
by a significant interaction variable Group Allocation x Baseline Dietary Fat
Consumption (^  = .04). In patients with relatively low dietary fat intake at baseline
(i.e. < 80 grams/day), the intervention group showed a reduction of dietary fat
intake of 10%, whereas the control group increased dietary fat intake with 28%, F
(1, 141) = 9.76, /> = .(X). In patients with high baseline dietary fat intake, no
intervention effects were found. In this subgroup of patients, the intervention and
control group reduced dietary fat intake with 16% and 14%, respectively.
Change in dietary fat consumption did not contribute to a change in serum
cholesterol, / ( I , 146) = .00,/) = .98. A posteriori-performed subgroup analyses,
however, revealed that the relation between scrum cholesterol levels and dietary fat
consumption depended upon baseline fat consumption. Reduction in dietary fat
consumption contributed significantly to a reduction in serum cholesterol in the
subgroup of patients with relatively low baseline dietary fat intake (i.e. < 80
grams/day, « = 48), F (1, 45) = 8.9, /> = .01. In patients with high baseline dietary
fat intake (i.e. > 80 grams/day), no relation was found.
'Lam observation carried forward' analyses
During this study, 10 patients had missing lipid values at 9-month follow-up,
equally divided among control group and intervention group. These values were
replaced by the last observed value. For patients with missing values at baseline,
missing data were replaced for the mean of all baseline values, provided that at
least one follow-up measurement was available.
The intervention remained effective in reducing total cholesterol levels with a trend
for significance, F (1, 174) = 3.54,/> = .06. The effects on LDL cholesterol for the
total group were no longer significant, F ( l , 174) = 2.04,/> = .16, HDL cholesterol
increased to a larger extent in the control group compared to the intervention
group, F (1, 174) = 8.24,/) = .01, and the changes in triglycerides did not differ
between both groups, / ( I , 174) = 0.28,/) = .60. Controlling for statins did not
lead to changes in these findings.
Fat consumption was no longer reduced to a larger extent in the intervention
group compared to the control group, F (I, 170) = 1.59,/> = .21, and adding the
alterations in tat consumption from baseline to follow-up as a covariate to the
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analyses, revealed again that tat consumption did not contribute to the alterations
in cholesterol levels.-
In the subgroup of paoents with elevated baseline total cholesterol levels, the last
observanon earned-forward analyses did not reveal results that differed from the
initial analyses. In this high lipid group, the intervention favorably altered total
cholesterol, J-'(l, 87) = 4.42,/) = .04 and LDL cholesterol levels. / ( I , 87) = 4.58, />
= .04, and had no effect on HDL, F (1, 87) = 0.94,/>= .34, and tnglyccndes, / ( I ,
87) = .07,/) = .79. Controlling for statins did not change these results.
DISCUSSION
Total serum cholesterol was significantly reduced in the intervention group
compared to the control group. This effect was especially strong in patients who
needed the intervention the most: those with high baseline total cholesterol levels.
1.D1. cholesterol was also reduced to a larger extent in the intervention group as
compared to the control group. Again, the effects were strongest for patients with
high baseline LD1. cholesterol. The intervention group had a larger increase of
prescribed dose of statins than the control group, and correcting the analyses for
this difference weakened the favorable effects of the intervention on 1.1)1.
cholesterol and total cholesterol, although the favorable effects on total cholesterol
still showed a trend for significance. In patients with high baseline cholesterol
levels, thus in the patients who needed most, the intervention had a beneficial
effect on total and LDL cholesterol irrespective of the taking of statins. Moreover,
if missing values are considered and included in the analyses, the effects of the
intervention on total and LDL cholesterol in patients with high baseline cholescrol
levels continue to be significant.
How can the favorable reductions in total and LDL cholesterol in the intervention
group be explained? The intervention focused on a reduction of dietary fat
consumption, and this was reflected in the fact that dietary fat intake decreased to
a larger extent in the intervention group as compared to the controls. This effect
was particularly found in patients with already relatively low baseline dietary fat
intake, but not in patients who consumed much dietary fat at baseline. Remarkably,
the reduced dietary fat consumption was not related to altered scrum cholesterol
levels. Perhaps even more disturbing, we found a relation between reduced dietary
fat consumption and favorably altered serum cholesterol levels in patients with
relatively low dietary fat consumption at baseline. This relation was not found in
patients with high baseline dietary fat intake, an effect that could not Ix- explained
by a restriction of range in the latter group. How can these puzzling results be
explained? Patients who consumed much dietary fat to begin with, reduced their
fat consumption irrespective of their group allocation. Moreover, in both groups -
-In the initial analyses, change in dietary fat consumption from baseline to follow-up could not
be added as a covanate to the analyses, due to many missing data in dietary t|ueifionnair<« In
the last observation earned-forward analyses missing data were less of a problem. v> change in
dietary fat consumption from baseline to follow-up was added as a covanate to the analyses
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control and intervention - cholesterol levels are reduced, irrespective of group
allocation. On the other hand, those who already consumed a healthy diet at entry
in the study started eating even healthier after the intervention, and serum
cholesterol levels arc significantly reduced. Control patients who consume a
healthy diet at entry in the study do not exert themselves to reduce their fat
consumption any further, and serum cholesterol levels do not change.
Why is the reduced fat consumption after the intervention not associated with
reduced cholesterol levels in all patients, but only in those with low baseline fat
consumption? We can only speculate about explanations for this remarkable
finding. Perhaps the self-reported dietary cjuesnonnairc was not reliable for the
subgroup of patients with high baseline fat consumption, whereas it may have
been reliable for patients with low baseline fat intake, because of which the true
relation between favorably altered dietary habits and lowered serum cholesterol
levels was obscured. Although a valid dietary questionnaire was used, it is quite
conceivable that persons with high dietary fat intake may be less concerned with
their eating habits; thus they may hardly realize what they consume, and
consequently they may have difficulty filling out a dietary questionnaire reliably.
Persons with low fat intake may ensure they eat a healthy diet, which makes them
aware of precisely what they eat, which in turn makes it easier for them to fill out a
questionnaire on dietary habits. Unfortunately, no studies are known concerning
the difference in reliability of the dietary questionnaire between people who
consume much and little dietary fat. Another speculation which might explain the
obscure relation between fat consumption and cholesterol in our study may be that
the reduction in fat consumption that is needed in those who consume much
dietary fat in order to bring about lowered cholesterol levels, is much larger than
the reduction in fat consumption they achieved.
What now may be the explanation for the fact that our intervention led to reduced
cholesterol levels in those patients with elevated cholesterol levels, if the reduced
fat consumption we reported is not responsible for this effect? A plausible
explanation is that the intervention indirectly modified serum cholesterol levels by
enhancing adherence to medication regimen. If patients in the intervention group
were taking their cholesterol-lowering medication more consistently than control
patients, this may account for the larger reduction of total and LDL cholesterol
found in the intervention group. This may also explain the finding that the positive
intervention effect is particularly found in patients with elevated cholesterol levels;
after all, these are the patients with the highest dose of statins. Side effects (e.g.,
muscular pain, gastric or intestinal complaints) are dose-dependent, and perhaps
patients are more willing to accept the adverse side effects of their medication after
participation in the intervention. Unfortunately, no data were available on patients'
compliance with medication regimen.
Could the favorable effects of the intervention on total cholesterol and LDL
cholesterol be explained by regression to the mean, especially since the effects were
found in the high risk groups? We may indeed expect that high cholesterol levels at
baseline will drop at follow-up measurements because of regression to the mean.
Baseline cholesterol levels were, however, only a little bit higher in the intervention
74
(-holcsti-rol changes
group than in the control group, a difference that was far from significant.
Moreover, cholesterol levels of the intervention patients dropped to a lower level
than in the control group, and this can not be accounted for by regression to the
mean. So the favorable effects on total and U)L cholesterol can not solely be
explained by regression to the mean. Moreover, regression to the mean can not
explain the difference in intervention effects for the subgroup of pancnts with high
baseline cholesterol. For this subgroup, baseline cholesterol levels were equally
high in the intervention group and in the control group, and we may expect that
cholesterol levels drop both in the intervention and in the control group. Although
this is indeed what we found, we also saw that the reduction in the intervention
group was larger than that in the control group. It is not so surprising though, that
the effects were particularly found in patients with high baseline cholesterol. After
all, one can hardly expect an intervention to gain a profit in patients with low
cholesterol levels to begin with.
An unexpected rinding was that although HDL cholesterol increased in both
groups, the increase was larger in the control group. At 9-month follow-up. HI %
of our study population received statins for cholesterol lowering, and it is known
that statins raise HDL cholesterol. This does not, however, fully explain why the
increase of HDL cholesterol was larger in the control group, since controlling for
altered statin prescriptions did not change the results. A sound explanation yet has
to be found. Perhaps patients in the control group increased their use of
vegetables, fruit, whole grains or fish to a larger extent than patients in the
intervention group, but data fail us to study this in detail. The unexpected finding
that the increase of HDL cholesterol was larger in the control group than in the
intervention group was not found in the subgroup of pancnts with elevated
baseline levels. Controlling for statins, however, again showed a negative effect on
the increase of HDL cholesterol in the intervention group. It should be noted
though that the increase of prescribed statins in itself might be an effect of the
intervention. As suggested before, it is possible that as a result of the intervention,
patients in the intervention group are more willing to accept the unpleasant side
effects of cholesterol-lowering agents, and consequently receive a higher dose of
the drug.
Limitations of the study
Nearly 14% of all patients included in the study dropped out, which limits the
study to a certain extent. If missing data for cholesterol values are included, about
22" o of patients could not be included in the analyses. Although this seems like a
large dropout percentage, it should be noted that similar studies usually encounter
comparable dropout rates (DeBusk et al., 1994; hngblom, Korpilahti, Hamalaincn,
Puska, & Ronnemaa, 1996; Van Elderen & Dusseldorp, 2001).
A second limitation of the study is that we do not have any cost comparison data
of our mtervennon and usual care, which makes it impossible to draw any
conclusions about the cost-effectiveness of the program.
In general, current medication policies have large effects on cholesterol levels,
because of which it may be hard to exert an additional favorable effect on
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cholesterol with a diet. In our study, 53% of all patients were already receiving
cholesterol-lowering drugs at entry in the study, which partly explains the rather
favorable total serum cholesterol levels at baseline (a mean of 5.1 mmol/L or 197
mg/dl for the total study population). In spite of the large proportion of patients
with cholesterol-lowering medication, we were able to show an additional
cholesterol lowering effect of the intervention concerning total cholesterol and
LDI. cholesterol. This favorable effect is important, not only because a major risk
factor for CAD is reduced, but also because patients are shown that they can take
control of their own health by following the advice given in the intervention
program.
Thus, our short intervention was effective in reducing the cardiopathogenic total
and 1.D1. cholesterol levels, especially in patients with elevated cholesterol levels,
which may lead up to a cardioprotective effect in the long run. The positive
indications of these findings are, however, restrained by an unexpected finding on
the lower increase in HDI. cholesterol levels in the intervention group compared
with the control group. Studies on the relative risks of elevated LDL and lowered
HDI. cholesterol report ambiguous results as to which is more important (Pfeffer,
Sacks, & Moye, 199'); West of Scotland Coronary Prevention Study Group, 1998).
Since the subgroup of patients who are in highest need of cholesterol lowering, i.e.
those with high baseline cholesterol levels, profit from the intervention with
reduced total and 1.1)1. cholesterol levels without marked negative side effects on
111)1. cholesterol, such an intervention may be advisable. The lower increase of
HDI. cholesterol in the intervention group, however, should make us cautious of
advising the intervention to the general population of AMI and CABG patients
under the age of 70.
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APPENDIX TO CHAPTER 3:
SECONDARY CLINICAL OUTCOME MEASURES
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Introduction
While cholesterol levels were considered primary outcome measures in this study,
the effect of the intervention was also determined on secondary outcome
measures, i.e. smoking, blood pressure, and Body Mass Index. The results
concerning these secondary outcome measures are reported in Tables A through
D. The main results will briefly be described in the general discussion of this thesis.
Secondary clinical outcome measures
Height of the patients was measured during the first outpatient visit, whereas
weight, systolic and diastolic blood pressure were measured at baseline, three
months after discharge, and at 9-month follow-up, and treated if indicated. From
height and weight measures, Body Mass Index (BMI) was calculated. Self-report
smoking habits were measured through a structured interview on lifestyle (Falger,
1989).
Table A. Results of Chi-square analyses comparing the intervention and control
group on postintervention and 9-month follow-up smoking cessation rates, in
which baseline smoking rate is used as a covariate*
Measure
Smoking
Hctorc incident
Baseline
Post
9 months
Intervention
%
47
15
20
26
89
89
89
89
43
9
11
21
Control
81
81
81
81
2.46
0.29
No*. 'Covanatcs in these analyses were baseline smoking rate, gender, age,
"CABC". vs. noCABCi".
• />< ,0.S. 1/>< .10
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Table B. Results of ANCOVA comparing the intervention and control group
on postintervention and 9-month follow-up Body Mass Index (BMI), in which
baseline BMI is used as a covariate*
Measure
Bodv Mass Index
(kg/m2)
Baseline
Post
9 months
Af
26.5
26.5
26.8
Intervention
5D
3.2
3.3
3.3
•
80
80
80
Af
26.3
26.5
26.7
Control
JD
34
3.5
3.7
•
81
81
81
F
0.66
1.24
. *G>vanates in these analyses were baseline BMI (kg/m^), gender, age, "(lABti v». no
CArKi", anndiabetk medication at baseline, baseline angina pectons, baseline dyspnoea.
Table C. Results of ANCOVA comparing the intervention and control group on
posdntervenrion and 9-month follow-up blood pressure, in which baseline blood
pressure level is used as a covariate*
Measure
Systolic (mm Hg)
Baseline
Post
9 months
Diastolic (mm Hg)
Baseline
Post
9 months
Af
131.5
129.2
131.7
82.7
834
84.1
Intervention
iT>
21.7
18.4
18.4
10.2
10.5
9.4
»
83
83
83
83
83
83
Af
125.5
128.3
133.2
79.9
81.5
84.1
Control
J7)
19.3
19.4
18.6
10.8
8.6
6 9
•
82
82
82
82
82
82
F
0.91
2.59
0.25
0.28
A'o/Sr "Covariatcs in these analyses were baseline blood pressure (mm Hg), gender, age, "CABCi vs.
no CABCi", blood pressure lowering medication at baseline
V < .05.1/>< .10
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Table D. Medicauon with an effect on blood pressure at baseline and at 9-month
follow-up in intervention and control group
Medication
All blood pressure
lowering medicauon
Intervention
Control
Bcta-blockers
Intervention
Control
Calcium antagonists
Intcrvcnuon
Control
AC I*, inhibitor*
Intervention
Control
Diuretics
Intervention
Control
Baseline
91.9
88.0
74.7
65.9
15.7
11.0
30.1
25.6
8.4
8.5
9 months
86.0
84.3
53.0
43.9
9.6
6.1
18.1
19.5
7.2
7.3
83
82
83
82
83
82
83
82
83
82
/Vo/r "Included are only those patients with known blood pressure levels at baseline,
nonintervention and at 9-month follow-up, i.e. only padents who are also included in
the blood pressure analyses.
Medication with an effect on blood pressure
During the 9-month period of follow-up, the intervention group had a larger
decrease of prescribed dosage of captopril (/> = .04) and diltiazemhydrochloride (p
= .09) than the control group. If the ANC.OVAs were corrected for change in
prescribed dosage from baseline to 9-month follow-up of these agents, the results
for diastolic blood pressure remained the same. The 9-month effect of the
intervention on systolic blood pressure, however, reached statistically a trend for
significance in favor of patients in the intervention group; F( l , 157) = 3.77,/> =
.05.
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DO META-ANALYSES OF THE EFFECTS
OF PSYCHOEDUGATIONAL INTERVENTIONS
FOR CORONARY PATH-NTS STILL (ilVE A
VALID ESTIMATE OF THE EFFECT?
Sebregts, E.H., Appcls, A. and Bar, l-.W. Do mcta-analyscs of the effects of
psychoeducadonal interventions for coronary patients sail give a valid estimate of
the effect?
Chapter 4
ABSTRACT
Meta-analytic studies are sometimes conducted to estimate the effects of
psychosocial interventions for patients with coronary artery disease (CAD) on
cardiac mortality or morbidity. We studied the influence of secular trends on the
effects of psychocducational intervention studies for patients with CAD. Effects of
psychocducational interventions on cardiac mortality rates decrease in more
recently published studies compared to older studies. The waning effect on
mortality is not related to decreasing mortality rates in time. Instead, it seems to be
associated with changes in the composition of the study samples. Because of this,
mcta-analytic studies, which include old samples, may lose their external validity.
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INTRODUCTION
Psychological inter\'enrions often aim to reduce mortality and morbidity rates in
coronary artery disease (CAD) patients after hospitahsanon, through improvement
of lifestyle or by reducing psychological distress. Since many studies suffer from a
lack of power to investigate effects on mortality, studies are often combined in a
meta-analysis in order to increase power. Substantial improvements in cardiac care
during the last 30 years, however, hamper the comparability of old and new
studies. Mortality rates have been reduced and populations of recent studies arc
very likely to differ substantially from those in older studies. For instance, primary
prevention efforts may have changed the smoking and eating habits of a
population that participates in an intervention programme into a population of
inveterate smokers or hardened dietary fat consumers. Therefore, older studies
might lose their external validity. Due to changes in external validity through the
years, one should question whether it is correct to combine old and new studies in
a meta-analysis.
The goal of our study was to investigate the influence of secular trends on the
effects of psychoeducational intervention studies. This paper tackles the following
questions: 1) Are the reported effects of psych<xducauonal interventions on
cardiac mortality rates and recurrent infarction rates stable over rime? 2) If not,
may this change be explained by a) changing cardiovascular mortality rates and
changing rates of recurrent myocardial infarction, b) altering characteristics of
study populations in the course of time?
METHODS
Selection of studies
To test the hypotheses, the data of the most recently published meta-analysis
concerning the effects of psychoeducational programmes on cardiac mortality and
morbidity rates in CAD patients were used (Dusseldorp et al., 1999). Since the
Dusseldorp et al. study included studies published before 1998, we additionally
performed a MELDL1NE and PSYCINFO computer search to identify studies
concerning health education or stress management interventions published from
1998 until 2<X)2.' Following Dusseldorp ct al., three types of key words were used
(Dusseldorp et al., 1999). The first type concerned patient characteristics: A//,
dfro/i/rr, a»</ <v/rd!wrtf.rr* r^ <£rord!rr. The second type of key word concerned the
outcome variables: «»rfci///y, /v«rfod!r/y, MW/vrrw/nr,
' For detailed descriptions of health education or stress management interventions, the reader i»
referred to Dusseldorp ct al Dusscldorp et al., 1999;
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o/* Z^. The third type of key word concerned the type of
programme: ftW/df n?/w/>/7//tf/fo>», />.nr/w/<$«tf/ or />.nrAwd<tt»/?ort<// ;»/mw»/70»,
Following Dusseldorp et al., we included only studies with patients who had
experienced a cardiac event within the six months prior to the start of treatment
(Dusseldorp et al., 1999). A cardiac event was denned as AMI, CABG, PTCA, or
some combination of these. Studies reporting effects on emotional distress were
included only if effects on risk factors, related behaviours, morbidity or cardiac
mortality were also reported. Only relatively high-quality studies were included in
our study, that is, studies that included a control condition or comparison
condition (i.e., randomised experiments or quasi-experiments). Quasi-experiments
were included only when samples were stratified or matched pairwise, or when a
certain time period was used as an assignment rule for patients from the same
hospital. For risk factors, related behaviours, and psychological variables, a pre-test
measurement was required.
Forty five studies concerning the effects of psychoeducational programmes for
CAD patients were included in our study (37 reported in Dusseldorp et al., and 8
additional studies published from 1998 onwards).- Of these, 8 studies could be
included in our analyses concerning effects of interventions on mortality rates; 11
studies could be included in our analyses concerning effects of interventions on
recurrent myocardial infarction rates (table 1). In addition, patient characteristics
and inclusion criteria were studied in all 45 studies.
- The following studies were included: Ibrahim ct al., 1974; Rahc, O'Neil, I lagan, & Arthur,
1975; Po/en el al., 1977; Wielding, l')79; Kallto, llamalainen, Hakkila, & l.uunla, 1<F9; Karvetn,
I<>81. Theorell. P>82; Young. Kottkc, McCall, & Blume. 1982; Bcngtsson, 1983; Krdman &
Duivcnvoorden. 1983; Mayou, 1983; Sivara|an et al.. 1983; Stern. Gorman. & Kaslow. 1983;
Dnuup et ill., 1984; Hot-lick, Cameron, l'iror, Hhalerao, & Baltzan, 1984; l-'rasure-Smith &
Prince, 1985; Oldenburg, Perkins, & Andrews, 1985; Saloncn. Hamynen, & Hcinonen, 1985;
I'ncdman ft al., 1986; Marshall, Pcnckoter, & IJcwellyn, 1986; Stransky, Kalin, Schwarzenbach,
& Schir. 1986; I ledback & Perk, 198"\ Munro. Creamer. Haggerty, & Cooper. 1988; Oldenburg,
Allan, & lastier, 1989; Van Dixhoorn, Duivenvoorden, Staal. & Pool, 1989; Perk, Hedback, &
Hngvall, 1<)«H); Taylor et al., 1990; Indlund. Hogstcdt. Udell. & Ursson. 1991; F-.ngblom ct al.,
1992; Mitsibounas. Tsouna llad|is. Rotas. & Sidens. 1992; CiiUiss ct al.. 1993; DeBusk et al.,
1994. Vail l-.ldcrcn ct al., 1994; Van lildcren-Van Kcmcnadc , 1994; ljndcn, 1995, Jones &
West. 1996. Insure Smith et al.. 199"; Carlsson. 1998; Horman Bang ct al.. 1999; VCalliicr ct al.,
I W ; Oonu-las. Sampson. Ciray, \X'atcrs, A: Thompson, 200O. Higpns, Hayes, & McKenna,
2tX>li Stagmo, Wcsnn. Carlsson, & lsraelsson, 2tX)l; Van l-.ldcren & Dusseldorp, 2001; Hatek.
Taylor. & Mills. 2(X>2.
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Table 1. Methodological characteristics of studies with 12-month mortality and recurrent infarction endpoints
Study Randomisation Target population Baseline •ample
size
R.iht- e( al. Random assignment to
19~5 control and treatments."
1'aacnts under 60 years of age surviving their first AMI, and likely to remain in
the hospital area following hospital discharge.
60: C 22, T 38
Kalbo el al.
IT9
Random assignment to
control and treatment
All paocnts under 65 years who had been treated in hospital for AMI. 375: C 187, T188
Y< mng et N on randc im C( msecunvc
al 1982 recruitment ot control and
treatment
All patients 65 or younger admitted to the coronary unit with a first confirmed
AMI or having returned to work atter previous AMI, absence of other disabling
or bfc threatening illness, employed or. if reared, following a physically active
lifestyle; sumded the acute phase of the AMI
197:CI00,T97
Bengtsson
1983
Random assignment to
control and treatment
All pancnts under 65 years of age with AMI treated at the intermediate-care
ward of the cardiological unit. Inclusions: new infarction during the
investigation period; cardiovascular disease (severe cardiac failure, PMI
syndrome, aortic regurgitaaon. cerebral in fare t hemiparcsu); orthopaedic states;
other somanc disease; mental illness; living more than 50 km from the hospital.
171: C 90, T 81
Stern et al. Random assignment to
1983 exercise, group counselling
and control group by
blocks of 6 patients
All panents between 30 and 69 vears of age with a documented AMI not less
than six weeks nor more than one year prior to admission to the srudv, and I)
work capacity level of less than *" met (men) or less than 6 met (women),
and or a Taylor Manifest Anxiety Scale raw score of 19+ and/or /ung Self-
ranng Depression Scale raw score of 40+ Exclusions: unstable cardiovascular
condition, i.e.. congesnvc heart failure, or requirement ot n-carment for any
physical/psychological reason.
106: F.xercisc 42,
Counselling 35, C 29
\««r. C = Control. T = Treatment
'Problem: After tint rear no randomisanon to control group because of contamination of treatment control patients refused
- table continues -
Table 1 - continued
I
Study Randomisation Target population Baseline
sample size
Erasure- Random assignment to
Smith and experimental and control
Pnnce, 1985 condition in 2 groups:
medium nsk or high nsk
.Ml male panents admitted to the coronarv care unit with AMI. Exclusion
criteria: not admitted for ischenuc heart disease problems; severe concurrent
non-cardiac disease such as carcinoma, renal failure, or cirrhosis, living more
than 20 miles from Montreal; speaking insufficient English or Trench;
cogniovely impaired, deaf, or history of psychotic illness; not fitting into one of
the major study nsk groups; parnciptoon in other studies, no phone.
461: C 231, T 230
Friedman et
al. 1986
Random assignment to
control or treatment
All panents of 64 years of age or vouiger with one or more documented AMI 6
months or earlier, who never smokeJ or quit smoking for 6 months or longer,
and never been treated for exhibited signs of diabetes mellitus.
884: C 270, T 614
Hcdback
and Perk,
1987
Treatment group
compared with non-
random control group
admitted to die ad|acent
hospital
All surviving paacnts below 65 years of age who had been admitted to the
hospital with an AMI.
305: C 158, T 147
Fndlund et
al. 1991
Random assignment to
control and treatment
All patients aged 65 or younger with AMI, and widi an independent living in the
hospital district after discharge from hospital, and a meaningful communication
and rehabilitation not hindered bv the AMI or other scnous illness.
11O:C58.T52
DcHusk et Random assignment to
al. 1994 control and treatment
All panents aged 70 years or younger who were hospitalised for AMI.
Exclusions: death before randomisation, severe comorbid disease, sub-
stancc abuse or other psychological problems; inability to speak English.
585: C 292. T 293
Jones and
West 1996
Random assignment to
control and treatment
All patients discharged home from hospital widun 28 days ot confirmed
myocardial infarction irrespective of ige. sex, or previous cardiac history.
Exclusions: prolonged hospital stay tover 28 days) and discharge to long term
institutional care.
2328: C 1160, T1168
Erasure- Random assignment to
Smith ct al. control and treatment
1997
Patients with AMI not related to a coronary procedure. Exclusions: other life-
threatening conditions; residence mere than 20 miles from study hospital; no
telephone; deafness; cognitive impaiiment; inability to speak English or French;
refusal by the paocnt's physician; participation in other randomised trials.
1376: C 684, T 692
Meta-analvscs of effects
Analyses
To improve comparability of effects observed in different studies, we used only
studies in which cardiac mortality rates or recurrent myocardial infarction rates
were reported at 12-month follow-up.* Spearman's rho correlation coefficient (r,)
was computed between year of publication of the studies and the 12-month odds
ratios for cardiovascular mortality and recurrent infarctions. Twelve -month odds
ratios were computed according to the method by Flciss (Fleiss, 1994) (pp. 245-
260, formula 17-18). If any cell frequency was zero, 0.5 was added to all cell
frequencies. •* Higher odds ratios indicate larger favourable effects of the
intervention on survival rates or on rates of recurrent myocardial infarction.
a) Spearman's rho correlation coefficient fr) was computed between year of
publication of the studies and cardiovascular mortality rates. Next, Pearson's
correlation coefficient (f) was computed between the mortality odds ratios and
mortality rates. This was repeated for recurrent myocardial infarction rates.
b) In order to study trends in study populanon characteristics, we examined those
characteristics that are reported in the majority of studies, i.e. mean age of the
study population, percentage of women in the study, percentage of patients with
one or more previous infarctions at entry in the study, and the percentage of
patients with hypertension at entry in the study. Spearman's rho correlations were
computed between year of publication of the studies and characteristics of the
study population. Next, correlation coefficients were computed between the odds
ratios for mortality and characteristics of the study populations. The analyses were
repeated for recurrent myocardial infarctions. Subsequently, Spearman's rho
correlations were computed between year of publication of the studies atid
inclusion criteria of the studies.
' Studies with reported 12-month follow up rates for mortality: Rahe et al., 1975; Kalllo ct al.,
9; Stem et al., 1983; Irasure-Smirh & Pnnce, 1985; Friedman ct a!, 1986; Hcdbark & Perk,
^; DcBusk et al, 1994; Frasurc-Smith ct al., 1997 Studies with reported 12 month follow up
rates for recurrent myocardial infarctions: Rahe et al., 1975; Young et al., 1982; Bcngtuton, 1983;
Stern et al., 1983. rrasure-Smith & Pnncc, 1985. Friedman ct al., 1986, Hcdback & Perk, 1987.
Fndlund et al.. 1991. DeBusk ct al.. 1994, Jones & West, 1996; Frasurc-Smith ct al., 1997.
' This was done in 2 studies included in the mortality analyses, and in 1 ttudy that wan included
m the morbidity analyses
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RESULTS
Are the reported effects of psychoeducationaJ interventions on cardiac
mortality rates and on recurrent myocardial infarction rates stable over
time?
In the 8 studies reporting 12-month cardiac mortality rates, the year of publication
of the studies correlates negatively with the odds ratios of cardiac mortalit)' rates (r,
= -.79,/) = .02; figure 1). Thus, older studies reported larger favourable effects of
interventions on cardiac mortality rates than more recently published studies.
Year of publication
Figure 1. Correlation of cardiac mortality odds ratios at 12-month follow-up with
year in which the study was published.
In the 11 studies reporting 12 month recurrent myocardial infarction rates, the year
of publication of ihc studies does not correlate with the effect of the interventions
on the rate of recurrent infarctions (r, = -.04,/> = .91).
May the larger favourable effects of interventions in older studies be
explained by changing cardiovascular mortality rates or recurrent
myocardial infarction rates?
(Cardiovascular mortality rates of all 8 studies are shown in table 2. Mortality rates
seem to decline in the course of time. Spearman's rho correlation coefficient
between year of publication and mortality rate (expressed as a percentage) is
negative, but not significant (r, - -.55, /> = .16). Moreover, the odds ratios for
mortality an- not correlated with mortality rates (r = .01,/) = .98). Thus, higher or
lower mortality rates in the studies arc not associated with larger or smaller effects
of interventions on mortality.
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Twelve-month recurrent infarction rates of all studies are reported in table 2. The
year in which the studies were pubbshed was not correlated with the 12-month
recurrent infarction rates (r, = .03,/> = .94).
Table 2. Twelve-month cardiovascular mortality and recurrent infarction rates in
the control groups of all studies, in percentage
Study
Rahc ct al
Kalho et al.
Young ct at.
Bcngtsson
Stem et ai.
I'rasurc-Smith and Prince
Friedman ct al
HcdHack and Perk
tndlund et al.
IXBusk et al.
Jones and West
Frasurc-Smith ct al.
Year of
publication
I T S
1 T 9
1982
1983
1983
1985
1986
|98"
1991
1994
1996
199?
'/•Cardiovascular
mortality
4 8
14 0
3.5
9 6
(19
7.8
34
3.4
*/» Recurrent
infarction!
19.1
4.0
6.3
3.5
9.6
3.0
16.5
23.0
6.9
4.5
5 0
May the larger favourable effects of interventions in older studies be
explained by altering characteristics of study populations?
In the mortality analyses, we found that characteristics of the study populations
from more recent studies differ from patient characteristics in older studies. With a
trend for significance, patients in more recent studies are older (r, = .69,/) = .06, JV
= 8), and more recent studies consist of a higher percentage of hypertensive
patients (r, = .71, /> = .07, A' = 7). Moreover, in recent studies there is a higher
percentage of patients who are female (r, = .62,/) = .10, /V = 8), and have had one
or more previous infarctions at entry in the study (r, = .54,/) = .27, ,V = 6), but
these correlations are not significant. The odds ratios for cardiac mortality correlate
significantly and negatively with the mean age of the study population (r = -.71,/)
= .05, iV = 8) and the percentage of patients with previous AMI (r = -.96,/) - .00,
N = 6), and correlate with a trend for significance with the percentage of
hypertensive patients (r = -.70, /> = .08, TV = 7). Thus, larger effects on mortality
are found in studies with younger patients, fewer patients with previous myocardial
infarction, and fewer patients with hypertension.
In the analyses for recurrent myocardial infarcrions, more recent srudics arc
characterised by older study populations as well (r, = .78,/) = .01, N = 10), and a
higher percentage of women (r, = .65, /> = .03, » = 11). The odds ratios for
recurrent infarcrions correlate significantly and negatively with the percentage of
patients with previous myocardial infarction (r = .89, /> = .00, /V = 9), and
correlate with a trend for significance with the mean age of the study population (r
= -.60, /> = .07, .V = 10). Thus, larger effects of interventions on recurrent
89
<\haptc-r 4
myocardial infarction rates are found in studies with younger patients and studies
with fewer patients who had previous myocardial infarctions.
Which changes in population characteristics are revealed if all 45 studies are
analysed? In this larger sample, we found that CAD patients included in more
recently published studies are on average older than patients participating in older
studies (r, = .37, /> = .02, « = 38). Furthermore, more recently published studies are
characterised by a higher percentage of women compared to older studies (r, = .50,
/> = .00, N = 44), and there are indications of a larger proportion of patients with a
history of previous myocardial infarcrion(s) at entry in the study (r, = .32,/) = .12,
N = 25).
In more recently published studies, no inclusion criterion is used at all, or inclusion
criteria in reference to age are higher compared to older studies. We found a
significant correlation between year of publication of the study and the age
criterion applied (r, = .45,/) = .00, J\' = 43), in which age criterion was distributed
evenly in 5-ycar steps (i.e., 'no inclusion criterion concerning age', '< 80 years of
age', '< 75 years of age', etc.). In addition, whereas older studies often include men
only, more recent studies apply no exclusion criteria for women (r, = -.33,/) = .03,
N = 45). If we consider only studies without inclusion criteria with reference to
male sex, we find again a positive correlation between year of publication and
percentage of women in the study (r, = .40,/) = .02, » = 36). If we consider only
studies without inclusion criteria with reference to gender and age, no significant
correlations are found between year of publication and mean age of the study
population and percentage of women in the study. Moreover, there is an indication
thai olilcr studies more often select patients with a first myocardial infarction than
more recently published studies, which may select patients with a history of
myocardial infarction(s) (r, = -.27,/> = .08, N = 43).
DISCUSSION
The effect of psychoeducarional intervention programmes for AMI patients on
cardiac mortality decreases significantly over time, as was demonstrated in the
studies reporting 12-month cardiac mortality rates. This decline of the
effectiveness of these programmes cannot be attributed to lower mortality rates.
What phenomenon then may account for this trend? Researchers are increasingly
less inclined to apply age limits in their studies, or they readjust these limits upward
to include older patients. In addition, more and more studies include women,
whereas in older studies solely men were included. We found shifts in patient
characteristics from young, male patients in older studies to older patients with a
larger proportion of women in more recently published studies. Moreover, there
are indications that the study participants are shifting towards a 'sicker' populanon
consisting of more patients with a history of myocardul infarction. The increasing
age of the participating patients and the higher percentage of panents with
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previous myocardial infarctions are correlated with the waning effect of
interventions on mortality.
How may this be explained? The changing patient characteristics may affect the
scope of the interventions. Interventions used to be designed for and directed at
the improvement of health status in young men. Are the contents of the
interventions still valid to yield an effect in the increasingly older and more often
female patients? Several recent studies show that it is precisely women that do not
respond positively - in some cases even negatively! - to psychological interventions
(Frasure-Smith et al., 1997; Sebrcgts, 2003). It might be that intervention
programmes need more adaptation to major patient characteristics such as gender
and age.
One may expect that the quality of psychoeducational interventions would
improve based on experience gained from the past. Consequently, we would
expect the effects of more recent intervennons to be larger, not lower. It is also
true, however, that lifestyle interventions that were found to be effective in earlier
studies are nowadays integrated in standard cardiac rehabilitation. Control groups
in psychoeducational intervention studies often receive standard exercise
rehabilitation that contains many components also used in behaviour change
therapies and stress management programmes. Because of this, more recent studies
may contain more inveterate smokers or hardened dietary fat consumers than older
studies.
Contrary to our expectations, we did not find a decreasing effect of
psychoeducational intervention programmes for AMI patients on recurrent
infarction rates over rime. Neither did we find a trend of decreasing recurrent
infarction rates over time. We did find changes in patient characteristics over time
toward older and more often female patients. But in spite of the finding thai the
year of publication of the studies included in the recurrent myocardial infarction
analyses is negatively correlated with age, the intervention effects on recurrent
infarctions do nor wane in the course of time. This phenomenon is not so easy to
account for.
We specularc that the effect of the interventions on recurrent myocardial
infarctions in recent studies might partly be produced by patients' improved
adherence to medication. This effect will probably be larger in more recent studies
than in older studies because of increased use of drugs, and may have a larger
effect on the rate of recurrent myocardial infarctions than on cardiac mortality.
When the older studies in our sample were conducted, medical treatment was
predominantly directed at the treatment of complications caused by the AMI from
which the patient was suffering. Thrombolytic therapy, percutaneous coronary
intervention, and other medical treatments, which are increasingly popular, were
aimed at limiting infarct size, and this way preventing mortality as a consequence
of the AMI. Drugs that prevent or diminish the chances of a recurrent cardiac
event gained ground in later years, with the introduction of drugs such as befa-
blocking agents, statins, or ASA. This may be illustrated by a random recent report
from the GISSI -group, where 44% of patients had [3-blockcrs at baseline, 47 %
had ACE inhibitors and 91% had antiplatelet drugs to start with (Marchioh et al.,
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2(X)2). Consequently, if the effect of psychoeducational interventions is partly
related to improved adherence to medication, the interventions in more recent
studies may be effective in reducing myocardial infarctions.
Limitations of the study
This study has some weaknesses. The precision of our estimates may have been
affected by focusing on publication year. It would have been more accurate to use
the years in which studies were actually conducted, but in some of the studies this
information was not reported. We did, however, redo the mortality analyses using
the starring year of the study and replaced the (one) missing study-year by the year
of publication minus mean delay until publication for all studies. The results of
these secondary analyses showed again a negative correlation between study year
and decreasing effect on mortality.
We studied the trends in effects of psychoeducational interventions on mortality
and recurrent myocardial infarction rates in a limited number of studies, since only
a few studies reported 12-month mortality and morbidity rates. The resulting small
power of our analyses prescribes caution in drawing firm conclusions from our
results. Nevertheless, we had sufficient power to demonstrate changing
characteristics of study populations over time.
Another factor we should bear in mind is that the methodological quality of more
recently conducted studies generally exceeds the quality of older studies. We tried
to preclude this possibility by including only relatively high-quality studies in our
analyses. We are unable to pronounce upon qualitative factors concerning the
realisation ot the study design and contents of the interventions, since
methodology sections of publications often lack detailed descriptions. Some
uncertainties in the measurement and definition of AMI and hypertension in
studies also limit our study, which warrants caution in interpreting correlations
concerning these variables. This does not alter the findings in reference to age and
gender <>t the study populations over time, however.
Finally, we focused the analyses on cardiac mortality and recurrent infarctions at
12 month follow up, whereas differentiation of cardiac mortality and morbidity-
rates might start at a later stage after the cardiovascular incident. This turned out to
be impossible to study since very few publications on psychoeducarional
intervention studies report cardiac mortality' rates at uniform long-term follow-up
moments.
The results of this study show that mcta-analyric studies are losing their external
validity. The estimate they give about the effects of an intervention on cardiac
mortality and morbidity is becoming invalid unless it is corrected for changes in
the composition of the study populations.
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ABSTRACT
It is still unclear whether the efficiency of cardiac rehabilitation can be improved
by preselection of patients. The primary aims of this study were therefore to
examine the quality of a screening device that was developed to select patients for
a multifactorial intervention, and to determine whether selected patients profited
more from a multifactorial intervention than patients, who did not meet the
selection criteria. Two hundred and one acute myocardial infarction patients or
patients who underwent coronary artery bypass grafting were randomized to a
multifactorial behavioral group intervention or to a usual care control group. All
patients were screened in order to select patients with an unfavorable risk factor
profile for coronary artery disease. Results confirmed the validity of the selection
device. The hypothesis that patients with an unfavorable risk profile would profit
more from the intervention than patients with a favorable profile was tested by
including the interaction Ciroup Allocation x Profile in the analyses computing the
effect of the intervention on clinical and psychological risk factors. The effect of
the intervention did not differ between those with or without a poor profile. Post-
hoc analyses showed that two of the eight risk factors studied changed significantly
in the group with an unfavorable risk profile, while another three risk factors were
improved with a trend for significance. In the group with a favorable profile one
risk factor changed significantly. It is concluded that restricting an intervention
program to patients with an unfavorable risk factor profile may increase the
efficiency of cardiac rehabilitation.
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INTRODUCTION
Marked improvements in the survival of acute myocardial infarction (AMI)
patients during the last 20 years have led to a growing number of AMI patients
sent to cardiac rehabilitation. Traditionally, patients suffering from AMI were
referred to physical exercise therapy in order to improve or restore their physical
condition. Initially, this was needed because patients were immobilized for 4-6
weeks. However, due to the short admission rimes today (± 1 week) and the early
mobilization after 1-2 days, physical condition is not hampered in most patients.
Later on, efforts were added to restore psychological well-being. Nowadays,
cardiac rehabilitation is becoming increasingly a multifactorial activity. Physical
exercise is supplemented with psychosocial and lifestyle modifications through
education, counseling and behavior interventions. Studies that evaluate
psychosocial rehabilitation interventions for coronary artery disease (CAD)
patients do not always report favorable effects, however (t-'rasurc-Smith et al.,
1997;Jones&West, 1996).
The limited effectiveness of today's programs may be attributable to the fact that
standard programs are offered to all patients, irrespective of whether or not they
are in need of such a program. Since some subgroups would probably profit more
than others, the selection of patients should be more focused. International
guidelines for cardiac rehabilitation stimulate individually tailored programming
(British Association for Cardiac Rehabilitation, 1995; Corstjens, Kuijs-Wouters,
Bar, & Falger, 1999; Nederlandse Vereniging voor Cardiologic en de Nederlandsc
Hartstichring, 1995). Studies that evaluate the merits of preselection for cardiac
rehabilitation are lacking, however. The aim of the present study was to determine
the validity of a screening procedure developed at the University I lospital
Maastricht in the Netherlands, and to determine whether patients selected by this
procedure profit more from a multifactorial intervention than patients who do not
meet the selection criteria.
METHODS
Screening and selection of patients with a poor risk factor profile
A multidisciplinary team, consisting of a physiotherapist, a cardiologist and a
psychologist, used two screening questionnaires in order to select patients who
were likely to benefit from the intervention, planned on the basis of risk
assessment and individual need. The two screening questionnaires had been
developed at the University Hospital Maastricht, and were complemented with
existing questionnaires (Corstjens et al., 1999).' The first screening questionnaire
was taken during hospitalizarion, and the second several weeks later, after
' Selection of patients for the multifactonal intervention was only one of several purposes of the
screening questionnaires. Additional purposes were selection of patients for the physical training
program, and evaluation of progress during the physical training program.
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discharge from hospital. Both questionnaires contained items concerning diagno-
sis, risk factors for CAD, demographic information, and emotional state. A more
detailed description of their contents is depicted in table 1.
Based on both screening moments, each patient was screened by the
mulridisciplinary team in order to assess whether selection criteria were met that
would select patients who were most in need of cardiac rehabilitation. This
selection procedure was performed blinded for the patients' names. The selection
criteria were developed such that patients who were assumed to have a poor risk
factor profile for CAD were distinguished from patients who were assumed to
have a favorable risk factor profile for CAD. Therefore, patients that were
selected are hereafter indicated as 'poor profile' patients, whereas non-selected
patients are indicated as 'favorable profile' patients. Patients were considered poor
profile patients if they met one of the following criteria: (1) possessing more than
one modifiable risk factor for CAD, without clear improvement in those risk
factors after discharge from hospital; (2) unfavorable emotional profile during
hospitalization and no improvement after hospital discharge as indicated by five or
more negative self-descriptions at the Visual Analog Scale (table 1).
Participant* and procedure
All patients admitted to the University Hospital Maastricht during the period of
rebruary 1996 through November 1997 were identified as eligible for the study by
a team of physiotherapists working at the hospital's physiotherapy department.
These patients were referred to them by cardiologists and cardiac surgeons, for
physical training following AMI or coronary artery bypass grafting (CABG).
Patients included were less than 70 years of age, who were admitted to the hospital
with a confirmed diagnosis of AMI, CABCi, or both, and who were able to
participate in the regular physiotherapy exercise-program starring early after
hospital discharge. The number of patients included in this study was based on
feasibility within the time limits of the study. Patients were excluded if they were
non Dutch speaking, illiterate, or were currently suffering from any psychiatric
disorder that would severely disturb participation in the intervention. During this
21 month period, signed informed consent was given by 204 parienrs (67° o of all
eligible patients).
After informed consent was given, panents were randomly assigned to either the
intervention or to a usual care control group. This was independent of patient
profiles. Both groups received usual medical care, which consisted of regular
medical check-ups by a cardiologist, and postdischarge exercise training sessions.
Table 1. Contents of the screening quesrionnaires administered during hospitalizarion and after discharge
Screening during hospitalization Screening after discharge
Cardiac history, cardiac and physical complaints, medication
Risk factors
Diabetes, blood pressure, serum cholesterol level,
weight, eating habits, smoking habits, alcohol
consumption, hereditary defect of coronary artery
disease
• Patient's view of factors that contributed to his or her
cardiovascular complaints. Factors that the patient
wishes to change
• Activity level (past 6 months)
• Demographic:
Education, employment
• Emotional state:
Visual Analog Scale with 1" pairs of opposite
adiecnves concerning emotions, e.g. 'insecure-secure', or
exhausted-fresh' (during hospitahzaoon)
HPPQ (past 3 months)
Cardiac and physical complaints, medication
- Risk factor changes (after hospital discharge):
Weight, eating habits, smoking habits, alcohol
consumption
- Risk factors that the paoent is currently changing
- Activity level (current)
Emotional state:
Visual Analog Scale with 17 patn of opposite
adjective concerning emooom, e.g. 'insecure-secure',
or 'exhausted-fresh' (current)
Phy rapeuoc report
Patients attitude towards physical exercise (e.g., anxiety),
signs of type A behavior
«*. HPPQ = Heart Patients Psychological Questionnaire (Dutch version; MPVH; Erdman. 1981).
Admission:
Informed consent and
randomizaoon to
intervention or usual
care control group.
Admmistraoon of first
screening questionnaire.
Administration of 2nd
screening quesaonnaire.
1 st Interview and
quesaonnaires of
lifestyle and
psychological variables
1st Clinical
measurement.
Mulndisaplinary team
selection of poor
profile and favorable
profile patients.
Start of intervention -
end of intervention.
I.asr interview and
questionnaires.
1-ast clinical
measurement.
Tune 0 weeks 3 weeks 4-8 weeks- 12-16 weeks 12 months
Figure 1. Schema of the study procedure in time.
Selection of coronary patients (for a group intervention)
In addition, patients that were assigned to the intervention group enrolled into a
muinpie nsk modification program tor secondary prevention of CM). The
selection of poor profile and favorable profile patients was performed
independently of group assignment, after the second screening questionnaire was
administered. Figure 1 presents the flow chart of the study procedure.
Psychological measures and clinical data for the intervention groups were assessed
(1) at baseline, which was approximately four weeks after hospital discharge
{hereafter indicated as 'Baseline"), and (2) nine months after termination of the
intervention, which was approximately one year after hospital discharge ("9 month
follow-up").- Measures for control patients were collected at comparable moments
in time. Clinical data were obtained from the medical files, blinded to the patients'
group allocation.
Intervention
Patients allocated to the intervention group were offered a combined stress-
management, risk factor modification and health education program during eight
weekly 2.5 hr-sessions, starting within 3 to 8 weeks after hospital discharge.' The
therapists and cothcrapists of the intervention were not aware of the outcome of
the selection procedure. The contents of the intervention were primarily based on
the methods of three major long-term clinical (rials, the Recurrent Coronary
Prevention Project (Brackc & Thorcscn, 19%), Project New Ufe (Burell, !<>%),
and the lifestyle Heart Trial (Ornish ct al., 1990), adapted to a format that would
be feasible within the context of a short intervention program. During the sessions,
6 to 10 cardiac patients and their partners (whose participation was encouraged)
were informed about CAD risk factors and risk factor modification by a
mulridisciplinary team. The group sessions were primarily educational, focusing on
relevant information about specific topics concerning the development and course
of CAD: e.g., the importance of a healthy non-fat diet, low serum cholesterol level,
physical exercise, or risk of stress and type A behavior/hostility. Kach session was
concluded with breathing and relaxation exercises based on the work of Van
Dixhoorn (Van Dixhoorn, 1997).
Measures
The following outcome measures were used: A. Physical clinical measures I) Total
serum cholesterol was measured during outpatient clinical visits. 2) Systolic blood
pressure was measured during outpatient clinical visits. 3) Weight was measured
during outpatient clinical visits. Body Mass Index (BMI) was calculated from
weight and heigth. 4) Self-reported smoking habits were measured in a structured
interview on lifestyle (Falger, 1989). B. Psychological measures 5) Type A
Behavior was measured using a Dutch version of the Videotaped Structured
Interview (VSI) (Friedman & Powell, 1984). 6) Vital exhaustion was measured by
- A posomervennon measurement was performed immediately after the intervention, which wan
approximately three months after hospital discharge, but will not be studied in this paper
' For a more detailed description, see Sebregts et aJ., 2003.
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the Maastricht Interview for Vital Exhaustion (MIVE)(Meesters & Appels, 1996a).
A score of 58 is considered positive for vital exhaustion. 7) Anxiety was measured
by administering a Dutch version (ZBV) of the Spielberger State-Trait Anxiety
Inventory (STAI) (Spielberger et al., 1970; Van der Ploeg et al., 1980). 8) Quality
of life was determined by a Dutch translation of the Multidimensional Index of
ljfc Quality (MIL(^) (Avis ct al., 1996). The total score was computed by taking
the unweighted sum of all scores.
Data analyttifi
(1) The selection procedure makes no valid distinction between selected poor
profile patients and non-selected favorable profile patients. This hypothesis was
listed by comparing selected poor profile patients with non-selected favorable
profile patients in reference to major clinical and psychological risk factors for
CAD (i.e. cholesterol level, blood pressure, body mass index, smoking, type A
behavior, vital exhaustion, anxiety and quality of life), using chi-squarc analyses and
t-tcsts.
(2) Selected poor profile patients do not profit more from the intervention than
non selected favorable profile patients do. To test this hypothesis an interaction
variable was computed, i.e. Group Allocation (control or intervention) x Profile
(poor or favorable profile). The interaction variable was subsequently included in
the ANCOVAs that were used before to study the effects of the intervention. The
effects of the intervention on clinical and psychological risk factors were studied
previously, and are or will be reported elsewhere (Sebregts, I'alger, Bar, Kestcr, &
Appels, submitted; Sebregts, I'alger, Appels, Bar, & Kestcr, 2003). Covanatcs in all
analyses were baseline risk factor level, gender, and age. Additional covariates in
analyses of clinical risk factors were medication at baseline and "CABG vs. no
CABG", since risk factor levels can be temporarily altered as a consequence of a
CABG operation itself. Baseline angina pectons and baseline dyspnea served as
supplementary covariates in the BMI analyses. An additional covariate in the
analyses of psychological factors was "AMI versus CABG only", because of the
possible influence an AMI experience might have on the psychological outcome
measures.
Par/-Aw* <j«<;/V.ff.r
Post hoc analyses were used to compare changes in risk factors in the intervention
group and the control group in poor and favorable profile groups separately.
ANCOVAs were used to study the following questions: a) Do poor profile
patients profit from the intervention as compared with poor profile patients
allocated to the control group? b) Do favorable profile pancnts profit from the
intervention as compared with favorable profile patients in the control group?
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RESULTS
Dropouts
A total of 304 patients were approached for the study, of which 204 patients (67
%) were willing to participate. Twenty patients dropped out after hospital
discharge but before baseline psychological measurements. These patients were not
aware of group allocation.
Hypothesis 1. Validity of the selection procedure
Of the 204 patients, 114 (57° o) were classified as 'poor profile', and 87 (43%) were
identified as 'favorable profile'. Three patients could not be screened due to
missing screening questionnaires.
Selected poor profile patients differed from non-selected favorable profile patients
on all studied risk factors, with the exception of cholesterol and type A behavior
(table 2).
Table 2. Baseline measurements concerning clinical risk factors and psychological
characteristics of non-selected (favorable profile) and selected (poor profile)
patients
Measurement
Total cholesterol (mmol/I.)
Systolic blood pressure (mm/Hg)
Bodv Mass Index (kg/W)
Smoking (°o)
Type A behavior (VSI)
Vital Exhaustion (MIVE)
State Anxiety (STAI)
Quality of I jfc (MII.Q)
Not selected [5£J
5.1 |1.2]
124.6 118.6]
25.5 13.11
6.3
208.3 |60.4]
3.9 [3.3]
35.6 |9.1]
192.1 |27.2]
1 "
81
81
81
80
80
80
75
77
Selected (50)
5.2 11.11
129 9 [21 .op
27.3 | 3 . 3 | "
18.3*
220.8 |56.9]
6.8 [5.3]"
40.8 [10.7]"
172.5 [29.4]»»
n
105
105
KW
104
KM
103
94
96
fr. VSI = Videotaped Structured Interview; MIVE = Maastricht Interview for
Vital Exhaustion; STAI = State Trait Anxiety Inventor)-; MII.Q = Multidimensional
Index ofljfe Quality; Ranges type A behavior 2-358; Vital Exhaustion 0-23;
State anxiety 20-80; Quality of life 35-245.
V < 10;*/> < 05;"*/>< .01
It should be noted that at the time the study was conducted, cholesterol values
were not always known at the time of hospital discharge. Cholesterol levels could
therefore not accurately be taken into account at the time of screening. Moreover,
the physiotherapist's judgement concerning signs of type A behavior was often
lacking in the screening questionnaire.
101
Chapter 5
There was no significant difference between poor profile patients and favorable
profile patients concerning medication. Of all poor profile patients, 54% received
cholesterol-lowering medication at baseline, as opposed to 46% of favorable
profile patients (Z> = .31). Ninety-three percent of the poor profile patients received
medication with an effect on blood pressure, versus 88% of the favorable profile
patients (p = .31).
Hypothesis 2. Selected poor profile patients do not benefit more from the
multifactorial intervention than non-selected favorable profile patients do
The distribution of poor profile and favorable profile patients among the
intervention and control group is reported in table 3. Baseline risk factor measures
and changes in those measures at follow-up for poor profile and favorable profile
patients in the intervention and control group are shown in table 4.
Table 3. Distribution of poor profile patients and favorable profile patients
among intervention and control group
Randomization:
PcKir profile
Selection:
Favorable profile
Intervention C.ontrol
/»= 114
« = 105 JV = 201
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Table 4. Baseline risk factor measures and changes in nsk factor measures for
poor profile and favorable profile patients in the intervention group and control
group
Outcome
Cholesterol
Systolic BP
BM1
Smoking
Type A
behavior
Vital
Kxhausnon
State anxiety
Quality of
life
Profile
Poor
Favorable
Poor
Favorable
Poor
Favorable
Poor
Favorable
Poor
Favorable
Poor
Favorable
Poor
Favorable
Poor
Favorable
Treatment
I
C
1
C
I
c:
I
c
1
c
1
c
I
c
I
c
I
c:
i
c
i
c
i
c
I
c
1
c
I
c;
i
c
a
49
43
35
41
51
43
35
40
49
45
33
38
53
44
36
42
53
44
36
42
53
43
36
42
47
41
33
40
48
42
35
40
Baseline (SO|
5.2(1.2)
5.0 |1.01
5.1 [1.3]
5.21101
134.2 |22.2|
128.0 119.6]
126.1 |19.8|
122.8 [18.51
27.1 [3.0]
27.2 |3.4]
25.6 |3.3|
25.4 |3.2|
10
5
3
2
218.9 [55.2|
223.0 J57.91
220.8 (55.2|
197.1 164.4]
7.1 [5.1|
5.4 |4.7)
4.2 |3.4|
3.6 |3.3]
40.8 112.1 ]
40.7 (9.8)
36.3 [10.9]
35.0 [7.7]
167.5 (32.7]
178.4 |25.11
192.3 [27.0]
191.4 [27.6]
Change from
baseline to
9-month follow-
-0.5 (1.3|
+0.1 |0.8]
•O.3[1.2|
-0.3 11.01
•2 3 118.9)
+8 5|16.9]
+4.7 115.3J
+ 7.1 |17.9]
+0.4 11.5]
+O7|1.5|
+O.2|12|
-0.0(1.2]
+ 7
+ 5
+ 3
+ 5
-68.9 (57.9|
-56.2 (67.6]
-80.9 [62.1]
•45.9 [54.21
1.6|6 4|
+ 1.0(4.6)
-1.0 |S.0|
•0.9 [2.9]
-0.9 110.7)
-2.0 (7.6]
-1.1 (7.2|
-l.7p.71
+ 15.9|26.4|
+4.4 |15.0|
+ 6.6 |23.6]
+9.4 [19.5]
f. 1 = Intervention group, C = Control group; BMI = Body Mass Index in kg/W;
Total cholesterol in mmol/L; Systolic blood pressure in mm Hg; Smoking = number of
smoking patients. Range of scores for each measurement: Type A behavior 2-385; Vital
exhaustion 0-23; State Anxiety 20-80; Quality of Ijfe 35-245.
For none of the eight nsk factors we studied were the effects of the intervention
in the group of poor profile patients significantly different from the effects in the
group of favorable profile patients (table 5). The interaction vanable Ciroup
Allocation (control or intervention) x Profile (poor or favorable profile) was not
significant for any of the outcome measures. The intervention effect was only
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•0.2
-5.8
-0.6
13.1
-2.0
-0.1
10.0
-0.7 / 0.2
-14.9 / 3.3
-1.4/0.2
-22.3 / 48.5
-4.9 / 0.9
-5.1 /4.8
• 1.2/23.0
.34
21
.14
.47
.17
.96
.08
168
169
164
175
174
161
165
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larger in poor profile patients compared to favorable profile patients concerning
quality of life, with a trend for significance.
Table 5. Results of ANCOVA on 9-month follow-up risk factor levels, analyzing
the interaction variable Group Allocation x Profile"
Outcome 0 95% CI (?) /> TV
(Cholesterol
Systolic BP
HMI
Type A behavior
Vital hxhausuon
State anxiety
Quality of life
OR_ 95% CI (OR) £ JV
Smoking U 4 0.24/12.8 .59 175
N«/». BMI = Body Mass Index in kg/m-; Total cholesterol in mmol/l.; Systolic blood pressure
in mm 11 ;^ Smoking - smoking: Yes vs. No Range of scores for each measurement: Type A
behavior 2-3H5; Vital exhaustion 0-23; State Anxiety 20-80; Quality of Ijfc 35-245.
•In the interaction variable Croup Allocation x Profile, Group Allocation was defined as
intervention group = 1; control group = 0; Profile was defined as poor profile = 1;
favorable profile = 0.
PoHt-hnc an;dysea: Do poor profile patients profit from the intervention as
compared with poor profile patients allocated to the control group? And do
favorable profile patients profit from the intervention as compared with
favorable profile patients in the control group?
A sub analysis with poor profile patients (not in table) showed that the reduction in
a number of risk factors was (significantly, or with a trend for significance) larger
in patients allocated to the intervention group than in patients in the control group,
l o r poor profile patients, the reduction in total cholesterol level was 0.4 mmol/L
larger in the intervention group than in the control group (ANCOVA, 95% CI: -
0.7 / -0.1, /•' (1, 84) = 4.98,/> = .03). The intervention group also showed a 7.1
mm I Ig larger reduction in systolic blix>d pressure compared to the control group
(95" o CI: -13.8 / -0.4, /• (1, 87) = 4.38, /> = .04), an 0.5 points smaller increase in
BMI (95% CI: -1.1 / 0.1, 1- (1. 84) = 2.88, /> = .09), a reduction in vital exhaustion
that was 2.0 points larger (95% CI: -4.2 / 0.3, J (I. 90) = 3.10,/> = .08), and an
improvement in quality of life that was 8.5 points larger in the intervention group
compared to the control group (95% CI: -0.2 / 17.1, / ( I , 84) = 3.78,/) = .06).
In a sub analysis with favorable profile patients, only type A behavior was reduced
to a larger extent in intervention patients compared with control panents, with a
difference of 32.9 points (95".. CI: 59.5 / -6.2,1- (1, 72) = 6.02,/) = .02).
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DISCUSSION
The use of screening in cardiac rehabilitation permits professionals to identify
patients with a poor profile of risk factors for CAD, who would derive maximal
benefit from risk factor modification, while excluding from treatment those who
rail to meet the risk cutoff. The results of this study show that it is possible to
develop a device to select patients with a poor and a more favorable risk factor
profile. The results of this study do not give direct support to the belief that a
behavioral intervention is more effective in poor profile patients than in favorable
profile patients. For eight CAD risk factors we analyzed whether poor profile
patients profited significantly more from the intervention than favorable profile
patients did, and apart from a trend for significance in the quality of life analysis,
this was not the case.
However, the results of the post-hoc analyses showed thar the patients with
unfavorable risk factor profiles seem to profit from the intervention, considering
the significantly larger reduction these 'poor profile" patients in the intervention
group showed in serum total cholesterol level and systolic blood pressure, while
BM1, vital exhaustion and quality of life were improved with a trend for
significance compared to poor profile patients who only received standard usual
care. Patients with relatively favorable risk factor profiles, on the other hand,
showed significantly larger reductions in Type A behavior - and not in any ot the
other reported risk factors or psychological variables - if they were allocated to the
intervention group compared to 'favorable profile' patients who received usual
care. The intervention thus seems to be particularly effective in reducing risk
factors and psychological distress in those who need it. For clinicians, referring
poor profile patients to a mulrifactorial intervention seems worth the effort,
because on average five out of the eight CAD risk factors we studied will be
reduced.
Several reasons may account for the lack of statistical evidence that the
intervention is more effective in poor profile patients than in favorable profile
patients. First and most importantly, the study size is limited because of the
restricted time span due to the grant scheme of the study, resulting in 21 months
of patient recruitment. Consequently, we may not have had enough power to
detect a significant interaction between intervention effect and risk factor profile.
In addition, most patients met our criteria that defined 'poor profile' patients,
which led to a relatively small group of 'favorable profile' patients. Second, our
study population showed relatively low risk factor levels at entry, which can partly
be explained by pharmacotherapy. Fifry-rhree percent of all patients were already
receiving cholesterol-lowenng drugs at entry in the study, while 90% received
medication with an effect on blood pressure. The risk factor levels of poor profile
patients were relatively low, even though they were higher than the risk factor
levels in the favorable profile patients. It is hard to reduce risk factor levels after a
mulrifactorial intervention if the levels arc already low. Perhaps statistical effects
would have been more convincing if the poor profile patients had been more
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distressed. Third, the statistical null finding might be explained by shortcomings in
the screening method, leading to overlap between groups. For one thing, the team
making the decision did not have full access to all relevant data. Cholesterol values,
for instance, were frequently unknown at die time mat die screening
questionnaires were evaluated for selection. This is illustrated by the fact that
favorable profile patients and poor profile patients had similar cholesterol levels at
entry. Since the patients themselves filled out the screening questionnaires, the
information that was derived from diem was often incomplete and inevitably
subjective. Moreover, screening by a team was a more or less subjective process as
well. It often involved a process of weighing up the pros and cons for each patient.
Is it useful to select CAD patients for a multifactorial behavioral group
intervention.'' Clinicians may feel that it is worth the effort, since patients widi a
poor CAD risk factor profile showed improvement in five out of the eight risk
factors we studied, whereas patients with a favorable CAD risk factor profile
showed improvement in only one. The low risk factor levels displayed by die
favorable profile patients in diis study cast doubt on the need of additional
mulnfactonal rehabilitation efforts in this group. Although in these patients
significant improvement was found in type A behavior, diis benefit might
disappear with improved screening of type A behavior. Screening of poor profile
patients need not be time-consuming and the screening procedure described in diis
study parallels standard hospital protocol activities. On die odier hand, die lack of
statistical evidence that screening pays off may argue against the screening and
selection of patients with a poor CAD risk factor profile for a multifactorial
intervention. Kvcn though the clinician may decide otherwise, we need to study the
use of screening for multifactorial interventions in larger study populations, and
preferably in more distressed patients. Furthermore, we need to find ways in which
the screening of CAD patients for mulndisciplinary interventions can be
optimized. The question is whether it is possible to select patients properly for an
intervention that aims to modify multiple risk factors. We do believe that
interventions should be tailored to specific groups of CAD patients. It seems
useful to select patients with elevated risk factor levels for an intervention to
reduce that particular risk factor. But in order to screen patients for mulnfactonal
rehabilitation programs, the program itself perhaps should be tailored first.
Selection of patients for a mulnfactonal intervention is complicated, and its
evaluation possibly even more so. How can we expect that a patient's cholesterol
level will drop as a result of the intervention if he or she was selected for diis
intervention because of - say - his or her hypertension?
In conclusion, although we did not find statistical evidence for die effecrivity of
preselection for multifactorial interventions in the main analyses, subgroup
analyses indicate that confining intervention programs to patients with a poor risk
factor profile may improve the efficiency of cardiac rehabilitation. Many patients
show such low nsk factor levels that improvement after an intervention program
can hardly be expected. One suggesnon for improvement of the current policy
may be that a short general multifactorial intervention is offered to groups of
patients with a poor nsk factor profile. Individual targets for each patient may dien
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be determined, which could be followed by tailored treatments for. e.g., reducing
weight or depression.
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GENERAL DISCUSSION
Is the eight-week multiple risk modification group intervention for patients with
acute myocardiai infarction (AMI) and coronary artery bypass grafting (CABG),
which was developed at the University Hospital Maastricht, effective in reducing
clinical risk factors and psychological distress? And is it useful to select coronary
artery disease (CAD) patients for this intervention? The aim of this thesis was to
answer these two major questions. Limitations of the study, which may put the
results in perspective, have been discussed in each of the separate previous
chapters of this thesis, and will not be repeated. Instead, in this last chapter the
results of the study will be briefly reviewed and tentative explanations as well as
implications of the findings will be discussed, taking into account the most
important restraints of the study. In addition, suggestions will be made for future
research.
Effects of the intervention on clinical risk factors and psychological distress
In a randomized controlled trial, we studied whether patients randomized to the
intervention group showed a larger improvement in psychological risk factors for
CAD and distress - i.e. type A behavior, vital exhaustion, depression (primary
outcome measures in the study), quality of life, and anxiety (secondary outcome
measures, appendix chapter 2) - compared to usual care control patients.
I-'urthermore, the effects of the intervention on reducing the clinical factors
cholesterol (primary outcome measure), body mass index, blood pressure and
smoking (secondary outcome measures - appendix chapter 3) were evaluated.
As for emotional distress, the intervention had no overall impact on vital
exhaustion, depression (measured by the Beck Depression Inventory), and quality
of life. Yet, patients with high vital exhaustion scores at baseline displayed larger
reductions of these scores after 9 months if they were allocated to the intervention
group as opposed to the control group. Trie intervention also had a favorable
impact on overall type A behavior and more specific on its components hostility
anil time urgency, both directly after the intervention and after 9 months. On the
other hand, state anxiety decreased to a larger extent in the control group than in
the intervention group at postintervention. Moreover, unwanted results were
found at postintervention concerning the percentage of patients with major
depression, favoring the control group. While the percentage of depressed patients
in the intervention group increased from 15% at baseline to 17% at
postintervention. the control group showed a reduction from 9% tot 5% at
postintc-rvention.
The intervention had no impact on the clinical factors body mass index, blood
pressure and smoking. Compared to the control group, patients in the intervention
group showed larger reductions in total scrum cholesterol level and IJ}L
cholesterol after 9 months, the effect of the intervention being stronger for
patients with the highest cholesterol levels at entry. On the other hand, HDL
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cholesterol increases were larger in the control group than in the intervention
group.
Is it useful to select coronary artery disease patients for a multifactorial
behavioral group intervention?
AMI patients and CABCJ patients who were selected through a screening
instrument which had been developed at the University Hospital Maastricht,
displayed more unfavorable nsk factor levels than patients who wen- not selected
through this screening instrument. We studied whether the patients with poorer
nsk factor levels found more benefit in the intervention than patients with more
favorable nsk factor levels. Light nsk factors were used as outcome measures, i.e.
total serum cholesterol level, systolic blood pressure, body mass index, smoking,
type A behavior, vital exhaustion, state anxiety, and quality of life.
We analyzed for these eight (IAD nsk factors whether the patients with relatively
poor nsk factor profiles profited significantly more from the intervention than
patients with more favorable nsk factor profiles, and this was not the case. In post-
hoc analyses, however, the group of patients with a more unfavorable risk factor
profile showed a (significant or with a trend for significance) favorable impact of
the intervention on five out of the eight studied nsk factors for (IAD. In the group
of patients with relatively favorable risk factor levels, on the other hand, the
intervention had a favorable impact on only one risk factor.
Explanations for the impact or lack of impact of the intervention
The results of this trial indicate that the behavioral intervention may result in
persistent favorable reductions in some psychological and clinical nsk factors.
Nevertheless, we may argue that the overall effect of the intervention was modest,
since a good few risk factors remained unchanged by the intervention efforts,
while other risk factors were increased or favorably altered to a lesser extent than
in the control group. Why was the intervention effective in reducing some risk
factors while other risk factors stayed behind, or were even altered negatively*'
Several tentative explanations arc discussed below, taking into account strengths
and weaknesses of the study.
The intervention was aimed at modifying multiple risk factors, and comprised
health education concerning the risk of smoking, elevated blood pressure, obesity,
unhealthy dietary habits and elevated cholesterol levels, lack of exercise and type A
behavior, while consequences of coronary artery disease such as depression were
discussed as well. During the relatively short intervention, explicit attention was
paid to the reduction of excessive consumption of dietary fat and its relation to
elevated serum cholesterol levels, altering type A behavior, and lack of physical
exercise. As much as two sessions were oriented towards altenng stress and type A
behavior. Following the cognitive social learning model - after the Recurrent
Coronary Prevention Project - cognitive, behavioral, environmental and
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physiologic aspects of the type A behavior pattern were treated. Although the
sessions had a predominantly health education nature, treatment of type A
behavior comprised discussion of basic cognitions frequently recognized in people
exhibiting type A behavior, and recommendations of behavioral drills. The
favorable impact of the intervention on type A behavior and cholesterol may be
explained by these relatively elaborate efforts. Conversely, the risk of smoking or -
for example - obesity was only briefly discussed, while vital exhaustion, depression,
anxiety and quality of life were addressed indirectly or briefly through health
education.
The negative findings concerning anxiety and depression are not so easy to
account for. Perhaps for some patients the program confronted them with their
disease, thereby interfering with their habitual coping strategy of denial. This
explanation remains, however, speculative, and deserves future research.
All patients participating in the study received regular medical check-ups, while
pharmacothcrapy was initiated if indicated. The overall impact of the intervention
on total scrum cholesterol level was not associated with altered prescriptions of
cholesterol-lowering medication, nor could this unequivocally be explained by
altered dietary fat consumption. The explicit attention paid to adverse effects of
elevated blood cholesterol may have encouraged patients in the intervention group
to take medication more conscientiously. Unfortunately, we have no means
available to study medication compliance in the study population.
The program had overall impact only on type A behavior and total serum
cholesterol levels. Strikingly, for several risk factors intervention effects were more
prominent at more unfavorable baseline risk factor levels. The program had a
positive impact on total scrum cholesterol and IJ)L cholesterol in patients
displaying relatively high baseline levels. Patients with higher baseline levels of vital
exhaustion found benefit in the intervention as well, if their reductions in vital
exhaustion are compared with patients in the control group. These findings suggest
that the program may have a favorable impact in patients who are distressed or
who display elevated risk factor levels, thus in those who need it. Scrutinizing the
risk factor levels of the patients teaches us that the study group was only
moderately distressed at entry of the study. Risk factors were only moderately
elevated as well, which may partly pertain to the fact that many patients received
ph.uinacother.ipy before they entered the study. The modest impact of the
intervention might partly be explained by these low entry levels. After all,
improvement is hardly feasible if patients show only moderately elevated risk
factors to begin with. I'uture studies should focus on more distressed study
populations, such as patients with a score of > 8 on vital exhaustion, a score of >
10 on HOI depression, or serum total cholesterol levels > 5.0 mmol/L.
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Although the number of women was considered too small to permit sub-analyses
concerning gender, we may argue that intervention effects for men and women
differ based upon previous literature and the limited data we have in the study. A
study on the impact of a psychosocial nursing intervention tor patients recovering
from myocardial infarction published by Frasure-Smifh et al. (Erasure-Smith ct al.,
1997) found a gender difference in mortality, favoring men. In our own study men
seemed to respond to the intervention more favorably than women as well,
particularly with regard to anxiety, quality of life and vital exhaustion, l'emalc
patients are older, and have been shown to have poorer quality of life after AMI,
CABG and PCI compared with male patients, which should be taken into account
in the clinical management of these patients, since female patients may need special
attention (Westin, Carlsson, Erhardt, Cantor-Graae, & McNeil, 1999). The recently
published Enhancing Recovery in Coronary Heart Disease (ENR1CI1D) study
seems to indicate as well that women tend to be better off in usual care than in a
special intervention (Writing Committee for the ENR1CHD Investigators, 2(X)3).
If so, the question remains why the intervention would be less effective for women
than for men.
L' /#<*/ <vwr
We compared the intervention group with a usual care control group. I'sual care
implies that patients received the medical care they would have received had they
not participated in the intervention study. Perhaps very effective usual care in this
population reduced the additive value of the intervention. Moreover, the usual care
provided to patients that are engaged in research, by definition deviates from
regular standard usual care, since patients are interviewed or fill out questionnaires
for the purpose of the data gathering process. In itself this may lead to
insurmountable dissimilarities with regard to the usual care that is provided under
normal, non-research circumstances. It is conceivable that patients in the control
group of the study brought about favorable changes in CAD risk factors as a result
of the 'extra' usual care per se, thereby reducing the differences between the
intervention and control patients.
The use of self-report measures might have hampered the validity of the results.
Among other things, this applies to the results we reported concerning type A
behavior. The Structured Clinical Interview was used to measure this behavior
pattern, which by itself is no self-report measure since psychomotor characteristics
are scored in addition to a self report structured interview. We observed, however,
that the answers patients provided in response to the cognitive questions in this
interview were not accompanied by likewise psychomotor characteristics. Since
these psychomotor scores are what distinguish the clinical interview from self-
report questions, we might question the validity of the results concerning type A
behavior. Since we did not use a second, non-self-report measurement device for
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type A behavior, we have no objective evidence that patients really changed their
type A behavior.
For practical reasons, we measured the outcome of the intervention study directly
after the intervention, and again after 9 months. Was the time of follow-up long
enough to permit us to find relevant effects? A study conducted by lisspers et al.
reported substantial changes in lifestyle behavior as well as profound effects on
long term cardiac events and mortality frequency after a behavioral oriented
program. The favorable effects in this study seem to increase after two years of
follow-up and become more pronounced over time (Lisspers, 2003).
And what about prc-selection?
The results of the screening study indicate that the screening instrument, which
was developed at the University Hospital Maastricht, was adequate to distinguish
AMI or ('ABC patients with more favorable nsk factor levels ('favorable profile*)
from patients with less favorable risk factor levels ('poor profile"). In the poor
profile- group, the intervention was effective in (significantly) reducing two out of
eight risk factors, while another three risk factors were improved with a trend for
significance. In the group of favorable profile patients, only one nsk factor was
significantly reduced after the intervention. Although this may be a clinically
relevant finding, statistically, the patients with more unfavorable risk factor levels
did not profit more from the intervention than patients with relatively favorable
risk factor levels. Several tentative explanations for this result are discussed below.
Since the time span of the study was limited due to the grant scheme of the study,
the study size is limited. Consequently, we may not have had enough power to
detect a significant interaction between intervention effect and risk factor profile.
The study is among the first, however, to make an attempt at developing and
studying effects of preselection for a mulrifactorial program for CAD patients,
and in doing so we hope to give an impulse on subsequent trials in future.
We discussed before that the study population generally showed low distress and
low risk factor levels. Because of this, patients that were selected as patients with
poor nsk factor profiles did in tact not display very unfavorable risk factor profiles.
Because of this, the contrast between *p(x>r risk factor profile' patients and
'favorable risk factor profile' patients was not large, though it was significant at a
statistical level; for instance, the mean score for vital exhaustion was 3.9 in the
favorable profile group, compared to 6.8 in the poor profile group. One may
wonder whether the differences were relevant at a clinical level. Statistical
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differences in the impact of the intervention between poor profile patients and
favorable profile patients may be hard to find because of this relatively small
difference between both groups.
Implications for clinical practice and suggestions for further research
Do the results warrant the routine implementanon of the intervention for patients
recovering trom AMI or CABG? We showed that a relatively short intervention
may lead to favorable reductions in type A behavior and total and 1.1)1. cholesterol
levels. The clinical relevance of the favorable findings may be illustrated by the fact
that favorable effects on total and LDL cholesterol were most profound in patients
with elevated levels, thus in those panents who need it. We also found .1 favorable
impact of the intervention on vital exhaustion in exhausted patients.
Notwithstanding the overall impact of the intervention on cholesterol and type A
behavior, however, we are inclined to say that the intervention should not be
implemented in general health care, because the intervention had unwanted effects
with regard to anxiety and depression. At postintervention, state anxiety decreased
to a larger extent in the control group than in the intervention group, and while the
percentage of patients with major depression in the intervention group (slightly)
increased, the control group showed a (small) reduction.
In the previous text we elucidated that much remains obscure concerning the
effective or ineffective components of the intervention. Cienerally, clinical trials
studying psychological interventions for CAD patients lack insight of the
mechanisms by which programs are effective, and this study is no exception to the
rule. For instance, was the impact of the intervention on cholesterol caused by
improved compliance to medication? Nowadays, adherence to medicine is
probably most important in controlling the levels of blood pressure and
cholesterol in patients with CAD. 1 f psychological interventions lead to improved
adherence to drug therapy, enormous profits may be realized. Especially since
compliance to medication is generally low (Brewer, Chapman, Brownlee, &
Lcventhal, 2002). Second, what is the mechanism behind the favorable impact of
the intervention on type A behavior? Assuming that the Structured Clinical
Interview produced valid data, the question remains whether dysfunctional type A-
cognitions were altered, or whether the behavior pattern was altered merely at a
behavioral level. Third, what is the mechanism behind the unwanted finding
concerning depression and anxiety in the study? More generally, how can we
accomplish reduced depression and anxiety in coronary patients? Clan depression
and anxiety in CAD patients be reduced by treating dysfunctional cognitions, i.e.
cognitive behavior therapy (CBT)? In the recently published ENRICUD trial, CBT
improved depression and social isolation in AMI patients (Writing Committee for
the ENRICUD Investigators, 2003). Generally, studies should examine the
effective and non-effective elements of psychological interventions.
The possible poorer overall outcome for women in this intervention needs
additional studying. Worse outcome for women compared to men in psychological
interventions has been reported in other studies (I'rasure-Smith ct al., 1997). A
possible harmful impact of interventions for women underlines the need for
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further research and the inclusion of adequate numbers of women in trials with
AMI and (-ABCJ patients. In general, however, it may be difficult to recruit women
for a psychological intervention. In this study, non-response was higher among
women than among men, which was reported in previous studies as well (Frasure-
Smith et al., 1997). Reasons for nonparticipation should be elucidated. In chapter
four of this thesis we discussed that more recently published studies seem to be
less effective in reducing mortality than older studies, and this was associated with
changes in the composition of the study samples. Psychosocial interventions used
to be aimed at favorably altering distress and risk factors in men of young age,
while nowadays the study populations consist of increasingly larger proportions of
older and female patients, partly due to changing inclusion criteria. Future
interventions should be modified in line with the altering patient populations at
which they are targeted. Intensive research into sex-specific treatments for post-
AMI and post-CAB(i women is needed. An as yet uncompleted and unpublished
study on the impact of a one year group stress management intervention
specifically for women with coronary heart disease indicates significant reductions
in stress and vital exhaustion and improvements in quality of life (Burcll, 2003).
Cardiac mortality is frequently used in effect studies of psychosocial interventions
to measure the outcome. After all, hard data are needed to demonstrate the value
of these programs. The trouble is that the chances of reaching reduced cardiac
mortality are diminutive. The rapid development of modern and more complex
technology has been accompanied by decreasing mortality and morbidity figures,
and these figures will continue to decrease in future. Many studies enroll thousands
of patients in order to show positive effects on mortality. Therefore, in more and
more trials a combined endpoint is used, like death, reinfarction, and stroke.
Perhaps we should abandon the idea of proving effectivity of psychosocial
interventions through figures on mortality impact. From HNRICHI), for example,
we cannot (as yet) claim that treatment for depression, even if effective, will
improve the chances of survival. Does this mean the intervention is not successful?
Reduced depression may be worth the effort even without demonstrable effect on
mortality or morbidity. We should consider a variety of psychological outcomes if
we measure treatment effects, and examine these from different perspectives.
And what about pre selection for multifactorial interventions? The results of the
effect study show that the impact of the intervention on vital exhaustion and
cholesterol level is more profound in patients with more unfavorable levels of
these risk factors at entry of the study. The aforementioned HNRICHD study
found larger treatment effects for patients with more severe depression than for
patients with low depression, which concurs with the results. The results of our
screening study, however, indicate that although pre-selecrion of patients with
relatively poor risk factor profiles may be easy, demonstrating the efficiency of pre-
selection for multifactorial interventions may not be easy. We did not find
statistical evidence for the effectivity of preselection for multifactorial
interventions in the main analyses, but subgroup analyses indicate that confining
intervention programs to patients with a poor risk factor profile may improve the
efficiency of cardiac rehabilitation. A major problem we encounter is that the
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intervention, for which we are developing tailored selection criteria, is not a
tailored program itself. It may be relatively easy to set up selection criteria for a
smoking cessation program, but what will be the criteria to select patients for a
multifactonal program-' Naturally, the most tailored interventions are individual
treatments, but these would raise health care costs. A suggestion may be that
patients with a poor nsk factor profile are offered a relatively short general
intervention comparable to the one presented in this thesis. During the program
individually tailored goals can then be set, which may be followed by tailored
treatments or even individual treatments.
CONCLUSION
The short behavioral intervention program evaluated in this study had positive
effects on total cholesterol, I.DI., type A behavior, and vital exhaustion. It had an
unwanted short-term effect on depression, anxiety, and HDI. cholesterol. The
observanon that the number of depressed patients slightly increased in the
intervention group raises serious concerns, despite the fact that this observation
was not paralleled by the scores on the BD1. Wide implementation of the program
requires the inclusion of effective methods to influence depression.
From the modest effects of the intervention on several risk factors we- may
conclude that each risk factor in a multi-factorial intervention needs its own
management. The positive impact of the intcrvennon was largest for the nsk
factors that received the most elaborate attention. Success of an intervention
correlates with the attention given to the separate nsk factors. Apparently more is
needed for many other risk factors than was provided in the intervention.
The favorable effects of the intervention on cholesterol and exhaustion were
particularly found in patients with unfavorable levels at baseline. In general, it was
observed that the intervention had little beneficial effects in patients with low nsk
factor levels. Prc-selecrion of patients with unfavorable nsk factor levels may
increase the effectiveness of behavioral intervention programs.
In our opinion, we should not stop short interventions altogether, since despite the
fact that long interventions generally show more favorable results, such
interventions are not so easy to implement in common hospitals. Moreover, long
duration of interventions may lead to low participation, while the infrastructure
necessary for implementation may not be feasible and costs will increase. This
study showed that several favorable results are achievable in a relatively short
penod of time. Other risk factors may need more elaborate attention than was
offered in the intervention. Moreover, effective components of interventions must
be studied in more detail.
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Summary
SUMMARY
Coronan- artery disease (CAD) is the leading cause of death in most developed
countries. Although mortality rates from CAD arc declining as a consequence of
prevention efforts and improved medical treatment after acute myocardial
infarction, the number of hospitalizarions from CAD is growing, since the patient's
life span is lengthened. Patients may. however, suffer more often from heart failure
when older. Secondary prevention of CAD is of major importance since many
patients survive their myocardial infarction. One approach to the secondary
prevention of CAD is by means of interventions aimed at behavior modification,
but successful interventions are usually lengthy and thereby expensive programs,
which may not be easily implemented in general health care. This thesis focuses
primarily on the effectiveness of a relatively short inten-ention that was based on
promising and successful - but length trials of the past decades.
In chapter 1 of this thesis, a review is described concerning the effects of mm
pharmacological intenenrions on risk factor modification in patients with coronary
artery disease. A MHDI.INK and PSYCHlit computer search was performed to
identify studies on non-pharmacological inten-entions aimed at modification of
smoking, serum cholesterol, physical exercise, type A behavior, hypertension or
body weight. In order to study the effects of risk factor modification by means of
non-pharmacological intcn-enrions in patients suffering from CAD, we scrutinized
every risk factor separately. The nsk of each of these factors on CAD is outlined
before relevant inten-ention studies arc presented. Hach factor was amenable to
modification through intenentions aimed at behavior change. Inicncniions aimed
at healthy lifestyles may stimulate smoking cessation rates, reduce elevated scrum
total and I.DI. concentrations and favorably modify type A behavior in CAD
patients. Moreover, reduction of coronary atherosclerosis has been reported after
intensive lifestyle and exercise inten-cntions, whereas exercise and type A behavior
intenentions may also lead to reduced CAD morbidity and mortality. As for
hypertension and obesity, studies aimed at secondary prevention are lacking. The
chapter concludes with an outline of limitations of the study and suggestions for
improvement.
The contents of the intenennon that is evaluated in this thesis were primarily
based on the methods of three major long term trials, the Recurrent Coronary
Prevention Project (Bracke & Thoresen, 19%), Project New Life (Hurell, 19%),
and the lifestyle Heart Trial (C)rnish et a!., 1990). During the period of February
1996 until November 1997, consecutive patients admitted to the I 'niversity
Hospital Maastricht were identified as eligible for the study. Patients included were
less than 70 years of age, had a confirmed diagnosis of acute myocardial infarction,
coronary artery bypass grafting, or both, and were able to participate in the regular
groupwise physiotherapy exercise program at the hospital. Patients were randomly
assigned to either the intenxntion or a usual care control group. Both groups
received usual medical care, while patients that were assigned to the inten-cntion
group enrolled into a multidisciplinary multiple risk modification program for
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prevention of CAD. Measurements were performed or collected (1) at baseline,
before the beginning of the intervention, which was approximately four weeks
after hospital discharge; (2) eight weeks later, immediately after the intervention
(postintervcntion); (3) nine months after termination of the intervention, which
was approximately one year after discharge. Two hundred-and-four patients gave
signed informed consent (106 were randomized to intervention group, 98 to
control group), which was 67% of all eligible patients. Of these patients, 20
dropped out, reducing the total number of patients in the study to 184.
I Effects of the intervention on outcome measures were assessed by means of
analyses of covariancc, using at least baseline scores as a covariate. After the main
analyses, an interaction variable was included in the analyses to check whether
intervention effects were different for patients with high or low baseline scores.
The effects of the intervention on primary psychological outcome measures type A
behavior, vital exhaustion and depression arc described in chapter 2, whereas
secondary outcome measures are added to the chapter as an appendix. Type A
behavior was measured by a Dutch version of the Videotaped Structured
Interview, Vital Kxhaustion by the Maastricht Interview for Vital Kxhaustion, and
depressed mood state was measured by the Beck Depression Inventory (BDI) and
the structured interview according to the Diagnostic and Statistical Manual of
Mental Disorders classification of Major Depressive Disorder (SCID). At baseline,
patients randomized to the intervention group had higher scores on vital
exhaustion and BDI depression than patients in the control group, whereas other
variables were comparable in both groups. The results showed that the reduction
in overall type A behavior at 9-month follow-up was significantly larger in the
intervention group than in the control group. Both hostility and time urgency, two
major components of type A behavior, were reduced to a larger extent in the
intervention group than in the control group at postintcrvcntion and at 9-month
follow-up. No significant intervention effects were reported on vital exhaustion,
although a significant interaction and subsequent sub-analysis of patients with
relatively high baseline scores showed that the intervention was effective in
reducing vital exhaustion in patients with relatively high baseline scores. The
intervention did not reduce depression as measured by the BDI. At
postintcrvcntion, major depression, assessed by the SCID, was significantly less
prevalent in the control group. With a trend for significance, the control group
showed a larger reduction of state anxiety at postintervention. The intervention did
not have an effect on quality of life. The results thus show that several
psychological risk factors can be reduced in coronary patterns through a relatively
short intervention aimed at behavior change and risk reduction. The positive
implication of these results is, however, restrained by the unwanted findings
concerning anxiety and major depression. Results are compared with relevant trials
from the past, and are discussed considering the contents of the program and
limitations of the study.
Chapter 3 describes the effects of the intervention on the primary outcome
measure scrum cholesterol. Clinical data were collected by a cardiologist who was
blinded to the patients' group allocation. Dietary fat consumption was measured
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through a self-report questionnaire, the "VUT-expres". Baseline demographic and
clinical characteristics of the intervention and control group did not differ. At 9-
month follow-up, total cholesterol was significantly reduced in the intervention
group compared to the control group. This effect was especially strong in patients
with high baseline total cholesterol levels. 11)1. cholesterol was also reduced to a
larger extent in the intervention group as compared to the control group. Again,
the effects were strongest for patients with high baseline 1.1)1. cholesterol. During
the 9-month period of follow-up, the intervention group had a larger increase of
prescribed dose of statins than the control group, and correcting the analyses for
this difference weakened the favorable effects of the intervention on 1.1)1. and
total cholesterol, although the favorable effects on total cholesterol still showed a
trend for significance. In patients with high baseline cholesterol levels, the
intervention had a beneficial effect on total and 1.D1. cholesterol irrespective of the
taking of statins. Although dietary fat consumption declined to a larger extent in
the intervention group than in the control group (with a trend for significance), the
change in dietary fat consumption was not found to contnbutc to the reduction in
serum cholesterol. Remarkably, reduced fat consumption during follow-up was
associated with reduced cholesterol levels only in patients with low baseline fat
consumption. An unexpected finding was a lower increase in 111)1. cholesterol in
the intervention group than in the control group. Results are discussed from the
perspective or the reliability of the dietary questionnaire and regression to the
mean. Adherence to medication regimen is considered as a mediating factor, li is
concluded that the positive indications of the findings are restrained by an
unexpected finding that the increase in HI)1. cholesterol was largest in the control
group.
The intervention had no impact on the secondary outcome measures smoking.
Body Mass Index and blood pressure. During the 9 months of follow up, the
intervention group had a larger decrease of prescribed dosage of ACH inhibitors
and Calcium antagonists. If the analyses were corrected for change in prescribed
dosage from baseline to follow-up, the effects of the intervention on systolic blood
pressure reached a trend for significance in favor of patients in the intervention.
Recurrent morbidity rates in this study were low during follow-up, and none of the
patients died of a cardiovascular cause. Generally, many studies suffer from a lack
of power to investigate effects on mortality, and studies are often combined in a
meta-analysis in order to increase power. In chapter 4, the influence of secular
trends on the effects of psychoeducational intervention studies arc investigated.
The following quesnons arc studied: 1) Are the reported effects of
psychoeducational interventions on cardiac mortality rates and recurrent infarction
rates stable over urncr' 2) If not, may this change be explained by a) changing
cardiovascular mortality rates and changing rates of recurrent myocardial
infarction, b) altering characteristics of study populations in the course of timer"
The data of the most recently published meta analysis concerning the effects of
psychoeducational programs on cardiac mortality and morbidity rates in CAD
patients were used (Dusseldorp ct al., 1999), which included only relatively high-
quality studies. We additionally performed a MIi.DI.lNI-. and i'SYCJNI'O
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computer search to identify studies published after 1998. Forty-five studies
concerning the effects of psychoeducahonal programs for CAD patients were
included in the study. In the 11 studies reporting 12-month recurrent myocardial
infarction rates, the year of publication of the studies does not correlate with the
effect of the interventions on the rate of recurrent infarctions. In the 8 studies
reporting 12-month cardiac mortality rates, the year of publication of the studies
correlates negatively with the odd ratio's of cardiac mortality rates; thus, older
studies reported larger favorable effects of interventions on cardiac mortality rates
than more recently published studies. Although mortality rates seem to decline
over time in these studies, the decline is not significant, and the lower mortality
rates in the studies are not associated with the smaller effects of the interventions
on mortality. The smaller effects on mortality are, however, associated with mean
age of the study populanon, which is older in more recent studies. We studied
changes in population characteristics in 45 studies, and it was found that CAD
patients included in more recently published studies are older than patients in older
studies. Furthermore, more recently published studies are characterized by a higher
percentage of women compared to older studies. The changing population
characteristics are associated with changing inclusion criteria in the studies. The
results show that mcta-analytic studies are losing their external validity. We discuss
that the changing patient characteristics may affect the scope of the interventions.
Interventions used to be designed for and directed at the improvement of health
status in young men, whereas studies include increasingly older and more often
female patients.
Professionals stress the need for tailored programming in cardiac rehabilitation,
but studies that evaluate the merits thereof are lacking. The primary aims of
chapter 5 were to examine the quality of a screening device that had been
developed to select patients for a multifactorial intervention, and to determine
whether selected patients profited more from a multifactorial intervention than
patients, who did not meet the selection criteria. All 204 patients included in the
effect study were screened in order to select patients with an unfavorable risk
factor profile for coronary artery disease. The hypothesis that patients with a poor
profile would profit more from the intervention than patients with a favorable
profile was tested by including an interaction variable in the analyses that were
used to compute the effects of the intervention on clinical and psychological risk
factors. Selected patients showed more unfavorable risk factor levels than
unselected patients. The interaction variable was not significant for any of the eight
studied risk factors, indicating that the effects of the intervention did not differ
between those with or without a poor risk factor profile. A post-hoc sub analysis
with poor profile patients showed that for this group, the intervention was
(significantly) effective in reducing cholesterol and systolic blood pressure levels,
while favorable effects on Body Mass Index, vital exhaustion and quality of life
reached a trend for significance. A sub analysis with favorable profile patients
showed that in this group the intervention was significantly effective in reducing
one risk factor, i.e. type A behavior. The use of preselection for mulnfactonal
interventions should be studied in larger, and preferably more distressed, study
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populations. In sum, although we did not find statistical evidence for the eiYectivitv
of pre-selecrion for mulrifactonal interventions in the mam analyses, subgroup
analyses indicate that confining intervention programs to panents with a poor nsk
factor profile may improve the efficiency of cardiac rehabilitation.
In the general discussion the results of the study are briefly reviewed and tentative
explananons for the impact (or lack thereof) of the intervention and prc selection
are discussed, taking into account the most important restraints of the studv.
Implications of the findings for clinical practice are discussed and suggestions are
made tor future research. Among other things, it is suggested that future studies
should examine the effective and non-effective components of psychological
interventions in more detail.
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SAMENVATTING
Han- en vaatziekten zijn de belangnjkstc dixxisi>orzaak in Ncderland, zoals in dc
meeste onrwikkelde landen het geval is. Met name coronarialijden is
veranrwoordelijk voor een groot stcrftepercentage. Hoewcl de sterfte aan
ischemischc hartziekten dalcndc is ten gcvolgc van inspanningcn met bctrckking
tot prevenrie en verbcterde bchandcling van het acute nwxard infarct, nccmt hct
aantal zickenhuisopnamen ten gcvolgc van ischcmische hart/iekten nog steeils
gestaag toe. Dit is mede te danken aan de vcrgrij/ing en aan hct t'eit dat paticnten
door verbcterde medischc kennis langcr in leven worden gehouden. Hct aantal
parienten met hartfalen ten gcvolgc van ccn ccrder doorgrmaakt infarct nccmt
daarmec echtcr toe. Secundairc prevenrie van coronarialijden is van groot belung,
aangczicn veel panenten tcgcnw(x>rdig hun myocard infarct overlcven. Ken van de
benadcringen voor secundairc prevenrie van coronanalijdcn bestaat 1111 hct
aanbicden van intervenries die gencht zijn op gedragsverandering. Intcrvcnries die
succes boeken in het vcrmindcrcn van risicofactorcn en psychosocialc
problcmariek zijn echtcr vaak langdung en dicntcngevolge wcinig motivcrend voor
dc patient, duur, en onpraktisch, waardoor implcmcntatic in de algemcnc
gczondhcidszorg wordt bemoeilijkt. In dit proefschnft ligt de nadruk op dc
effecnviteit van cen relaticf korte intcrvenrie waarvan dc inhoud is gcbascerd op
veelbelovcndc en effecnev - maar langdung - studies van dc afgclopen deccnnia.
In hcx>fdsruk 1 van dit proefschnft wordt ccn overzicht gegeven van studies naar
dc effecrivitcit van niet-farmacologische intcrvenrics op vcrandcring van
risicofactorcn bij parienten met coronarialijdcn. Dc literatuurbestanden
MED1.INK en PSYCHlit wcrden systemarisch door/ocht om studies tc
idenriheeren bcrretrende nict-farmacologischc intcrventics gencht op vcrandcring
van rookgedrag, cholcsterolgehalte, lichaamsbeweging, type A gcdrag, hypcrtensic
of lichaamsgewicht. Om de effecten van nict-farmacologische intcrventics op
vcrandcring van risicofactorcn bij parienten met coronanalijdcn te hestudcren,
werd clke nsicofactor apart in detail onderzocht. Alvorcns de rclevantc
intcrventiestudies worden beschreven, wordt cerst hct risico geschetst dat elk van
deze factoren heeft op coronarialijdcn. Kike nsicofactor bleek vcrvolgcns
ontvankelijk tc zijn voor verandenng door middel van intervenries die zijn gencht
op gedragsverandering. Intervenries gcricht op ecn ge/onde lecfsnjl kunncn hct
stoppen met roken bevordercn, vcrhoogde concentratics totaal- en 1,1)1,
cholesterol in het bloed vcrlagcn, en n,pe A gcdrag bij parienten met
coronarialijden ten gunste beinvlocdcn. Bovcndicn wordt cr melding gemaakt van
een gunsngc bcinvlocding van het atherosclerorische proces na interventies gencht
op intensievc verandenngen van leefsrijl en lichaamsbeweging. Intcrventics gencht
op bevordering van lichaamsbeweging en verandenng van type A gcdrag zouden
ook kunnen leiden tot afname van morbiditcit en mortaliteit ten gcvolgc van
ischemische hartziekten. Studies gencht op secundairc preventic van hypertensie
en overgewicht bij deze paricntengroep wcrden nict gevonden. Het hoofdstuk
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worth afgesloten met cen bespreking van beperkingen van de studie, alsmede
suggesties voor verbctenng.
Dc intervenrie die in dit proefschrift wordt geevalueerd is voornamelijk gebaseerd
op de mcthoden van drie belangrijke langduhge studies, nl. het 'Recurrent
Coronary Prevention Project' (Bracke & Thoresen, 1996), 'Project New Life'
(Burell, 1996), en de 'Ufestyle Heart Trial' (Ornish et al., 1990). Van alle
achtereenvolgende patienten die gedurende de periode tussen februari 1996 en
november 1997 werden opgenomen in het Academisch Ziekenhuis Maastricht
(AZM), werd beoordeeld of zij in aanmerking kwamen voor deelname aan de
studie. Patienten werden geincludeerd als ze jonger waren dan 70, een diagnose
hadden van een acuut myocard infarct en / of een coronairc bypass operatie
hadden ondergaan, en in staat waren deel te nemen aan de reguliere
groepsfysiotherapie in het AZM. Patienten werden aselect toegewezen aan ofwel
de interventie, ofwel een controlegroep. Beide groepen ontvingen standaardzorg,
terwijl patienten die waren toegewezen aan de intervennegroep aanvullend een
multidisciplinair programma kregen aangeboden ter prevenrie van coronarialijden,
gencht op verandcring van nsicofactoren. De meringen werden uitgevoerd 1) voor
aanvang van hei programma, ongeveer vier weken na ontslag uit het ziekenhuis
(voormeting); 2) acht weken later, onmiddellijk na de intervenrie; 3) negen
maanden na becindiging van de interventie, hetgeen ongeveer een jaar na ontslag
was. Twechonderdvier patienten gaven toestemming (waarvan er 106 aselect
werden locgcwczen aan de intervennegroep en 98 aan de controlegroep), hetgeen
67% van alle in aanmerking komende patienten was. Van deze patienten trokken
20 patienten zich terug, waardoor het totale aantal patienten in de studie daalde
naur IH4.
Hffecten van de interventie op de uitkomstmaten werden berekend door middel
van covariantie analyses, waarbij in elk geval de voormering werd gebruikt als
covariaat. Na de hoofdanalyses werd een lnteractievariabele toegevoegd om te
bekijken of er vcrschillen waren in effecten tussen patientcn met hoge of lage
scores op de voormeting.
De effecten van de intervenne op de primairc psychologische uitkomstmaten type
A gedrag, vitale uitputting en depressie worden beschreven in hoofdstuk 2, terwijl
de sccundaire uitkomstmaten aan het hoofdstuk zijn toegevoegd als bijlage. Type A
gedrag werd gemeten d.m.v. een Nederlandse versie van het 'Videotaped
Structured Interview', Vitale litputring door middel van het Maastnchtse
Interview voor Vitale Uitputting, en depressieve stemming werd gemeten met de
Beck Depression Inventory (BD1) en het gestructurecrde interview volgens de
DSM 111 R classiticatic van een Depressieve Stoornis (SC1D). Bij de voormering
hadden patienten die aselect waren toegewezen aan de interventiegroep hogere
scores dan patienten in de controlegroep met betrekkmg tot vitale uitputting en
depressie zoals gemeten door de BD1, terwijl de andere vanabelcn in beide
groepen vergelijkbaar waren. De reductie in de totaalscore voor type A gedrag was
na 9 maanden in de intcrvennegroep significant grotcr dan in de controlegroep.
Zowel vijandigheid als ti|dsdruk, twee h<x>fdcomponenten van type A gedrag,
d.uLlen sterker in de inten ennegroep dan in de controle groep; zowel bij de eerste
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nameong aJs na 9 maanden. Kr werdcn geen sigruficante intervenrie cffecten
gevonden met betrekking tot vital? uirpurang. VX'el werd door een significance
interacae en ecn daarop volgende sub-analyse van paricnten met rclatief hoge
uirputtingsscorcs op de voormeang aangetoond, dat de intervenrie leidde tot ccn
verlaging van utale uirpurang bi) pauenten met rclatief hoge scores op dc
voormcting. Kr werden gccn effected gevonden met bctrckkmg ti>t dcprcssic zoals
gemcten door dc BDI, maar hct percentage pauenten met ccn dcprcssicvc scoornis
zoals gemcten door hct SCI I) interview lict op de cerste namcting ccn vootxlecl
zien voor de controlegrocp ten opzichte van dc intcrvcnticgrocp. Met ecn trend
voor significannc was direct na dc intcrventie in dc controlcgrocp ook ecn grotcrc
afname tc zien in dc sccundaire uitkonistma.it tocstandsangst, terwijl cr gccn
cffecten werdcn gevonden met betrekking tot kwaliteit van leven. Dc rcsultatcn
van dc srudie latcn dus zicn dat vcrschillendc psychologische nsicofactorcn bij
paricntcn met coronarialijdcn kunncn worden vcrlaagd door middcl van ecn
relanef korte lntervcnuc gencht op gcdragsvcrandcnng en nsicovcrlagmg. Dc
positicvc implicarie van dezc resultaten wordt center beperkt door dc negaticve
bevindingen met betrekking tot angst en dcpressieve stoornis. Dc rcsultalcn
worden vergelcken me! rclevantc studies uit het verlcdcn, en worden
bediscussicerd in hct hcht van dc inhoud van hct programma en de bcperkingcn
van de srudie.
In hootdsruk 3 worden dc cffcctcn van de intcrventie beschreven op de primairc
uitkomstmaat cholesterol. Kiinischc data zi|n verzanield door ecn tardioloog die
was geblindecrd m.b.t. dc groepsu>ewijzing van dc paricntcn. Vctconsumpric wcrd
gemcten door middcl van een zelfrapportagc vragcnlijst, dc "\'I*.T exprcs". Kr
waren op dc voormcting gccn vcrschillcn lusscn de lnicrvcnticgrocp en
controlegroep met betrekking tot demografische en kluusche kenmcrken. Na 9
maanden was hct totaal cholesterol in de intervenricgrocp significant gcdaald
vergelcken met dc controlegrocp. Dit effect was met name aanwe/ig l)i| patienicn
met een hoog totaal cholcstcrolgchaltc op dc voormcting. Dc dating in 1.1)1.
cholesterol was ook groter in dc intcrvenriegrocp dan in dc controlegrocp, en ook
deze effectcn warcn hct stcrkst bi| pauentcn met hogc I.DI. waarden op dc
voormcting. Gedurcndc dc 9 maanden follow up was cr sprake van ccn grotcre
verhoging van dosenng van statines in dc intcrvcnticgrncp dan in dc
controlegrocp. Als dc analyses werdcn gccorngccrd voor dit vcrschil werdcn dc
gunsuge effectcn van de intcrventie op l.DL en totaal cholesterol cnigszins
afgezwakt, hocwcl dc gunsuge effecten op totaal cholesterol nog aanwe/ig warcn
met een trend vixir significannc. Bij paricntcn met hogc cholesterolwaardcn op de
voormcting had de intervenrie ccn gunsug effect op totaal en 1.1)1. cholesterol
ongeacht doscring van statines. Hocwel vctconsumpue in de intcrvcnticgrocp ccn
grotere daling bet zien dan in dc controlcgroep (met ccn trend voor significannc),
was dc verandering in vctconsumpric met gcrelatcerd aan dc rcductic van hct
cholesterol. Mcrkwaardig genocg was slcchts bi) pancntcn met ccn lagc
vetconsumprie op dc voormcting afgenomen vctconsumpric gcassociccrd met
afgenomen cholcstcrolnivcaus. lien onverwacht rcsultaat was dat dc sujging van
HDL cholesterol groter was in dc controlegrocp dan in dc intcrvcnticgrocp. Dc
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rcsultaten wordcn besproken in hct licht van de bctrouwbaarheid van de
vocdselvragcnlijst en regressie naar hct gemiddelde. Therapietrouw met betrekking
tot medicaae wordt besproken aJs mogelijke medierende factor. lir wordt
gcconcludcerd dat dc positieve implicaties van de bevindingen worden beperkt
door dc onvcrwachte bcvinding dat de tocname in HDL cholesterol groter was in
de controlegroep dan in de interventiegroep.
Dc intcrvcntic had geen invloed op dc secundairc uitkomstmaten roken, quetelet-
lndcx en bloeddruk. Ciedurende de 9 maanden van follow-up was er sprake van
ecn grotcre afnamc in voorgeschreven doscring ACE remmers en Calcium
antagf>nistcn in dc intcrvcnticgroep vergcleken met de controlegroep. Als in de
analyses wcrd gccontrolecrd voor verandenng in voorgeschreven dosering van
voormcting tot follow-up, bereiktcn de effecten van de intervenrie op systolische
bloeddruk een trend van significant^ ten voordelc van patienten in de
intcrventiegrr>cp.
In dc studic was dc morbiditcit gedurendc follow-up laag, en niet een patient
overlccd ten gcvolge van een cardiovasculaire oorzaak. Veel studies hebben
onvoldocndc power om effecten van intcrventies op mortalitcit te onderzoeken,
met als gcvolg dat studies vaak wordcn samengevocgd in ecn meta-analyse zodat
dc power om bcpaalde effecten tc bcrekenen toeneemt. In hoofdstuk 4 wordt de
invloed van trends besmdeerd die zich dc afgclopcn jaren in studies hebben
voltrokkcn op dc effecten van psycho-cducaticve intcrvcntiestudies. Dc volgende
vraagstellingen wordcn bestudcerd: 1) Zijn dc gcrapportccrde effecten van psycho-
cducatie intcrvcntics op cardiovasculairc mortalitcit en het aantal terugkerende
infarctcn stabiel gcblcvcn dc afgelopcn decenniad 2) Indicn dit met hct geval is, kan
.dczc XMaHsliyaq*' J.i\V MW&l'VT OeTlhaliYU' d'oof a) toencmend'c of" afnemende
cardiovasculaire mortahteit en veranderend aantal terugkerende intarcten
gedurende dc afgclopcn decenniad b) vcrandcrendc kenmerken van
studiepopulaties gedurendc dc afgclopcn decennia? Voor dczc srudie gcbruiktcn
we de gegevens van de mccst recent gepubliceerdc meta-analyse betreffende
effecten van psycho educatic programma's op cardiovasculaire mortalitcit en
morbiditcit in patienten met coronanalijden (Dusseldorp ct al., 1999), waann
slcchts studies werden gcincludccrd van rclatief hoge kwaliteit. Aanvullend werden
dc liicratuurbcstanden MKD1.INK en PSYCH lit systcmansch door/ocht om
studies tc idennticcrcn die zijn gcpubliccerd vanaf 1998. Yijfenveertig studies
werden geincludccrd in dc studic, die alle betrekking hadden op de effecten van
psycho-cducatie programma's voor paticnten met coronanahjden. In de 11 studies
die het aantnl terugkerende infarctcn na 12 maanden rapportecrden, correlccrt
puhlicaticjaar van dc studic niet met het effect van dc intcrvcntics op de
hoevcelhcid icrugkerende infarctcn. Acht studies rapportercn 12-maands
cardiovasculaire mortalitcitscijfers, en in dezc studies correlccrt publicaticjaar
neg.uief met de odds ratio van cardiovasculaire mortaliteit; oudcrc studies
rapportercn dus grotcre gunsrige effecten van interventies op cardiovasculaire
mortaliteit dan nicer recent gepubliceerdc studies. Hoewel mortalitcit li|kt te dalcn
in dczc acht studies is dczc daling niet significant, en is dc dalende mortaliteit met
gecorrelccrd aan dc klcincrc effecten van de intcrvcntics op mortalitcit. Dc klcincre
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effecten op mortabteit gaan echter gepaard met con toenemende gcrruddclde
leefnjd \-an de studiepopulaoe in recentere studies. We besrudeerden verandenngen
in populaaekenmerken in 45 studies, en vonden dat pancnten met coronanalijden
die in recentere studies werden ge'includeerd gcmiddeld ouder zijn dan pancnten in
oudere studies. Bovcndien worden recente studies gckenmcrkt door ecu linger
percentage vrouwen in vergeliiking met oudere studies. Lie vcranderrnde
kenmerken van de popularie zijn gecorrcleerd aan veranderende incliisiecritcna in
de studies. Deze resuJtaten laten zien dat de externc validiteit van meta analyses
ameemt. We bediscussieren dat de vcrandcrende pancntkcnmcrkcn hct draagvlak
van de mtervenries aantast. Intervenries werden ontworpen voor en gencht <>p de
vcrbctenng van de gczondheid van )onge mannen, terwijl in studies steeds vaker
oudere en vrouwelijke patienten worden ge'includeerd.
Deskundigen benadrukken de noodzaak van zorg op maat in de cardiorcvalidatic,
maar vcx>ralsnog ontbreken de studies die de vcrdiensten hicrvan aantonen. I let
belangnjkste docl van hootdstuk 5 was om de kwaliteit te onderziK-ken van een
screeningsinstrument dat was onrwikkeld om pancnten vooraf tc sclccteren voor
een multiractorie'le interventie, en om te bepalen of aldus geselecteerde patienten
meer baat hadden bij een multifactonelc intcrventic dan patienten die met
voldeden aan de selectiecnteria. AUe 204 panentcn die werden gcincludccrd in
bovenbeschreven cftcctstudic werden gescrcend met als doel patienten tc
sclecteren met een ongunstig risicoproficl v(H>r coronanali|den. De hypothese dat
patienten met een slccht profiel mecr baat zouden hebben van de interventie dan
patienten met een gunstig profiel werd bestudeerd door een interactievanabele in
de covariantie analyses op te nemen waamiee de effectcn werden bestudeerd van
de interventie op klinische en psychologische nsicofactorcn. De geselecteerde
patienten bleken inderdaad ongunstiger niveaus van risicot'actorcn tc hebben dan
niet geselecteerde patienten. De interactievanabele was met significant in de
analyses van de acht bestudeerde nsicofactorcn, hetgeen impliceert dat dc effecten
van de interventie met verschilden tussen pancnten met of zondcr relatief
ongunstig risicoproficl. Ken post-hoc uitgevoerde sub-analyse met patic'nicn met
een relancf ongunsng nsicoprofiel toondc aan dat dc interventie voor deze groep
patienten (significant) effecticf was in het reduceren van het cholesterol en
blocddruknivcau, terwijl gunstige effecten met betrekking tot c|iietclet index, vitale
uitputnng en kwaliteit van leven een trend voor significanhe bereikten. 1 en sub-
analyse met patienten met gunstig nsicoprofiel toonde aan dat de intcrventie in
deze groep patienten significant effecrief was in het reduceren van een nsicofactor,
te weten type A gedrag. Het gcbruik van prc-sclcctic van patienten voor
mulrifactonele interventics moct bestudeerd worden in grotere en liefst zickcre
studiepopulanes. Hocwcl in de hoofdanalyses geen statistisch bewijs werd
gevonden voor de cffcctivitcit van pre-selectie v(K>r multifactonelc interventics,
duiden de subgroep analyses crop dat de cfficientie van cardiorcvalidatic mogehjk
kan worden verhoogd door deze te beperken tot patienten met coronanalijden die
een slecht nsicoprofiel hebben.
In de algemene discussic tcnslotte worden de resultaten van dc studie kort
samengevat en worden hypothetische verklanngcn voor het effect van de
145
Samenvarang
intervenrie (of het gebrek daaraan) en pre-selecrie besproken, waarbij de
belangrijkste beperkingen van de studie in ogenschouw worden genomen.
Implicaries die de bcvindingen hebben voor de klinische prakrijk worden
besproken, en er worden suggesries gedaan voor toekomsrig onderzoek. Rr wordt
onder mecr besproken dat toekomsrig onderzoek meer aandacht zou moeten
hebben voor het bestuderen van effecrieve en niet-effecrieve elementen van
psychologische interventies.
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